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Abstract 
Obtaining insights into the catalytic function of enzymes is an important area of research 
due to their widespread applications in the biotechnology and pharmaceutical industries. 
Among these enzymes, the aminoacyl-tRNA synthetases (aaRSs) are known for their 
remarkable fidelity in catalyzing the aminoacylation reactions of tRNA in protein 
biosynthesis. Despite the exceptional execution of this critical function, mechanistic details 
of the reactions catalyzed by aminoacyl-tRNA synthetases remain elusive demonstrating the 
obvious need to explore their remarkable chemistry. During the PhD studies reported in this 
thesis the mechanism of aminoacylation, pre-transfer editing and post-transfer editing 
catalyzed by different aaRS have been established using multi-scale computational 
enzymology. 
In the first two chapters a detailed information about aaRS and the addressed questions 
was given in addition to an overview of the used computational methodology currently used 
to investigate the enzymatic mechanisms. The aminoacylation mechanism of threonine by 
Threonyl-tRNA synthetases, glutamine by Glutaminyl-tRNA synthetases and glutamate by 
Glutamyl-tRNA synthetases have been clearly unveiled in chapter 3 and 4. Also, valuable 
information regarding the role of cofactors and active site residues has been obtained. While 
investigating the post-transfer editing mechanisms, which proceed in a remote and distinct 
active site, two different scenarios were experimentally suggested for two types of threonyl-
tRNA synthetase species to correct the misacylation of the structurally related serine. We 
explored these two mechanisms as in chapters 5 and 6. Moreover, the synthetic site in which 
the aminoacylation reaction is catalyzed, is also responsible for a second type of proofreading 
reaction called pre-transfer editing mechanism. In chapter 7, this latter mechanism has been 
  VI 
elucidated for both Seryl-tRNA synthetases and Isoleucyl-tRNA synthetases against their 
non-cognate substrates cysteine and valine, respectively. In chapter 8, an assessment 
QM/MM study using a variety of DFT functionals to represent the chemically active layer 
in aminoacylation mechanism of the unnatural amino acid ß-Hydroxynorvaline as catalyzed 
by Threonyl-tRNA synthetase has been carried out. Overall, it was found that substrate-
assisted mechanisms are a common pathway for these enzymes. 
One important application of such information is to establish the criteria required for 
any candidate to inhibit the catalytic functions of aaRS, which was applied in chapter 9 to 
screen potential competitive inhibitors able to efficiently block the bacterial Threonyl-tRNA 
synthetases.  
The investigations reported herein should provide atomistic details into the fundamental 
catalytic mechanisms of the ubiquitous and ancient aaRS enzymes. Consequently, they will 
also help enable a much-needed deeper understanding of the underlying chemical principles 
of catalysis in general. 
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1.1 Introduction 
Numerous biochemical reactions take place in every cell in all living organisms. The 
feasibility of such biochemical reactions might be kinetically challenging but enzymes are 
catalyze these reactions through tremendous rate enhancements.1 While many strategies are 
employed by enzymes, providing stabilization to the transition state lowering the energy 
barrier is central to enzymatic catalysis.2-3 For instance, the phosphodiester bond, the 
backbone linkage of DNA and RNA molecules, is exceedingly resistant to spontaneous 
hydrolysis.4 The half-life scission time of its hydrolysis is estimated to be 30 million years,5 
but in the presence of metallonucleases the hydrolysis rate is accelerated dramatically by a 
factor of 1017.6 Understanding the incredible catalytic power of enzymes has been a goal of 
chemical and biochemical research for the past century.7 Considerable progress has been 
achieved; however, deeper insights into the source of the catalytic power of enzymes8 and 
the roles of enzymes associated in different biological processes and diseases are still much 
in demand. This, in turn, will open many novel routes into the development of many 
biological and biotechnological applications.9-10  
 
Figure 1.1. The cellular synthesis of an aminoacyl-tRNA and its role protein biosynthesis. 
 
aaRS 
aatRNA
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The aminoacylation process catalyzed by the ubiquitous aminoacyl-tRNA synthetases 
(aaRS) is a critical step in faithful translation of genetic information into proteins.11 High 
accuracy in translation is essential for preserving cellular function.12 Additionally, aaRSs 
have been associated with viral assembly, chlorophyll biosynthesis, oxidative stress response 
and antibacterial therapy; however,  it is most known for its pivotal role in protein 
biosynthesis.13-14 The family is split into two main classes according to distinct structural and 
mechanistic elements.15 
Specifically, aaRSs catalyze the attachment of an amino acid to its corresponding 
transfer RNA (tRNA), the molecule responsible for providing amino acids to the elongating 
polypeptide chain, in the form of aminoacyl-tRNAaa as shown in Figure 1.1. The enzyme 
performs this role with outstanding specificity with an error rate of less than 1 in every 10 
000 reactions.16 This accuracy is vitally important, as errors in aminoacylation can lead to a 
variety of physiological and pathological problems including misfolded proteins, non-
functional enzymes, cancer, and possibly cell death.17-18 
AaRSs catalyze the aminoacylation reaction via a two-step process: activation and 
acylation. In the activation step, the aaRS aligns its cognate amino acid together with 
adenosine triphosphate (ATP) in an appropriate orientation for the carboxylate of the amino 
acid to attack the α-phosphate of the ATP, leading to the formation of aminoacyl-AMP 
accompanied by the release of the inorganic pyrophosphate. Subsequently, the acylation 
reaction takes place where the aaRS catalyzes the aminoacyl transfer onto its cognate tRNA, 
Scheme 1.1.19  
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Scheme 1.1. General two-step aminoacylation mechanism of aaRS. 
 
As a result of the large sizes of the tRNA molecules, it has been found to be simple for 
each aaRS to identify its cognate tRNA.20 However, due to significant structural similarity 
between the amino acids, it is much more complicated for aaRSs to select their cognate amino 
acids from a pool of structurally and chemically similar molecules.21 As a result, aaRSs have 
evolved numerous strategies to ensure high fidelity in catalysis and accordingly faithful 
translation of the genetic code.22 Through a size-base discrimination mechanism, the 
aminoacylation site of an aaRS recognizes its cognate substrate and rejects non-cognate 
ones.23 For example, cysteinyl-tRNA synthetase shows impressive fidelity in substrate 
recognition and consequently, aminoacylation24 with 108 fold selectivity.23  
Additionally, the majority of aaRSs possess an ability to edit mis-aminoacylation, either 
in the aminoacylation site through pre-transfer editing or by using a separate catalytic editing 
site through post-transfer editing, Figure 1.2.25 In the pre-transfer editing mechanism, the 
aaRS hydrolyzes aminoacyl adenylate intermediate to regenerate the free non-cognate amino 
acid which can then be cleared from the active site, Scheme 1.2.26 In addition, a self-
cyclization mechanism has been suggested for the pre-transfer editing against homocysteine 
and ornithine by Methionyl-tRNA synthetases and Lysyl-tRNA synthetases.27-28 Once the 
wrong amino acid is misacylated to the tRNA a post-transfer editing process can operate, 
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bond between the misacylated amino acid and tRNA is cleaved, Scheme 1.2.29  
For instance, the aminoacylation site of threonyl-tRNA synthetases (ThrRS) 
accommodates a unique Zn(II) metal ion which assists in the removal of the non-cognate 
valine.30 However, this synthetic site is unable to fully distinguish between its cognate 
substrate, threonine, and the structurally related noncognate serine.31 Rather, it acts under a 
double-sieve model and employs a range of editing approaches to clear misacylated Seryl-
tRNAThr, Figure 1.2.32 
 
Figure 1.2. Surface representation of the double discrimination model in threonyl-tRNA 
synthetase to ensure overall fidelity mechanism; the catalytic domain in blue where the 
editing one is in grey colour. 
Only yeast mitochondrial ThrRS lacks a separate editing site and thus appears to exploit 
only pre-transfer editing within its aminoacylation site.33 However, ThrRS from any other 
species is known to follow a double discrimination approach; that is, they exhibit both pre- 
and post-transfer editing.34 Notably, the post-transfer editing mechanism of ThrRS has been 
Aminoacylation Mechanism. Editing Mechanism.
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observed to be somewhat species specific; in the case of the N-terminus motif (archaeal) 
ThrRS, the post-transfer editing process is thought to proceed via an RNA-mediated 
hydrolysis pathway.35 Specifically, it is thought to be facilitated by the tRNA co-substrate’s 
2´-/3´-OHAdo76 group. Interestingly, sequence analysis has demonstrated a substantial 
sequence similarity between this motif in ThrRS and D-amino acid deacylases (DTD).36 The 
latter is utilized by aaRSs to ensure the homochirality of the synthesized protein by removing 
the misformed D-aa-tRNAaa37 but, unfortunately, the precise mechanistic role is unknown.38 
Meanwhile, in E. coli species, the hydrolysis mechanism is a matter of much more 
debate.39-40 It has been proposed that an editing site cysteine or histidine residue acts as a 
mechanistic base to activate the nucleophilic water molecule.41-42 Interestingly, even by 
employing a double discrimination mechanism, ThrRS can still have difficulties since the 
unnatural amino acid  β-hydroxynorvaline cannot readily be discriminated against and can 
be incorporated into proteins.43 Other aaRS are thought to go even further and employ a 
triple-sieve approach; for instance, distinguishing between serine and alanine by AlaRS is 
one of the greatest molecular-recognition challenges in nature.42, 44  
Scheme 1.2. Schematic drawing for the general editing mechanisms utilized by ThrRS. 
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However, it has been recently suggested that this inaccuracy in translation is a “double-
edged sword”.45 Absolute accuracy is not always essential and indeed, several aaRSs have 
been observed to tolerate moderate levels of misaminoacylation.46 In fact, this can be used 
as a physiological stress response or allow some amino acids to be incorporated into proteins 
even if their specific aaRS is lacking in certain species.47-48 For instance, it has been found 
that only eukaryota and some bacteria species possess twenty aaRS, each responsible for a 
specific, individual amino acid.49 Accordingly, indirect acylation pathways are required for 
the transfer of amino acids in those species that do not possess all 20 aaRS.49 For example, 
most prokaryota lack AsnRS and GlnRS enzymes; instead, non-discriminating glutamyl-RS 
and aspartyl-RS can mis-aminoacylate tRNAGln and tRNAAsn with glutamate and aspartate 
amino acids, respectively.50 These mischarged tRNAs are then converted to the desired Gln-
tRNAGln and Asn-tRNAAsn by Glu-tRNAGln and Asp-tRNAAsn amidotransferases.51 
The exact mechanisms of the aforementioned reactions remain quite poorly understood. 
This is highly unfortunate given their tremendous potential impact on molecular recognition, 
physiological and pathological processes, and catalysis. The outgrowing computer and 
software capabilities made it possible for the state-of-the-art multiscale computational 
chemistry to provide significant insights into these critical and far-reaching problems.52-53 
Specifically, it can shed light on the exact contribution of each active site residue to catalysis 
and thus precisely identify the catalytically active ones. This can provides the foundation 
required for the development of targeted and effective therapeutic agents for the treatment 
of the many disease states associated with these enzymes.54  
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2.1 Molecular Modeling of Enzymes 
	
Elucidating the complete catalytic mechanism of an enzyme means establishing and 
understanding all the factors that contribute to their remarkable ability to enhance the rate of 
reactions and to act with great specificity. This often requires, for instance, identifying and 
characterizing the structures, properties, and energy of all the intermediates and transition 
states along a reaction cycle. Experimental investigations have made numerous great strides 
and progress in the field enzymatic catalysis across many different aspects. Unfortunately, 
however, many aspects of enzymatic catalysis, particularly at the atomistic or electronic level, 
remain challenging or impossible to elucidate by current experimental techniques.1-2 
Fortunately, the exponential growth of computational power has enabled the development 
and application of computational chemistry methods to, for instance, ever increasingly large 
and complex chemical problems. Indeed, computational enzymology, the use of such 
methods to study enzymes, is now able to provide a tremendous wealth of accurate and 
reliable insights into their structures, properties, energies, and catalytic mechanisms.3 
Furthermore, such methods can be used to examine chemical systems from the atomistic to 
macromolecular level. Thus, computational enzymology has established itself as both a 
complementary and stand-alone approach to traditional experimental methods, and has 
become a booming area of active research and development in the field of enzymology. 
In this dissertation a range of computational methods have been applied to study a range 
of enzymes. There have several great reviews in the literature on the field. Hence, within this 
chapter only a brief introduction and summary of such methods and their application, as 
relevant to the work herein, is provided. 
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2.2 Molecular Dynamics Simulations 
	
Computational enzymology studies often start with obtaining or deriving a suitable 
chemical model from an experimentally derived high-resolution X-ray crystal structure. 
However, such experimental structures are themselves not necessarily an exact 
representation of the enzyme or complex in vitro being impacted by, for example, they are 
static, non-solvated, may contain mutations, and are potentially subject to crystal packing 
effects. 
For example, it has long been recognized that, for instance, within cells enzymes are in 
dynamic motion and can adopt a range of conformations over time that exist from a few 
femtoseconds to several seconds. In contrast, the observed time scale for a catalytic reaction 
can be on the order of a millisecond to microsecond scale.4 This inherent flexibility has been 
found to be central to enzymatic catalysis, including their efficient substrate binding and 
product release, and is represented through a multidimensional free-energy landscape.5 
Indeed, for any enzyme to function properly, it is essential to balance between its inherent 
flexibility and suitable stability to maintain its original	coordinates.	
Thus, unraveling enzymatic mechanisms at the atomistic level can require the use of 
molecular dynamics (MD) simulation, which enable one to model the time-dependent change 
of the atomic coordinates of the system under study.6 Specifically, the position of any atom 
in the protein at any time can be monitored. Furthermore, they can allow one to model the 
behaviour of a solvated system, as well as include the effects of temperature on conformation. 
MD simulations use classic Newtonian mechanics to determine the movement behaviour of 
a system under the pressure of the forces acting on it. Parametrized forcefields such as 
Assisted Model Building with Energy Refinement (AMBER)7-8 or Chemistry at Harvard 
Chapter 2 
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Macromolecular Mechanics (CHARMM)9 are used to compute the applied force on each 
atom of the complex systems and then integrate over time.	
 
	
Figure 2.1. Flow diagram for a common strategy used to obtain a suitable chemical model 
for subsequent QM/MM or QM-cluster calculations. The PDB ID for the starting X-ray 
structure in this example is 1TKY.10 
	
     In response to the enzyme flexibility, atoms are in a continuous movement during time 
and thus the applied forces are changing, thereby the latter need to be recalculated at each 
time step. Eventually, MD simulations sample the generation of all plausible conformations 
the enzyme can adopt in a certain time. The outcome of the MD simulations is a trajectory 
which reveals the fluctuations of all atoms in the specified time frame over thousands of time 
steps. Complete atomistic details of the atoms motion in the system under study can be 
obtained through the analysis of the generated trajectories. It is also crucial to mention that, 
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the length of the MD simulation should be adequate to allow the structural fluctuations to 
reach a plateau indicating the equilibrium of the generated conformations from which a 
snapshot can be chosen for the following QM/MM calculations, Figure 2.1. All the 
conformations obtained before this equilibrium state are usually discarded and a 
representative model is chosen from only the equilibrated ones. In complex biomolecular 
systems such as lipids, membrane proteins and related systems where longer timescales ( ≥ 
µs) are needed for proper simulations; a coarse-grained model can be applied.11 This model 
allows for a significant increase in the timescale of MD simulations by treating small groups 
of atoms as single particles.12  
In this thesis, the Molecular Operating Environment13 (MOE) was used to prepare all 
the chemical models and the simulations themselves were performed using the NAMD 
program.14 It is important to bear in mind that the X-ray crystal structures do not always 
contain the cognate substrates; either an analogue or even no substrate (apoenzyme). In the 
latter case, molecular docking is the tool we use to insert the substrate in the most favorable 
binding mode inside the active site. Many docking protocols have been developed based on 
the idea of inserting the substrate in all the possible orientations using molecular mechanics 
(MM) method. Each generated complex is then energy minimized and the complex with the 
lowest energy is the one predicted to exhibit the substrate bound in its most favorable position. 
It is also well established that there is a central influence of the conformational 
fluctuations of the enzyme on the calculated energy barriers for the studied mechanism.15-16 
The active site residues change their positions regularly during the simulation and thereby 
their catalytic contributions are varied from one conformation to another. Inaccurate 
selection of the starting structure for any enzymatic study can lead to a proposal of the wrong 
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reaction mechanism. Accordingly, it has been suggested to select multiple initial points from 
the generated conformations of MD simulations for subsequent enzymatic study.16 
 
   2.2.1 Molecular Mechanics: 
	
As we mentioned above, MD sampling is usually performed using molecular mechanics 
(MM). In this empirical-based approach, the calculation ignores the electronic motion and 
the energy is then calculated based on the nuclear positions only. Therefore, the chemical 
system is described as spheres joined by springs. Specifically, the energy of this system is 
derived as a function of its conformation and expressed as the sum of basic classic equations 
that describe the valence terms (such as bond stretching, bond bending, bond torsion), van 
der Waals energy, electrostatic interaction and cross terms (which describe the effects of the 
motion of one molecule on the other). The constants used in the equation are parametrized 
either from experimental data or through ab initio calculations. A set of equations with their 
respective constants is called a force field. Among many available forcefields, the most 
widely used for proteins and nucleic acids are the AMBER and CHARMM forcefields.8-9 
This simplicity of the calculations allowed MM minimizations to be applicable to very big 
chemical systems. 
2.3 Quantum Mechanics and Quantum Mechanics/Molecular Mechanics. 
	
A diverse range of computational tools are available and widely used in computational 
enzymology. Two of the most common are the quantum mechanical (QM)-only, also known 
as the QM-cluster method, and the Quantum Mechanics/Molecular Mechanics (QM/MM) 
methodologies.17 Indeed, these approaches have become essential for exploring the structure 
and the functions of biomolecules from the quite small to large multi-molecular species such 
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as enzyme-substrate complexes. However, each approach has its challenges and strengths 
and in the following sections we highlight at least some of these. 
 
   2.3.1 QM-only Approach: 
	
Modeling enzymatic reactions using the QM-only method has been successfully applied 
to the study of a range of chemical reactions and, in particular metalloenzymes.18-20 At the 
moment, the QM-cluster method can only be used to treat chemical systems of 200 atoms or 
less, thus it can not treat an entire enzyme. This is due to the fact that a single quantum 
mechanical method is used to describe the entire chemical model. According to numerous 
investigations on different metalloenzymes, the error of the QM-only approach is estimated 
to be less than 5 kcal/mol.21 
More specifically, a central foundational idea behind this approach is that for an 
enzymatic system the active site residues that are catalytically essential in the mechanism or 
responsible for productive binding of the substrate are excised out of the protein and treated 
with a high level of theory.22 As a result of discarding the protein environment, two main 
essential factors that influence the excised model are ignored: the steric effect employed by 
the protein to maintain the geometry of the active site, which can lead to artificial and non-
physically relevant geometry changes, as well as long-range interactions and polarization 
effects induced by the surrounding protein.23 
Two common solutions are introduced to overcome these limitations. It is typical to freeze 
one atom from each residue at its crystallographic or possibly MD minimized coordinate to 
help maintain the structural integrity of the model in place.22 Also, it is presently common to 
use a continuum medium with a dielectric constant to approximately represent the 
electrostatic effects due to the surrounding protein. The latter can be included via the use of 
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single point energy calculations on the optimized geometries. Different values for the 
dielectric constant can be used based on the polarizability of the protein, but a value of 4 is 
generally held to be the most representative of common protein environments.24 
The number of atoms included in the QM-only chemical model and that are ideal to 
accurately represent the real active site has been a matter of increasing debate.18-19, 25-26 But 
it is now generally established that the accuracy of the QM-only protocol increases when a 
large chemical model of 100-200 atoms is used.23 This has been concluded based on the 
finding that the impact of changing the value of the dielectric constant is insignificant when 
the model used is derived by truncation of the real system at some distance away from the 
active site.27 
Moreover, increasing the size of the QM model provides the system with two essential 
properties; (i) suitable flexibility to adapt to any required geometry changes along the 
chemical reaction, and (ii) a suitable compromise for treating the short- and long-range 
interactions. Many assessment studies have demonstrated that a convergence in the obtained 
potential energy surfaces of different chemical reactions can be achieved when chemical 
models in the range of 150-200 atoms are used.25-26 However, before expanding the size of 
the chemical model, special care should be taken to consider the consequences. In particular, 
the calculation time will increase dramatically and, the larger the model, the higher the 
chance to obtain various local minima during the optimization of the chemical pathway. In 
addition, larger chemical models do not allow for the use of the higher and thus more accurate 
and reliable computational methods. 
It is also important to mention that several QM-only investigations have been performed 
on different metalloenzymes to examine the choice of X-ray structure used to derive a 
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chemical model on the reliability of the obtained energy barriers.28 Applying different 
displacements on the fixed atoms was found to result in negligible changes in the kinetic 
energies as long as the system is composed of more than 100 atoms.29 Overall, if the 
resolution of the considered X-ray structures is reasonable, better than 2.0 Å, the starting 
structure is not critical to the computed energies by the QM-only approach. 
In practicality, the QM-only approach is found to be helpful to provide preliminary 
insights into the catalytic mechanism. Because of the less expensive time cost, it can be used 
to determine from a variety of proposed or potential mechanisms the one that is likely most 
feasible. It can also be useful for benchmark investigations; that is, to determine the most 
reliable QM method and basis set for reliably and accurately treating the chemical system 
under study. However, one must also be aware of the inherent limitations associated with the 
use of such models. 
 
   2.3.2 QM/MM Modeling 
	
The QM/MM multilevel methodology inspired by the pioneering work of Warshel and 
Levitt30, became the method of choice in studying enzymatic catalysis.17, 31-35 In this 
approach, the entire enzyme is split into two main subsystems according to their importance 
in the chemical reaction. The active site where the bond forming and bond breaking takes 
place is the electronically active region and is treated by the QM level of theory (inner layer). 
The criteria for choosing the size and the number of atoms in this region is the same as the 
QM-only approach. In fact, it is generally accepted that different sizes leads to different 
results and thus different models should be assessed to establish the consistency of the 
obtained energy.36  
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The remaining region of the protein is represented by an empirical MM method which 
treated by a forcefield such as AMBER or CHARMM.37 The entire protein can be 
represented but for the proteins that have many chains in its X-ray structure, the size of the 
model depends on the location of the active site. In most of the cases, one monomer 
containing the active site is a good representation for the entire protein. A large size of the 
chemical model makes it computationally more expensive in addition to the complexity of 
the generated conformations of the MM layer. The resulting error from the latter can be 
diminished by either fixing the alpha carbon atom of the residues 8 Å away from the substrate 
to its coordinates at the MM minimization or even fixing the remaining part of the protein 
entirely.34 
Also, the interaction between these two layers (QM__MM coupling) cannot be estimated 
by just combining the energy between them. Special precautions should be considered when 
selecting the boundary region. Two general approaches, additive and subtractive, are 
currently considered for treating the coupling between these two layers. 
 
2.3.2.1 Additive and Subtractive QM/MM schemes 
	
Additive Scheme. In this scheme the QM/MM energies are calculated by adding the MM 
energy of the low layer (EMM), the QM energy of the the active site region or high layer 
(EQM), and the QM energy of the electrostatic interaction between the high (QM) and low 
(MM) layers (EQM/MM, coupling), Figure 2.2. 
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Figure 2.2. Schematic illustration of how the additive (top scheme) and subtractive coupling 
schemes (bottom scheme) compute the energy of the chemical model.  
 
Subtractive Scheme. In this scheme, separate QM and MM calculations are performed. 
That is, the QM region is treated independently and the QM/MM coupling interaction is not 
counted explicitly but considered within the MM calculation.  The energy expression of the 
subtractive QM/MM scheme is the sum of the MM energy of the entire system (EMM, entire 
system) and the QM energy of the active site region (EQM, inner layer), minus the MM energy of 
the innery layer. The latter is done to avoid inclusion of the energy of the inner layer through 
both the QM and MM calculations, Figure 2.2.  
Because of this simplicity, the subtractive approach can be expanded to n number of layers 
and the ONIOM approach developed by Morokuma and coworkers is an example of this 
scheme.38-39 This example has been successfully applied to combine two QM methods to 
represent the entire system or covering three layers. In the case of three layers there will be 
an additional medium layer which can be treated, for example, using a less computationally 
EMM,	outer	layer EQM,	inner	layer
EQM/MM,	coupling
+ +
-+
EMM,	Entire	layer
EQM,	inner	layer EMM,	Inner	layer
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expensive QM method (e.g., semiempirical) than used in the high layer. The resulting 
QM/QM/MM energy expression can be represented by: 
EQM/MM= EMM,entire system + EQM, inner layer + EQM, medium layer – EMM,inner layer –  EMM,medium layer 
At the heart of a QM/MM calculation is the treatment of the interaction between the QM 
and the MM layers and should be described accurately. Two types of interactions between 
these two regions are normally represented: bonded (bond stretching, bond bending and 
dihedral rotation) and non-bonded (electrostatic and van der Waals) interactions. According 
to the treatment of electrostatic coupling between the QM and MM regions, QM/MM 
calculations are said to use either mechanical or electrostatic (or electronic) embedding. 
In the case of the mechanical embedding the interaction between the two layers is treated 
by a MM calculation, which is reasonable for van der Waals but not electrostatic interactions. 
In particular, as a result of being treated using an MM forcefield, the charge distribution of 
the outer MM layer does not directly interact with the inner QM layer, which can be a 
drawback for the mechanical embedding treatment. Increasing the size of the inner layer to 
account for the charge distribution is suggested to diminish the influence of this 
shortcoming.40 The integrated ONIOM method is by default a mechanical embedding 
method.37-38 It should be noted that the ONIOM approach can be expanded to include 
multiple layers. For example, the three layer ONIOM method has been suggested as one 
possible approach to enhance modeling of the polarity of the protein environment around an 
enzyme’s active site.39 
In the case of electrostatic embedding the electrostatic interaction between the layers is 
treated using a more advanced level of computation. While this makes it more accurate it is 
computationally more expensive. In particular, the change of the charge on the inner region, 
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resulting from the electrostatic influence of the outer layer is represented by incorporating 
an additional one-electron term in the QM Hamiltonian to represent the MM point charges. 
The treatment of the QM-MM van der Waals interaction in electronic embedding is identical 
to the mechanical embedding treatment. 
Interestingly, the mechanical embedding approach, which avoids the overpolarization of 
the QM layer caused by inclusion of the additional one-electron term in the QM Hamiltonian, 
was found to be more reliable than electrostatic embedding in several enzymatic 
investigations.41 However, electrostatic embedding led to faster convergence of the size of 
the QM layer relative to the mechanical embedding scheme.42 
Importantly, the explicit treatment of the junction area between the high and the low layer 
is found to be significant only in the cases where the outer region of the protein has an 
electronic influence on the inner layer. In the case of the additive QM/MM approach, 
however, there is no requirement for parameters to represent the link atoms which is not 
described by the force field.  
In addition, the treatment of the boundary between the QM and MM layers can be largely 
classified into the link atom43 (or parametrized atom44) and a localized orbitals approach.45 
In the link atom approach, a link atom, usually hydrogen, is used to saturate the chemical 
valence of the truncated atom in the QM layer. But this hydrogen atom is not treated by either 
the QM or MM methods. However, the use of a hydrogen atom results in limitations in the 
accuracy of the obtained QM/MM energy and electron density. This is because it is in a sense 
artificial, as it does not exist in the original connection, and the distance between this artificial 
hydrogen atom and the QM/MM boundary is only 0.5 Å, which is shorter than typical of an 
X-H bond. By comparison, in the localized orbital approach a QM calculation is used to 
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describe the connection between the inner and outer layers and thus, reduce errors due to 
overpolarization. However, the link atom approach is more straightforward and widely used. 
 
    2.3.2.2 Technical aspects to consider when constructing a QM/MM model. 
	
When truncating the QM-MM conjunction, the coupling boundary should be at an adequate 
distance from the active site to be feasible computationally. More specifically, the boundary 
should be at least three bonds away from the location of bond formation and breakage to 
guarantee enough flexibility to afford dihedral rotation. It is also important to avoid placing 
the boundary at any polarized or conjugated bond (either a linear bond or in a ring system). 
Globally, the most appropriate place to cut at is at a single bond between non-polarized atoms 
such as aliphatic C__C single bonds.  
 
     2.3.3 Comparison between QM-cluster and QM/MM approaches: 
	
Studying the enzymatic mechanism using QM-only was found to result in a significant 
change in the energy barrier compared to studies done using the QM/MM approach.32 
However, absence of the protein environment does not induce significant changes in the 
obtained relative energies for the chemical reaction if it is not associated with a large degree 
of charge transfer.46 To examine the effect of including the protein environment on the 
energy of the inner layer,  (EQM), the difference in QM energy of the isolated chemical model 
in the gas phase (EQM*) and the energy of inner layer inside the QM/MM model (EQM, QM/MM) 
is calculated,40 EMM= EQM, QM/MM - EQM* 
Convergence of energy using QM/MM models relative to the QM-cluster approach with 
respect to the chosen size of the QM model has been the subject of numerous studies.47 In 
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general, the QM/MM approach was found to converge faster with increasing system size 
than the QM-cluster approach. For instance, benchmarking QM/MM studies on the proton 
transfer from cysteine to histidine in [Ni,Fe] hydrogenase demonstrated the convergence of 
the obtained energy barrier once the QM/MM junction is moved away from the active site.41 
Following the same protocol, it was demonstrated that addition of more residues to the QM-
cluster system should not occur according to chemical intuition or to the residues’ proximity 
to the active site, but rather to their contribution to the QM/MM energy.48-50 In these studies, 
buried charged groups up to 20 Å away from the active site were found to significantly 
contribute to the obtained energy barrier. Moreover, including additional neutral residues in 
the QM region is significant only if they are located less than 4.5 Å away from the active 
site. Importantly, it is also suggested that all the polarized residues located up to 10-15 Å 
away from the active site should be treated at the QM level for accurate modeling of the 
enzyme.41, 49 To illustrate, a recent QM/MM study declared the convergence of the QM 
region when the size reached 200-300 atoms,51 while in another investigation, convergence 
in the energy was achieved beyond 300 atoms.52  
Another comparison between QM-cluster and QM/MM models in the study of 
enzymatic reactions has been performed on the mechanism of tungsten-dependant acetylene 
hydratase.36, 53 In this comparison, combining the two approaches to complementarily inform 
each other was found to be a necessary step towards  successful elucidation of the enzymatic 
reaction. However, unlike the previous suggestions,49 the authors do not support adopting 
the energy resulted from expanding the size of an optimized QM region in the QM/MM 
model through the use of single point energy calculations.53 Significant differences in the 
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obtained energies relative to the fully optimized QM/MM models have been observed and 
were found to be independent of the chosen models.36  
2.4 Density Functional Theory (DFT) 
	
Electronic structure calculations on the QM region can be performed using a variety of 
methods including ab initio, density functional theory (DFT), and semi-empirical 
calculations. The central goal of these treatments is to provide an approximate solution to the 
time-independent Schrödinger equation; the fundamental equation of quantum chemistry. 
Solving the time-independent Hamiltonian operator for multi-electron systems is incredibly 
complex, making it impossible to exactly solve the Schrödinger equation. A remarkable step 
toward expanding its applicability has been achieved upon the simplification made by the 
Born-Oppenheimer approximation. This allows us to assume that the atomic nuclei are 
stationary relative to the electrons due to their larger mass. As a result, the Schrödinger 
equation is separated into a nuclear and electronic part, simplifying the molecular 
Hamiltonian to the electronic Hamiltonian. Thus, many physical and chemical properties can 
be determined based on the ground state electronic structure.    
The Hartree-Fock calculation (HF) is the most basic type of ab initio calculation. It is a 
variational method, meaning the calculated energy is always equal to or greater than the exact 
one. It solves a series of one electron equations describing how each electron moves in a 
field of surrounding electrons and is built from a linear combination of basis functions 
(atomic orbitals). One of the main limitations of HF calculations is that it does not account 
for explicit electron correlation (repulsion), but just an average effect. Many types of 
correlated calculation such as Møller-Plesset perturbation Theory (MPn), and coupled cluster 
theory have been developed to correct for the lack of HF electron correlation. 
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Similarly, semi-empirical (SE) methods are another approach that was developed on the 
basis of the wave function to solve for the Hamiltonian operator with the inclusion of 
approximations obtained from empirical data. Thus, the SE method is much faster than any 
ab initio calculation, but the obtained results are not always accurate. In this approach, most 
of the core electrons of the system are omitted and not treated in the calculation, extending 
its application toward much larger systems. SE methods are parametrized to either 
experimental data or ab initio calculations to overcome the errors of ignoring the core 
electrons. This inaccuracy is a result of the fact that the molecule under study should 
necessarily have structural similarities to the database used to derive the parameters. The 
most commonly used SE methods are Austin Model 1 (AM1) and the parametrized method 
3 (PM3).  
Due to the limitations of electron correlation, the wave function theory that was globally 
applied to quantum mechanics has been avoided for large systems.54 Consequently, Kohn-
Sham Density Functional Theory (DFT) is presently the most popular and powerful tool for 
many applications in computational chemistry.54-55 It indicates that all the ground state 
properties of any system can be derived from the electron density distribution over space.56. 
The electron density is independent of the number of electrons, a substantial benefit when 
examining larger chemical models(cost scales with N4).57 With comparable efficiency to HF, 
DFT has an outstanding performance-to-cost ratio simultaneously being applicable to larger 
chemical systems 
Because the exact functional is unknown, DFT relies upon approximating the unknown 
exchange-correlation (XC) functionals of the electron density58. This approximation is 
known to be the main shortcoming of DFT calculations. In the scope of this approximation, 
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significant progress has been achieved in approximating the XC.59 The first generation 
approximations is the local spin density approximation (LSDA) in which the XC functionals 
depend only upon local spin densities.55 Despite its simplicity, LSDA is known to not be 
useful in studying chemical compounds as it overestimates bond lengths and underestimates 
chemical barriers. The second generation includes the generalized gradient approximation 
(GGA) methods which consider the gradient of the electron density in the XC functionals, 
improving the accuracy of results. Thereby, introducing this generation of functionals was 
the cornerstone that enabled computational chemists to use DFT. For instance, the exchange 
functionals of Becke8660 (B86) and the popular Lee-Yang-Parr (LYP) correlation functionals 
are pioneers of this generation.61 However, accurately describing the energy barriers is still 
not fully solved.  
	
Figure 2.3. Representative image for the different generations of DFT functionals 
according to J. Perdew62 with an example corresponding functional. 
As a result, developing the hybrid density functionals (H-GGA) that mix the XC from the 
GGA method with a percentage of Hartree-Fock exchange is one reason for the progress of 
DFT functionals. This remarkable step upon introducing H-GGA, particularly after the 
introduction of the common B3LYP functional, allowed DFT to become the most widely 
used method in quantum chemistry.61, 63 In fact, the B3LYP functional became the functional 
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of choice in studying numerous chemical properties, together with the hybrid meta density 
functional (M-GGA) , they led to a significant improvement in the accuracy of determining 
different chemical properties of molecules, Figure 2.3.64  
Despite the unparalleled success in the application of DFT functionals, it is unfortunate 
to know that they suffer from four major challenges.65  The largest error is the self-interaction 
error which arises from the electron interacting with itself in the columbic term described by 
the DFT Hamiltonian.66 This error directly influences the underestimation of barrier heights, 
but can be somewhat addressed by including additional contribution from the exact HF 
exchange.67 Also, another major limitation is the inability of these functionals to describe 
non-covalent long-range (van der Waals) interactions.68 Presently, there is ongoing progress 
towards eliminating this shortcoming through introducing empirical dispersion corrections 
such as Grimme’s empirical formula.69 Interestingly, either geometry optimization of the 
chemical models or single point energy calculations using B3LYP-D3 were found to be 
equally successful in minimizing this error in different systems.70 One more critical 
drawback of DFT functionals is that they all are ground-state methods and are unable to 
provide reasonable results for excited state applications. Finally, error arises from the 
inaccurate description of chemical systems containing transition metals, increasing with 
increasing the %XC included contrary to a solution to self-interaction error.71 To illustrate, 
M06L (with no HF exchange) led to accurate predictions in the excitation energies in some 
systems.72  
Quite noticeably, there is a clear conflict between the self-interaction error and inclusion 
of transition metals. To overcome the latter problem, it is suggested to utilize a DFT 
functional with low HF exchange; however this will lead to inappropriate estimation of the 
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barrier heights.64 Currently, the meta hybrid M05, M06, and the improved M08 suites of 
DFT functionals were found to be superior to other functionals in terms of diminishing the 
previously mentioned errors.73 In general, however, it is well known that there is not a single 
DFT functional that is suitable for all systems; the choice of the functional relies mainly on 
the property under evaluation and the nature of the chemical system under study.55 For 
instance, M062X outperformed the robust B3LYP functional in treating long range as well 
as providing a better description of barrier heights.64 Meanwhile, the local M06-L functional, 
is the most suitable for transition metal chemistry. The M06HF functional with full HF 
exchange takes advantage of this XC to avoid the self-interaction error, yet it is not suitable 
for transition metal chemistry.64 
It is also important to mention that M062X is parametrized to approximately describe long 
range interactions; however it fails to provide the same level of accuracy as dispersion 
corrected DFT functionals.69 In contrast, other studies demonstrated the success of the 
Minnesota functionals in describing long range interactions at a similar level to dispersion-
corrected ones.74 Generally, other than the description of noncovalent interactions, M062X 
was recently recommended to be the most accurate among the 14 Minnesota density 
functionals.75 
In conclusion, to determine which is the best DFT function to evaluate a chemical system, 
one of two main tasks should be considered. The literature should be consulted as to which 
functional best describes the system or perform a benchmarking study of several DFT 
functionals against a known standard method such as CCSD to represent your chemical 
model.49  
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3.1 Introduction  
     Proteins have a diverse array of critical roles in cells and organisms. Their proper 
functioning depends on the accuracy of their synthesis and thus, the process of transcription 
and translation.1 Aminoacyl-tRNA synthetases (aaRS) are central enzymes in the translation 
process as they charge transfer-RNA (tRNAaa) with their cognate amino acid (aa).2 This is 
achieved via two half-reactions2-3 in which they activate their cognate aa through reaction 
with adenosine triphosphate (ATP) to form an aminoacyl-adenylate (aa-AMP). Then, within 
the same site, they catalyze transfer of the aminoacyl moiety onto the Ado76 residue of their 
tRNA (tRNAaa). Using a lock-and-key specificity for their substrate, aaRS are able to achieve 
an outstanding overall reaction fidelity with an error rate of ~10-4.4 Thus, in addition to their 
central role in protein biosynthesis and potential as drug targets,5 they are also exemplars of 
molecular recognition. As a result, they have increasingly been the subject of experimental 
and computational studies.6 
Structural and chemical similarities between the amino acids presents a significant 
challenge to aaRS in distinguishing between cognate and non-cognate substrates. For 
instance, it has been stated that amino acids that differ by only one methyl group provide no 
more than 1 kcal mol-1 difference in binding energy.7 As a result, the active site of aaRS may 
also bind non-cognate amino acids potentially resulting in mischarging of their tRNAaa. For 
example, AlaRS may misacylate its cognate tRNAAla with the sterically larger serine as well 
as the smaller glycine.8 Meanwhile, IleRS, PheRS, and ProRS may mischarge their 
corresponding tRNAaa's with non-cognate valine, tyrosine, and alanine or cysteine, 
respectively.9-10 In order to overcome these errors, some aaRS use a double-sieve model 
wherein both the above aminoacylation site and a second editing site perform pre- and/or 
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post-transfer editing.11 In the latter site, removal of the mischarged aminoacyl moiety from 
aa-tRNA is achieved via a tRNA-dependent mechanism.12 
In particular, the class II aminoacyl-tRNA synthetase ThrRS must discern its cognate 
substrate L-threonine from multiple non-cognate amino acids including valine and serine.13-
14 It has also recently been the target of potential new antimicrobial drugs.15 Experimentally, 
several X-ray crystal structures of ThrRS with and without various ligands bound within its 
aminoacylation site have been obtained.13-14, 16 Notably, based in part on these structures the 
aminoacylation active site was found to contain an essential Zn(II) ion. Indeed, mutation of 
any of the three enzyme residues (a cysteinyl and two histidyl's) ligated to the Zn(II) 
inactivated or inhibited the enzyme.14, 17 
In general, aminoacylation as catalyzed by aaRS proceeds via a conserved substrate-
assisted mechanism.18 More specifically, a non-bridging phosphate oxygen of the aa-AMP 
substrate acts as the required base to abstract a proton from either the Ado76-2'- (class I) or 
Ado76-3'OH (class II) group of the tRNAaa.4 However, in the case of ThrRS, experimental 
mutation studies concluded that the substrates non-bridging phosphate oxygens do not act as 
the base.19 Recently, using molecular dynamics (MD) and DFT-cluster computational 
methods we suggested that the experimentally observed bidentate ligation of the threonyl 
moiety of L-Thr-AMP to the Zn(II) ensures that its α-NH2 group is neutral, and enhances the 
lability of the Zn(II)…NThr bond.20-21 As a result, the substrates α-NH2 is able to act as the 
required mechanistic base as shown in Scheme 3.1. 
Chapter 3 
 40 
 
However, in addition to aiding substrate recognition, it has also been suggested that a 
key role of the Zn(II) may be steric or chemical discrimination against non-cognate amino 
acids.11 For example, it may facilitate discrimination against the isosteric but non-cognate 
valine due to steric hindrance with the latter's side chain β-methyl group.22 Meanwhile, serine, 
which differs from threonine by a single -CH2- in its side chain, is able to bind in the same 
manner as threonine within the aminoacylation site of ThrRS. Thus, it has been suggested 
that the Zn(II) may help ensure that only amino acids possessing a b-hydroxyl group may 
bind within the aminoacylation active site.13-14 Experimentally, it has been indicated that 
ThrRS catalyzed aminoacylation by the non-cognate serine occurs at a rate 1000-fold less 
than for the cognate threonine.13-14 This difference in the reaction rate does mean that in 
addition to pre-transfer editing, post-transfer editing of mischarged Ser-tRNAThr is 
required.23-24 It has also been suggested that aaRS play a crucial role in ensuring the 
homochirality of amino acid residues in proteins, which is essential to the proper folding and 
thus function.25-26 The role of the Zn(II) and active site of ThrRS in discriminating against 
D-Threonine is, however, as yet unknown. 
In this present study, we have used a multi-scale computational approach to investigate 
substrate binding in the aminoacylation active site of threonyl-tRNA synthetase, and the 
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Scheme 3.1. The mechanism of ThrRS catalyzed threonylation of the corresponding 
tRNAThr where the substrate’s α-NH2 serves as the required base (based on ref. 22). 
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subsequent mechanism of aminoacylation. More specifically, the role of the Zn(II) ion in the 
binding and catalytic mechanism for the cognate substrate L-Thr-AMP and potential non-
cognate substrates L-Ser-AMP, L-Val-AMP, and D-Thr-AMP, was examined using 
molecular dynamics (MD) and quantum mechanics/molecular mechanics (QM/MM) 
methods. 
3.2 Computational Methods  
            3.2.1. Molecular Dynamic (MD) Simulations  
    The Molecular Operating Environment (MOE) program was used to prepare all Molecular 
Dynamics (MD) simulations,27 which were then performed using the NAMD program.28 We 
have previously performed an MD study on the fully bound ThrRS complex.20 As then, the 
Michaelis complex was constructed using several X-ray crystal structures as templates (PDB 
ID: 1QF6, 1EVL, and 4EO4)13-14, 29 with the threonyl substrate being manually docked such 
that both its a–NH2 and b-OH were ligated to the Zn(II) center as suggested by the 
experimental structures. Furthermore, our previous MD protocol was also used herein. First, 
the generated complete enzyme-substrate (ThrRS…L-Thr-AMP/tRNAThr) complex was 
minimized using the AMBER99 force field until the root mean square gradient fell below 
0.05 kcal/mol Å-1. Using this structure, the bound substrate was then manually modified to 
generate starting structures for the corresponding ThrRS…L-Ser-/Val-AMP/tRNAThr 
complexes. 
All three models were then solvated by adding a 2 Å layer of water (1361 water 
molecules) to generate fully solvated complexes of approximately 10971 atoms. Each 
resulting solvated complex was then minimized using the AMBER99 molecular mechanics 
force field until the root mean square gradient fell below 0.01 kcal/mol Å-1. The minimized 
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structures were then annealed over 100 ps from 150 to 300 K at constant pressure. This was 
followed by a 10 ns MD production run with a time step of 2 fs under constant pressure and 
temperature and without applying any restraints. In these simulations, the default settings 
implemented in the MOE software were used, including a cutoff of 10 Å for non-bonded 
interactions and tether ranges from 0-100 Å applied to the heavy atoms. For each simulation, 
the conformations obtained were analyzed and clustered based on the root-mean-square 
deviations (RMSD) of their active site heavy atoms and substrate. An average structure of 
the most dominant conformation for each ThrRS…L-aa-AMP/tRNAThr (aa = Thr, Ser, Val) 
complex was then selected for analysis and to generate suitable starting models for the 
QM/MM studies (see below). 
Table 3.1 Average values of key distances (Angstroms) and angles (degrees) obtained from 
10 ns production MD simulations of the ThrRS…aa-AMP/tRNAThr complex (aa=L-Thr, L-
Ser, L-Val). 
 
 
 
 
 
 
 
 
 
 
Geometrical 
Parameter 
Aminoacyl substrate 
Thr Ser Val 
3'O…Nα (Å) 3.01 2.99 2.98 
3'O…Ccarb (Å) 3.17 3.22 3.20 
αN…Zn (Å) 1.92 1.90 2.03 
βO…Zn (Å) 2.14 2.11 NA 
3'O-C-O (º) 84.0 81.1 77.4 
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An alignment analysis was performed on the three average structures obtained. No 
significant differences in their bound active sites was observed as indicated by the RMSD 
value obtained of just 0.26 Å. Furthermore, the average values of mechanistically important 
distances and angles of all three complexes are quite similar as seen in Table 3.1. For the 
aminoacylation mechanism involving D-Thr, the active site-bound L-Thr-AMP was 
manually changed to its D enantiomer to generate ThrRS…D-Thr-AMP/tRNAThr. 
 
      3.2.2. QM/MM Investigations: 
All QM/MM calculations were performed within the ONIOM formalism30-31 as 
implemented in the Gaussian 09 program.32 This approach has been successfully applied in 
the field of computational enzymology to investigate the catalytic mechanisms of other 
aminoacyl-tRNA synthetases33 and related enzymes.34 
A suitable chemical model was obtained by minimizing the average structure obtained 
from the corresponding MD simulation using the AMBER99 forcefield. The system was 
truncated to include the aa-AMP substrate and all residues and waters within ~20 Å of the 
substrate. Using a two-layer ONIOM(QM/MM) approach the entire chemical system was 
divided into two subsystems based on their relevance to the catalytic mechanism. The high-
layer (QM-region) consisted of the aa-AMP substrate, Zn(II) ion, the side-chains of the three 
residues ligated to the Zn(II) ion (His385, His511 and Cys334), the side-chains of residues 
directly hydrogen bonded with the aa-AMP moiety (Gln484, Gln381, Arg363, Asp383, and 
Lys465), the Ado76 ribose of the tRNAThr, and two active site water molecules. It should be 
noted that based on available X-ray crystal structures the Gln381, Arg363 and Lys465 
residues are thought to help stabilize the negative charge on the substrate's carbonyl oxygen 
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(Ocarb) and the non-bridging phosphate oxygens during the aminoacyl transfer reaction.13-14 
In total, the QM region consisted of 129 atoms. The low layer (MM region) contained all 
remaining residues and waters for a total number of 2283 atoms. 
For the QM-region, the density functional theory method B3LYP35-36 was chosen as it has 
been shown to perform the best of several common DFT functionals for studying Zn 
metalloenzymes.37 This method was used in conjunction with the 6-31G(d,p) basis set, while 
the AMBER96 force field was used to describe the MM-region. All QM/MM calculations 
were performed within the mechanical embedding (ME) formalism. Frequency analyses 
were also obtained at the same level of theory, i.e., ONIOM(B3LYP/6-31G(d,p):AMBER96) 
in order to characterize the nature of the stationary points (i.e., minima or transition structure). 
Relative energies were calculated by performing single point energy calculations on the 
above optimized structures at the ONIOM(B3LYP/6-311+G(2df,p):AMBER96) level of 
theory. To help ensure the integrity of the enzyme model was maintained, the α-carbon's of 
all low-layer amino acid residues were held fixed at their initial optimized MM positions. 
3.3 Results and Discussion  
      3.3.1 ThrRS…L-Thr/Ser-AMP/tRNAThr Michaelis Complexes: 
    The QM/MM optimized structures of the L-Thr and L-Ser containing pre-reactive 
Michaelis complexes (PRC), with selected distances (Angstroms), are shown in Scheme 3.2. 
As the two complexes share many similarities, only the ThrRS… L-Thr-AMP/tRNAThr PRC 
(ThrPRC) is discussed unless otherwise indicated. 
As part of an earlier QM-cluster based computational study on ThrRS we examined the 
Michaelis complex and aminoacylation mechanism of ThrRS.21 It was concluded that in the 
pre-reactive Michaelis complex, the threonyl moiety of the Thr-AMP substrate was 
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bidentately ligated to the Zn(II) ion via both its neutral α-NH2 and side chain β-OH groups, 
giving a pentacoordinate Zn(II) center. In the corresponding reactive complex (RC), 
however, the substrate's threonyl moiety was only monodentately ligated to the Zn(II) via its 
side chain β-hydroxy oxygen. Notably, in this slightly higher energy complex the threonyl 
side chain hydroxyl was anionic having transferred its proton to the nearby side chain 
carboxylate of the Asp383 residue. Furthermore, this reactive complex lay just 7.5 kJ mol-1 
higher in energy than the preceding initial PRC. 
In contrast, in this present study, which uses a considerably more extensive chemical 
model in conjunction with a QM/MM-based method, two pre-reactive complexes are 
obtained (Scheme 3.2). In the lower energy complex, aPRCThr, the threonyl moiety is singly 
ligated to the Zn(II) ion via its neutral α-NH2 group with a Zn(II)…NThr bond length of 2.11 
Å. Meanwhile, its β-OH group has shifted away from the Zn(II), as indicated by the large 
Zn(II)…Oβ distance of 3.31 Å, and is now strongly hydrogen bonded to the nearby side 
chain carboxylate of Asp383, r(Asp383COO–…HOβThr) = 1.58 Å. Consequently, the Zn(II) ion 
is tetracoordinate in its ligation.  In addition, in aPRCThr the side chain amide of the active 
site Gln381 forms a weak hydrogen bond with the carbonyl oxygen (Ocarb) of the Thr-AMP 
substrate, r(Gln381NH2…OCarb) = 2.34 Å. Meanwhile, the side chain guanidinium of Arg363 
forms a moderately strong hydrogen bond of length 1.95 Å with a non-bridging phosphate 
oxygen of the Thr-AMP moiety. The same non-bridging phosphate oxygen also strongly 
hydrogen bonds with the protonated side chain amine of Lys465 via an active site water with 
r(OH2…OP) and r(H2O…HNLys465) distances of 1.60 Å and 1.70 Å, respectively (Scheme 
3.2) 
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 Scheme 3.2. Optimized structures, with selected bond lengths (Angstroms) shown, of the 
fully-bound active sites of the pre-reactive and reactive ThrRS…aa-AMP/tRNAThr 
complexes for when the aminoacyl moieties β-hydroxyl is (a) neutral (aPRCaa, aRCaa) or (b) 
deprotonated (bPRCaa, bRCaa). (aa = Thr, R = CH3 (black);  aa = Ser, R = H (blue)). 
 
It has been observed that many Zn(II) metalloenzymes have a basic residue adjacent, but 
not ligated to the Zn.38 Often, the role of this residue is to aid the activation of an R-OH 
group bound to the Zn(II) ion by accepting its proton. A recent analysis determined that the 
β-OH groups of threonine and Serine do have acidic character.39 This can be enhanced by 
the Lewis acidity of the Zn(II) ion which often induces a decrease in the pKa value of the 
ligated R-OH group.40 ThrRS exhibits a similar feature with the positioning of the Asp383 
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residue adjacent, but not ligated, to the Zn(II) ion (see Scheme 3.2.). As a result, an alternate 
pre-reactive complex (bPRCThr; Scheme 3.2b) was obtained in which the substrate's 
threonyl moiety is bidentately ligated to the Zn(II) via both its neutral α-NH2 group and its 
β-hydroxy oxygen with bond lengths of 2.18 and 2.09 Å, respectively.  
Importantly, the threonyl's α-hydroxy group has now transferred its proton to the side 
chain carboxylate of Asp383 with which it forms a strong Asp383COOH…Ob hydrogen bond 
of just 1.67 Å. Notably, bPRCThr, which contains a pentacoordinate Zn(II), lies only 14.0 kJ 
mol-1 higher in energy than aPRCThr in which the Zn(II) is tetracoordinate. In addition, the 
barrier for interconversion of aPRCThr to bPRCThr is just 21.3 kJ mol-1. This suggests the 
possible occurrence of either bound-active site structure in vivo and highlights the flexible 
coordination of Zn(II) with tetracoordinate being the most common.41 
In bPRCThr significant differences are observed in the hydrogen bonding interactions of 
Ocarb and the substrates phosphate with the key active site residues (see Scheme 3.2). In 
particular, the Gln381NH2…Ocarb distance has shortened from 2.34 to 1.98 Å. Furthermore, the 
guanidinium of Arg363 now forms quite short and strong hydrogen bonds with non-bridging 
and bridging (Ob) phosphate oxygens of the substrate's AMP moiety with lengths of 1.83 and 
1.89 Å, respectively. During aminoacylation of tRNAThr the Ob centre gains significant 
negative charge due to the breaking of the Ob–Ccarb bond. It should also be noted that the side 
chain amine of Lys465 is now more strongly hydrogen bonded via a water bridge with the 
same non-bridging phosphate oxygen as Arg363 as indicated by r(OH2…OP) and 
r(H2O…HNLys465) distances of 1.46 and 1.54 Å, respectively (Scheme 3.2). 
We also examined the corresponding pre-reactive complexes (aPRCSer and bPRCSer) in 
which the non-cognate substrate Ser-AMP was bound within the aminoacylation active site 
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of ThrRS. Overall, the binding of Ser-AMP and the hydrogen bond network is similar to that 
seen in the case of the cognate substrate Thr-AMP (Scheme 3.2). In addition, key substrate-
enzyme distances were also generally in close agreement with differences of 0.2 Å or less, 
especially for bPRCSer (i.e., when the substrate being bidentately ligated to a pentacoordinate 
Zn(II)). The only exceptions occur for aPRCSer (i.e., when the substrate is monodentately 
ligated to a tetracoordinate Zn(II)) and in the Gln381NH2…Ocarb and Arg363…Ob hydrogen 
bonds which decrease by 0.29 and 1.40 Å to 2.05 and 1.97 Å, respectively. Energetically, 
the same trends are observed as for when Thr-AMP is bound; aPRCSer lies lower in energy 
than bPRCSer by 9.3 kJ mol-1 and can interconvert via TS1Ser at a cost of just 18.0 kJ mol-1 
(see below). 
These results are also in good agreement with recent X-ray crystal structures that observed 
very similar Zn…Nsubstrate and Zn…Osubstrate distances for threonine and serine bound in the 
active site of ThrRS.16, 42 It also supports the suggestion that size-based discrimination by the 
aminoacylation active site of ThrRS is insufficient to wholly discriminate between L-
SerAMP and L-ThrAMP.11 
      3.3.2 ThrRS…L-Thr/Ser-AMP/tRNAThr Reactive Complexes  
In our previous QM-cluster based computational study on the aminoacylation mechanism 
of ThrRS,21 the first step of the mechanism was determined to be cleavage of the labile 
Zn(II)…NThr bond so that the resulting unligated neutral α-NH2 group can act as the required 
base. Notably, the threonyl moiety remained ligated to the Zn(II) via its β-hydroxy oxygen. 
Based on the above pre-reactive complexes obtained, two reactive complexes are possible 
(aRCThr/Ser and bRCThr/Ser) and are shown Scheme 3.2. In general, structurally, the same 
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features and trends are observed in a/bRCSer as for a/bRCThr. Thus, unless otherwise indicated 
only those involving bound L-ThrAMP are discussed. 
The complex aRCThr can be thought of as arising from aPRCThr by a substitution. More 
specifically, the threonyl's side chain hydroxyl (Thrβ-OH) shifts and ligates to the Zn(II) with 
concomitant breaking of the Zn(II)…NThr bond. Notably, the Thrβ-OH group remains neutral 
(i.e., not deprotonated). Alternatively, it can be thought as arising from bPRCThr by breaking 
of the Zn(II)…NThr bond with concomitant proton transfer from the side chain carboxylic 
group of Asp383 onto the threonyl substrates Thrβ-oxygen center. 
In aRCThr the Zn(II)…NThr distance has increased from 2.11 Å (aPRCThr) to 3.16 Å. 
Importantly, the -NH2 group now forms a relatively short hydrogen bond of length 1.86 Å 
with the A763'-OH group of the tRNAThr (Scheme 3.2). Concomitantly, the Thrβ-OH group is 
ligated to the Zn(II) ion via its oxygen at a distance of 2.29 Å and retains its strong hydrogen 
bond with the adjacent Asp383COO–, though it has lengthened slightly to 1.64 Å. Meanwhile, 
the mechanistically relevant A763'-O…Ccarb distance, which corresponds to the bond to be 
formed, is 3.14 Å. In general, the rest of the substrate-enzyme hydrogen bond network 
remains little altered from aPRCThr (i.e., distances differ by ≤0.12 Å). The largest change 
occurs for the Gln381NH2…Ocarb interaction which shortens by 0.51 Å to 1.83 Å. It is also 
important to note that the tetratacoordinate Zn(II) complex aRCThr lies 35.3 kJ mol-1 higher 
in energy than the tetracoordinate complex aPRCThr. 
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The alternate reactive complex bRCThr also contains a tetracoordinate Zn(II) center and 
lies 7.7 kJ mol-1 lower in energy than aRCThr. It can be considered as being formed from 
bPRCThr by simple cleavage of the Zn(II)…NThr bond. Indeed, the latter has lengthened from 
2.18 Å (bPRCThr) to 3.17 Å with the α-NH2 group again making a strong hydrogen bond 
with the Ado763'-OH moiety, though now with a shorter length of 1.78 Å (Scheme 3.2). 
Meanwhile, the A763'-O…Ccarb and Thrb-O…Zn(II) distances in bRCThr are 2.77 and 1.96 
Å, respectively. Notably, these latter distances are both markedly shorter than observed in 
aRCThr. The latter shorter bond reflects the fact that the Thr β-oxygen remains anionic in 
bRCThr, and forms only a moderately strong hydrogen bond (2.05 Å) with the neutral side 
chain carboxylic of Asp383 (Scheme 3.2). Overall, the substrate-enzyme hydrogen bond 
network involving Gln381, Arg363, and Lys465 is similar to that observed in aRCThr with 
distances in agreement within 0.1 Å. An exception, however, occurs with the guanidinium 
aPRC
H385
C334
Zn(II)
bPRC
aPRC
3'OHA76
H551
H385
C334
Zn(II)
bPRC
aPRC
3'OHA76
H551
a) b)
Figure 3.1. Overlay of the substrates in the optimized structures of the bound Thr-AMP 
substrates in the a) pre-reactive complexes and b) reactive complexes when the Thr β-
hydroxyl is either neutral (tube) or deprotonated (ball and stick) when ligated to the Zn(II) 
ion. 
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of Arg363 which is now more strongly hydrogen bonded to the substrates Ob center at a 
distance of just 1.92 Å compared to 3.34 Å in aRCThr. 
The key cause of these differences in structure, and energy, is the protonation state of the 
Thrβ-OH group when ligated to the Zn(II) ion. The above observations suggest that when it 
is deprotonated the threonyl moiety is positioned closer to the Ado76 residue of the cognate 
tRNAThr. Meanwhile, the substrates phosphate Ob center is shifted towards the side chain of 
Arg363. These differences in position of the substrate between the two reactive complexes 
is illustrated in Figure 3.1. As can be seen, the comparatively modest differences between 
aRCThr and bRCThr in the position of the substrate's threonyl in the vicinity of the Zn(II) ion 
induce larger shifts in the position of its Ccarb and Ob centers. Importantly, the ∠A763'O…Ccarb–
–Ocarb angle in bRCThr and aRCThr is 85.5° and 58.9°, respectively. This further suggests that 
the A763'O center in bRCThr is better positioned for its subsequent nucleophilic attack at Ccarb 
than in aRCThr. The same trends are observed for the corresponding L-SerAMP-bound 
complexes. The only difference occurs for the Ado763'-O…Ccarb distance, where it is 
negligibly shorter in aRCSer than bRCSer by 0.02 Å. 
 
3.3.3 Aminoacylation (Threonylation) Mechanism.  
To further understand the effects of the structural and energetic differences of aRCThr and 
bRCThr, we examined the aminoacylation (threonylation) mechanism as catalyzed by ThrRS 
beginning from both reactive complexes. The resulting potential energy surfaces are shown 
in Figure 3.2. while the corresponding optimized structures, with selected bond lengths, are 
shown in Scheme 3.3. 
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 In ThrRS catalyzed aminoacyl transfer the substrates α-NH2 accepts a proton from the 
A763'-OH group. In addition, the A763'-oxygen nucleophilically attacks the substrates Ccarb 
center to form the required A763'O—Ccarb bond, while the scissile PO—Ccarb bond must be 
broken. In agreement with our previous QM-cluster based computational study21, 
threonylation occurs via a concerted mechanism regardless of whether it start from aRCThr 
or bRCThr. 
The threonylation mechanism involving the reactive complex aRCThr (i.e., the threonyl 
substrates b-OH remains neutral; pathway A), the reaction proceeds via aTSThr at a cost of 
115.6 kJ mol-1 with respect to aRCThr, or 150.9 kJ mol-1 relative to aPRCThr (Figure 3.2). 
The corresponding product complex aPCThr lies 88.6 kJ mol-1 higher in energy than aRCThr, 
aPRCThr
bPRCThr
bRCThr
bTSThr
bPCThr
TS1Thr
aTSThr
aPCThr
21.3
14.0
27.6
108.9
-9.8
123.9
150.9
35.3
0.0
aRCThr
Relative Energy kJ mol-1
Reaction Coordinate
Figure 3.2. The calculated PES surfaces for aminoacylation (threonylation) as catalyzed by 
ThrRS when the threonyl moieties β-hydroxyl group ligated to the Zn(II) is neutral (blue) or 
deprotonated (black) throughout the mechanism. 
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or 123.9 kJ mol-1 higher in energy than aPRCThr. That is, threonylation is markedly 
endothermic.  
Scheme 3.3. Optimized structures, with selected bond lengths in Angstroms (Thr (black); 
Ser (blue)), of the transition structures (TSaa) and product complexes (PCaa) for threonylation 
of the cognate tRNAThr as catalyzed by ThrRS. (aa=Thr, R=-CH3; aa=Ser, R=H)  
 
In contrast, when threonylation follows from the alternate reactive complex bRCThr (i.e., 
the substrates b-hydroxy remains deprotonated pathway B), the reaction proceeds via 
bTSThr at a markedly lower cost of 81.3 kJ mol-1 or 108.9 kJ mol-1 relative to bRCThr or 
bPRCThr, respectively. Furthermore, the corresponding product complex bPCThr lies 37.4 kJ 
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mol-1 lower in energy than bRCThr, and 9.8 kJ mol-1 lower in energy than aPRCThr. That is, 
threonylation via pathway B is exothermic. 
In both pathways, the hydrogen bond networks between the leaving AMP moiety and 
active site residues are essentially the same and with similar interaction distances. Namely, 
the side chains of Arg363 and Lys465, the latter indirectly via a water, stabilize the negative 
charge of the phosphate as well as the increasing negative charge on its bridging oxygen Ob 
(Scheme 3.3). The key differences between the pathways instead involve the ligands and 
coordination of the Zn(II) center. 
For pathway A, as can be seen in Scheme 3.3, in the transition structure aTSThr an active 
site water has ligated to the Zn(II) center with a Zn(II)…OH2 distance of 2.33 Å. 
Simultaneously, this water hydrogen bonds with both the side chain carboxylate of Asp383 
and the substrates carbonyl oxygen Ocarb with distances of 2.12 and 1.72 Å, respectively. It 
is noted that Ocarb also retains its hydrogen bond with the side chain amide of Gln381; 
r(Ocarb…H2NGln381) = 1.96 Å. In the resulting product complex aPCThr the water remains 
bound to the Zn(II) center, though now at a slightly longer distance of 2.58 Å. This is likely 
due in part to the fact that the b-OH group remains both neutral throughout the mechanism 
and hydrogen bonded to the side chain carboxylate of Asp383 in both aTSThr (2.29 Å) and 
aPCThr (2.29 Å). Consequently, the cationic Zn(II) center becomes and remains 
pentacoordinate. 
In contrast, in the alternate pathway B in which the substrates b-hydroxy group is 
deprotonated, the Zn(II) ion remains tetracoordinate throughout. More specifically, as seen 
in Scheme 3.3, in bTSThr an active site water forms a strong hydrogen bond bridge between 
the b-O and Ocarb centers with distances of 1.66 and 1.94 Å, respectively, Scheme 3.3. The 
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Ocarb center again retains its hydrogen bond to the amide of Gln381 with length 
r(Ocarb…H2NGln381) = 1.92 Å. These shorter hydrogen bonding interactions compared to 
those observed in aTSThr suggest that in bTSThr there is greater stabilization of the negative 
charge buildup on Ocarb that occurs during aminoacyl transfer. It should also be noted that 
despite maintaining a hydrogen bond with the neutral side chain carboxylate of Asp383 
throughout the mechanism, Thrβ-O also remains strongly ligated to the Zn(II) ion in both 
bTSThr and bPCThr with distances of 2.02 and 2.00 Å, respectively (Scheme 3.3). The lower 
energies of bTSThr and bPCThr compared to aTSThr and aPCThr is due to several factors 
including that for pathway B the Zn(II) ion is tetracoordinate and forms a neutral complex, 
being ligated to two histidyl's and a cysteinyl thiolate residue as well as the Thrb-O– centre. It 
has been previously noted that neutral charged Zn complexes are more stable than 
corresponding complexes with either positive or negative charges.43 
 
Figure 3.3. Overlay of the substrates in the optimized structures of the bound Thr-AMP 
substrate (bPRCThr) and the studied substrates a) bPRCSer, b) PRCVal and c) PRCDThr. 
 
3.3.4 Aminoacylation (Serinylation) Mechanism.  
Aminoacylation using the non-cognate but viable substrate SerAMP exhibited, in general, 
similar trends to that observed for ThrAMP (Figure 3.4). However, some key differences in 
the structures and mechanisms were seen (see also Scheme 3.2). 
Zn(II)
tRNA tRNA tRNA
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bPRCThr
bPRCSer
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For instance, aminoacyl transfer in which the serinyl's Serβ-hydroxyl group ligated to the 
Zn(II) is deprotonated (i.e., pathway B) occurs with a significantly lower barrier than the 
alternate mechanism for when it is neutral (pathway A; Scheme 3.2). More specifically, 
aPRCSer can readily interconvert with bPRCSer via TS1Ser with a barrier of just 18.0 kJ mol-
1. This step is simply proton transfer from the SerβOH group to Asp383. The pre-reactive 
complex bPRCSer can then readily form bRCSer by breaking of the labile Zn(II)…NH2 
substrate bond. Notably, bRCSer lies lower in energy than aPRCSer by 14.5 kJ mol-1. The 
subsequent aminoacyl transfer occurs via bTSSer with a barrier of 128.9 kJ mol-1 with respect 
to bRCSer (or 114.4 kJ mol-1 relative to aPRCSer). The final product complex lies slightly 
higher in energy than aPRCSer by 7.2 kJ mol-1. Thus, the overall serinylation mechanism is 
slightly endothermic. 
 
 
Figure 3.4. The calculated PES surfaces for aminoacylation (serinylation) as catalyzed by 
ThrRS for when the serinyl moieties b-hydroxyl group ligated to the Zn(II) is neutral (blue) 
or deprotonated (black) throughout the mechanism. 
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The alternate mechanism in which the Serb-OH group remains neutral while ligated to the 
Zn(II) ion (pathway A), proceeds via aTSSer with a significantly higher barrier of 153.5 kJ 
mol-1 relative to aPRCSer (Figure 3.4). Unlike that observed for threonylation, both possible 
serinylation pathways give the same final product complex bPCSer.  
That is, the product obtained is that in which the serinyl's β-hydroxy is deprotonated while 
ligated to the Zn(II) ion (Scheme 3.2). Thus, unlike that observed for ThrAMP, serinylation 
via either potential pathway is endothermic and hence disfavored. It is noted that the barriers 
for serinylation via aTSSer (153.5 kJ mol-1) and bTSSer (128.9 kJ mol-1) both lie higher in the 
relative energy than those for the analogous pathways for Thr-AMP which had barriers of 
150.9 kJ mol-1 (aTSThr) and 108.9 kJ mol-1 (bTSThr), respectively (Figure 3.2). 
Experimentally, both cognate Thr-AMP and non-cognate Ser-AMP are observed to be viable 
substrates for aminoacylation by ThrRS, with Thr-AMP preferred.13-14, 23 The present results 
suggest that in both cases aminoacylation proceeds via pathway B in which the substrates 
b-hydroxy group is deprotontated when ligated to the Zn(II) center. 
 
3.3.5 Discrimination against Val.  
As noted in the Introduction, ThrRS must necessarily also discriminate against valine 
due to its similar shape and volume to threonine. However, unlike threonine, and serine, it 
lacks a side chain b-OH to interact with the Zn(II) ion. In addition, it does not undergo 
ThrRS catalyzed aminoacylation.13 However, in order to obtain a more complete 
understanding of discrimination by ThrRS we also examined binding of Val-AMP within the 
active site of ThrRS and the subsequent possible mechanisms of aminoacylation. Optimized 
structures obtained for the pre-reactive, reactive, transition structure and product complexes 
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are shown in Scheme 3.4 along with select bond distances (Angstroms) and relative energies 
(kJ/mol). 
Two possible pre-reactive complexes, aPRCVal and bPRCVal, were obtained (Scheme 
3.4). In both, the valinyl moiety of the substrate is bound to the Zn(II) ion by only its neutral 
α-amine group. In the lower energy pre-reactive complex aPRCVal, the Zn(II)…NVal distance 
is 2.19 Å. More importantly, the Zn(II) is tetracoordinate as it is also still ligated to the 
enzyme via a cysteinyl thiolate and two histidyl imidazoles. In addition, the active site water 
which is ligated to the Zn(II) in the apoenzyme but presumably displaced upon substrate 
binding,13 forms a hydrogen bond bridge between the carboxylate of Asp383 and the 
substrates carbonyl oxygen with Asp383COO–…H2O and Ocarb…H2O distances of 1.66 Å and 
2.19 Å, respectively. Meanwhile, the Zn(II)…OH2 distance is 3.69 Å. 
The alternate pre-reactive complex bPRCVal lies markedly higher in energy by 63.5 kJ 
mol-1. Notably, the active site water is now also ligated to the Zn(II) ion with a distance of 
2.19 Å and as a consequence the Zn(II) ion is pentacoordinate, Scheme 3.4. The most 
significant difference in the substrate–enzyme hydrogen bonding network between the two 
pre-reactive complexes involves the substrates Ob center. In aPRCVal it is hydrogen bonded 
to the guanidinium of Arg363, whereas in bPRCVal the latter instead hydrogen bonds to one 
of the substrate's phosphate oxygens, r(Arg363NH2…Opro-R) = 2.32 Å. It should also be noted 
that unlike the orientation of the substrate in the corresponding ThrAMP analogue, bPRCThr, 
the position of the substrate’s Ob center in bPRCVal is also 1.24 Å further away from the 
Arg363’s guanidinium group with r(Arg363NH2…Ob) = 3.13 Å. This difference is also seen in 
an overlay of the active site-bound substrate structures of bPRCVal and bPRCThr (Figure 3.3). 
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We then examined possible mechanisms by which aminoacylation may proceed from 
either pre-reactive complex (i.e., beginning from a tetra- or pentacoordinate Zn(II) complex). 
However, a pathway could only be elucidated for the latter with a water ligated to the Zn(II) 
throughout. In the reactive complex (RCV), which lies 80.1 kJ mol-1 higher in energy than 
aPRCVal, the Zn(II)…NVal bond has broken. As for the other reactive complexes considered 
herein the nitrogen of the valinyl's α-NH2 now forms a strong hydrogen bond with the A763'-
OH group of the tRNAThr with a distance of 1.76 Å. Concomitantly, the r(Ado763'-O…Ccarb) 
distance has shortened to 2.82 Å, which is 0.05 Å longer than observed in bRCThr (cf. 
Scheme 3.2). 
The Zn(II) center is now tetracoordinate and the ligated water has been deprotonated, 
transferring one of its protons onto the carboxylate of Asp383. Consequently, the Zn…Owater 
distance has shortened markedly to 1.94 Å (Scheme 3.4). Aminoacyl transfer then occurs 
via TS2Val with an energy barrier of 161.2 kJ mol-1 relative to aPRCVal. This barrier is the 
highest of all aminoacylation pathways elucidated in this study and is not enzymatically 
feasible. The product complex PCVal, in which the valinyl moiety had been transferred onto 
the A763'-oxygen, lies 91.6 kJ mol-1 higher in energy than aPRCVal indicating that overall 
mechanism is also thermodynamically highly unfavorable. 
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Scheme 3.4. Optimized structures, with selected bond lengths (Angstroms) and relative 
energies (in parentheses; kJ mol-1) shown, of the pre-reactive and reactive complexes of 
ThrRS…Val-AMP/tRNAThr, and the transition structure and product complex for 
aminoacylation. 
 
3.3.6 Chiral Discrimination against D-Threonine 
 It has been stated that for correct protein folding it is imperative that their constituent 
amino acids be homochiral.44 Indeed, amino acids in proteins occur in their L-isomer form. 
It is known that D-amino acid deacylases (DTD), which show similarities to the editing site 
of ThrRS, edit D-aminoacylated-tRNA formed by aaRS.45-46 However, ThrRS may also help 
enforce the homochirality of the aminoacylation process by discriminating, at least partially, 
between D- and L-threonine. Indeed, for AspRS and HisRS differences in the enzyme-
substrate recognition network between the non-cognate D- and cognate L-substrates in their 
aminoacylation sites has been suggested as the main reason for their discrimination and 
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hence, stereospecificity of the aminoacylation process.47-48 Hence, the ability of the 
aminoacylation site of ThrRS to discriminate against the non-cognate enantiomer D-
threonine was investigated. Key optimized structures obtained along the aminoacylation 
pathway, with selected bond lengths (Angstroms) and relative energies (kJ mol-1), are shown 
in Scheme 3.5. 
As observed for its corresponding enantiomeric cognate substrate L-Thr-AMP, two 
different pre-reactive complexes were obtained, aPRCDThr and bPRCDThr. In the former 
complex the substrates threonyl moiety is ligated to the Zn(II) center via only its α-amine 
nitrogen with a distance of 2.14 Å (Scheme 3.5). The Zn(II)…(H)O-βDThr distance is 
considerably longer at 2.92 Å, though this is 0.39 Å shorter than observed in aPRCThr. In 
contrast, in bPRCDThr, which lies 33.0 kJ mol-1 higher in energy, the substrates threonyl 
component is ligated to the Zn(II) center via both its side-chain b-oxygen and α-amine 
nitrogen with distances of 2.09 and 2.34 Å, respectively. The latter Zn(II)…NDThr interaction 
is 0.16 Å longer than observed in the analogous complex bPRCThr. It is important to note 
that all other Zn(II)…Nsubstrate and Zn(II)…O-bsubstrate interaction distances obtained in the 
stationary points along the D-threonylation pathway are within 0.05 Å of those obtained for 
their corresponding L-Threonyl containing complexes (cf. Scheme 3.2 and Scheme 3.3). 
Furthermore, and as also observed in bPRCThr (see Scheme 3.2), the threonyl's b-hydroxy 
group has transferred its proton to the carboxylate of Asp383. But, in contrast to that seen in 
bPRCThr, the side chain guanidinium of Arg363 does not form a hydrogen bond with the 
mechanistically key bridging phosphate oxygen Ob as indicated by their separation of 
r(Ob…H2NArg363) = 3.25 Å. Instead, as in aPRCDThr it remains hydrogen bonded to one of 
the substrate's non-bridging phosphate oxygens and carbonyl oxygens with distances of 2.23 
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and 1.78 Å, respectively. Comparison of the bPRCThr and bPRCDThr complexes (Figure 3.3) 
suggests that the shift in position of the latter's Ob center relative to a terminal amine of the 
adjacent Arg363 is one of the main differences between these two complexes. 
In contrast to that observed for threonylation using L-Thr-AMP (cf. Figure 3.2), the 
corresponding reactive complex RCDThr lies 6.0 kJ mol-1 lower in energy than the preceding 
bPRCDThr. However, despite this, its energy relative to aPRCDThr (27.0 kJ mol-1) is in close 
agreement with that obtained when L-Thr-AMP is the substrate (Figure 3.2; 27.6 kJ mol-1). 
Structurally, as observed in the reactive complex for L-Thr-AMP, the Zn(II)…NDThr bond in 
RCDThr has cleaved as indicated by its distance of 3.39 Å. Again, the nitrogen of the α-NH2 
group now forms a relatively short hydrogen bond to the Ado76-3'OH group of the tRNAThr 
with a length of 1.86 Å. Meanwhile, the mechanistically relevant Ado763'O…Ccarb distance is 
now 2.73 Å, which is 0.04 Å shorter than observed in bRCThr (Scheme 3.2) It is also notable 
that the Ocarb center also now forms strong hydrogen bonds with the nearby Gln381, 
r(Ocarb…H2NQ381)= 1.91 Å, and Arg363, r(carbO…H2NR363= 1.79 Å). However, the Ob center 
still has not formed a hydrogen bond with Arg363, the shortest bO… HNR363 distance being 
3.14 Å (Scheme 3.5). 
Aminoacylation of the tRNA then proceeds via TSDThr at a cost of 116.9 kJ mol-1 relative 
to aPRCDThr. This is 8.0 kJ mol-1 higher in energy than obtained for the analogous 
mechanism involving L-Thr-AMP (cf. Figure 2). This may in part be due to the lack of charge 
stabilization on the Ob center via hydrogen bonds with any enzyme residues, in particular 
Arg363 as observed in bTSThr (cf. Scheme 3.5). It is also noted that the increasing negative 
charge on the Ocarb center is stabilized by hydrogen bonds with the side chains of Gln385 and 
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Arg363 with r(Ocarb…HNQ363) and r(Ocarb…HNArg363) distances of 2.0 Å and 1.69 Å, 
respectively (Scheme 3.5). 
 
Scheme 3.5. Optimized structures, with select bond lengths (Angstroms) and relative free 
energy (values in brackets) shown, of the fully-bound active sites of the pre-reactive (PRC), 
reactive (RC), transition structure (TS), and product (PC) complexes for aminoacylation by 
D-threonine as potentially catalyzed by ThrRS. 
 
In the final product complex PCDThr the A763'-O–Ccarb bond has formed with a length of 
1.36 Å. Aminoacylation is accompanied by concomitant release of the substrates adenosine 
monophosphate moiety. However, the Ccarb…Ob bond in PCDThr has only elongated to 1.53 
Å whereas in the analogous L-threonyl containing complex bPCThr the Ccarb…Ob distance is 
2.98 Å. This likely reflects a lack of stabilization of the negative charge on the AMP’s Ob 
center in bPCDThr by hydrogen bonding with the guanidinium of Arg363, unlike that 
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observed in bPCThr. In addition, distinct from that observed in all other product complexes 
examined herein, the AMP's Opro-s center remains unprotonated. In other words, the side 
chain protonated amine of Lys465 and active site water have not transferred a proton onto 
the Opro-S center in bPCDThr though it does retain a quite strong hydrogen bond with the 
bridging water, r(Opro-S…HH2O) = 1.49 Å. Importantly, PCDThr lies significantly higher in 
energy relative to aPRCDThr by 100.9 kJ mol-1, indicating that aminoacylation involving D-
Thr-AMP is highly unfavorable (Scheme 3.5) Furthermore, the reverse reaction has a barrier 
to reaction of just 16 kJ mol-1 suggesting that it is likely to occur quite readily for any product 
formed. 
3.4 Conclusion  
    The roles of the active site Zn(II) and residues in the aminoacylation mechanism catalyzed 
by threonyl-tRNA Synthetase (ThrRS) has been computationally investigated. Specifically, 
their role in ThrRS's ability to discriminate between its cognate substrate L-threonine and 
non-cognate L-serine, L-valine, and D-threonine has been examined using molecular 
dynamics (MD) and ONIOM QM/MM methods. 
For both L-Thr- and L-Ser-AMP two pre-reactive complexes (PRC) were obtained. In 
the lower energy complex (aPRCThr/Ser) the ligand binds to the Zn(II) only via its aminoacyl 
a-NH2 nitrogen; i.e., the Zn(II) is tetracoordinate. In the alternate PRC complexes lying 
higher in energy by 14.0 (bPRCThr) and 9.3 (bPRCSer) kJ mol-1, the aminoacyl is bidentately 
ligated to the Zn(II) via its a-NH2 nitrogen and b-hydroxyl oxygen; i.e., the Zn is 
pentacoordinate. 
Similarly, for both L-Thr- and L-Ser-AMP two possible reactive complexes (RC), in 
which the Zn(II)…N-asubstrate bond has been broken, were obtained. In the higher energy 
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complexes, aRCThr/Ser, the Zn(II)-ligated b-OH group of the substrate's aminoacyl moiety 
remains neutral. In contrast, in the lower energy reactive complexes bRCThr/Ser the 
aminoacyl's Zn(II)-ligated b-hydroxyl has transferred its proton to the nearby carboxylate of 
Asp383. This transfer and the substrate's b-OH group acidity is facilitated by the Lewis 
acidity of the Zn(II) and the presence of the Asp383 residue. Consequently, in bRCThr/Ser a 
neutral tetracoordinate Zn(II)-ligand complex is formed. Deprotonation of the b-hydroxyl 
results in shorter Zn…-O-bsubstrate bond which in turn helps better position the substrate 
relative to the tRNAaa and important active site residues for the subsequent aminoacyl 
transfer. Notably, the substrates a-NH2 forms shorter hydrogen bonds with the A763'-OH 
moiety and, in general, the mechanistically central A763'-O…Ccarb distance is greatly reduced 
in bRCThr/Ser compared to aRCThr/Ser. The substrate's non-bridging phosphate oxygen Ob 
forms shorter, stronger hydrogen bonds with Arg363. The subsequent ThrRS catalyzed 
aminoacyl transfer occurs in one step with barriers of 108.9 and 128.9 kJ mol-1 for L-Thr- 
and L-Ser-AMP, respectively. From both kinetic and thermodynamic perspectives, 
aminoacylation of threonine is preferred. When the substrates Zn(II)-ligated b-hydroxyl 
group remains neutral, aminoacylation occurs with significantly higher barriers of 150.9 and 
153.5 kJ mol-1 for L-Thr- and L-Ser-AMP, respectively. In addition, in their respective 
transition structures and product complexes the Zn(II) ion is pentacoordinate as they also 
bind an active site water and thus, is also not charge balanced by its ligands. Also, the 
increasing negative charge on Ob during the reaction is not stabilized by hydrogen bonding 
with Arg363.  
L-Val-AMP, lacking a b-hydroxyl, is unable to form a Zn…O-b bond and thus help form 
a neutral Zn(II) complex and facilitate cleavage of the Zn…N-a bond. Furthermore, it also 
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does not form a stabilizing Ob…H2NArg363 hydrogen bond. Hence, aminoacylation by L-
valine is kinetically and thermodynamically disfavoured. 
The enantiomeric D-Thr-AMP interacts with the Zn(II) center throughout the 
aminoacylation process in a manner similar to that observed for L-Thr-AMP. However, 
unlike L-Thr-AMP, its key non-bridging phosphate Ob center does not form and thus is not 
stabilized by a hydrogen bond with Arg363. Hence, the barrier for aminoacylation (116.9 kJ 
mol-1) is higher than that of its cognate L-enantiomer. Furthermore, the final product complex 
is 100.9 kJ mol-1 higher in energy than the initial complex aPRCDThr and hence is not 
thermodynamically favoured. This may indicate a possible role for the aminoacylation site 
of ThrRS in chiral discrimination. The present results illustrate how enzymes are able to 
modify the properties of their substrates and in doing so, can cause subtle but critical 
positional shifts in the bound substrate that facilitate the reaction. Furthermore, it also shows 
how this can be exploited by enzymes to discriminate against potential non-cognate 
substrates including chiral enantiomers. The present results also provide insights for possible 
future experimental studies including mutation of identified key active site residues such as 
Arg363, Asp383, and Gln381. 
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4.1 Introduction 
 
Aminoacyl-tRNA synthetases (aaRSs) are essential enzymes with extensive roles in a 
wide range of biological functions; however, protein biosynthesis remains their central 
purpose.1-3 AaRSs are a family of enzymes that are well known to ligate an amino acid to 
its corresponding tRNA with exceptional specificity.4 Many encoded amino acids are 
structurally or chemically quite similar and consequently it can be challenging to 
discriminate between them.5 Thus, to avoid any deleterious mistranslation errors, these 
enzymes possess different editing functions and almost half of them incorporate a separate 
proofreading domain.4, 6-7 
Glutaminyl-tRNA synthetase, GlnRS, is a class I aaRS which specifically attaches 
glutamine to the cognate tRNAGln yielding Gln-tRNAGln. It is able to discriminate against 
the isosteric non-cognate amino acid glutamate by 107-fold.8 This high accuracy is achieved 
without any free-standing editing domain.9 It has been suggested that unlike the noncognate 
glutamate, glutamine adopts a catalytically favourable binding mode in the active site of 
GlnRS; an arginine residue acts as a negative selectivity determinant and positions 
glutamate in a less productive orientation.10  
Although it is commonly thought that translation requires remarkable fidelity, it has 
recently been proposed that inaccuracies in the process should be considered a “double-
edged sword”.11 Particularly, many aaRSs are found to tolerate moderate levels of 
mistranslations,12 and these can be better described as adaptive translation.13 Only 
eukaryote and some bacteria species have the aaRSs for all twenty canonical amino acids, 
and accordingly tRNA-dependent indirect (noncanonical) pathways are needed for the 
biosynthesis of different amino acids in the remaining species.14 The aaRSs involved in 
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these pathways, in addition to identifying their cognate tRNAs, can also accommodate non-
cognate tRNA for which the corresponding aaRS is missing. 
For example, most prokaryotic species lack GlnRS. Instead, they use an alternative 
indirect route that involves a distinct type of non-discriminating (ND) GluRS enzyme, ND-
GluRS, to achieve glutamine aminoacylation.15-16 Specifically, the ND-GluRS covalently 
links glutamate to the noncanonical tRNAGln to yield the misacylated Glu-tRNAGln. A 
similar situation exists for the aminoacylation of tRNAAsn with aspartate, which is also 
catalysed by a non-discriminating enzyme, ND-AspRS.17 These mischarged tRNAs (Glu-
tRNAGln and Asp-tRNAAsn) are subsequently converted to Gln-tRNAGln and Asn-
tRNAAsn by Glu-tRNAGln and Asp-tRNAAsn amidotransferase, respectively.18 
The main difference between discriminating and non-discriminating GluRS is the 
presence of an arginine residue in the latter; its mutation to glutamine results in a ND-
GluRS.19 Aside from this structural difference, both GlnRS and ND-GluRS can recognize 
tRNAGln and participate in glutamine aminoacylation through direct and indirect routes.20 
AaRS-catalysed aminoacylation mechanism involving glutamine occurs within the 
aminoacylation site through two main steps, namely activation and acylation.21 Specifically, 
the glutamine amino acid is first reacted with ATP through an inline displacement 
mechanism to yield glutaminyl-AMP;22-23 in this form, the glutamine moiety is favourably 
oriented for the subsequent acylation. This is initiated when a base abstracts the proton 
from the Ado762′-OH group of the tRNA sugar terminal which attacks the carbonyl (Ccarb) of 
the substrate, producing the glutaminylated-tRNAGln (Gln-tRNAGln), Scheme 4.1.24 It is 
generally accepted that the catalytic domain of aaRSs lack a mechanistic base residue and, 
accordingly, a general substrate-assisted catalytic mechanism is believed to operate.24-25 In 
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particular, the aminoacylation mechanism of GlnRS has been proposed to exploit the same 
general mechanism as in HisRS, TrpRS, MetRS and PheRS: one of the non-bridged 
phosphate oxygens (O1p or O2p) of the glutaminyl-AMP acts as the requisite base.26-28 
 
Scheme 4.1. The general substrate-assisted acylation mechanism in Gln-/GluRS, (X=NH2 
or O), two different non-bridged oxygens (O1p and O2p) in addition to the bridged oxygen 
(Ob) are available to participate.  
 
In the case of HisRS, experimental substitution of one of the substrate's non-bridging 
oxygens for sulphur diminished the rate of reaction 10000-fold which is strongly indicative 
of the involvement of these oxygens in this substrate-assisted mechanism.24 More recently 
our group performed a DFT-cluster study on the aminoacylation mechanism in HisRS.29 In 
particular the potential for each of the substrate's phosphate oxygens to act as the catalytic 
base was examined, i.e. the bridging (Ob) or non-bridging oxygens (pro-R and pro-S). 
Importantly, the pro-S non-bridging oxygen was found to be the most favourable base and 
lead to the only feasible activation energy. 
In the case of GlnRS the catalytic mechanism is contested, being suggested to be 
promoted either by the nearby Glu34 active site residue or one of the phosphate oxygens.27, 
30-31 According to an early crystallographic study, Glu34 may be able to act as the required 
mechanistic base, via a bridging water molecule, that deprotonates the tRNA's Ado762′-OH 
group;30 the authors disputed the previously proposed mechanism where one of the 
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phosphate oxygens is the base. Furthermore, the pKa of the phosphate oxygens were 
calculated to be 1.5-2.0, which suggests an inability to abstract a proton. However, more 
recent mutagenesis analysis countered this hypothesis and emphasized that Glu34 plays no 
role in initiating the acylation mechanism. When Glu34 was replaced by glutamine the rate 
of reaction was decreased by a factor of 103-104 fold, but not completely inhibited.26 This 
significant impact on the reaction rate was found to be a result of a structural change in the 
conformation of the active site binding pocket upon mutation. This argument was supported 
by the observation that this glutamate residue is not conserved among the other aaRS, even 
in the structurally similar GluRS.26 In addition, they found that the pKa of phosphate group 
rises during the reaction, meaning the basicity of the oxygen atoms is enhanced. 
Our group has a long-standing interest in the mechanisms operating in aaRS 
enzymes;29, 32 the principal aim of this study is to provide atomistic details regarding the 
direct and indirect pathways towards the formation of Gln-tRNAGln. We have sought to 
clarify the impact of the Glu34 residue within the synthetic site of GlnRS and to identify 
the base in the mechanism. To further validate these findings, we have expanded our 
investigation to the non-discriminating enzyme, ND-GluRS. Our results clarify the 
suggested substrate-assisted scenario for this aminoacylation mechanism, which may be 
common to other class I aaRSs. 
4.2 Computational Methods  
 
      4.2.1. Molecular Dynamic Simulation 
 
Suitable experimental X-ray crystal structures for GlnRS (PDB ID: 1EUQ33) and ND-
GluRS (PDB ID: 3AKZ34) with substrate analogues bound were used as templates for the 
chemical models. Using the Molecular Operating Environment (MOE) software35 we 
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prepared the two X-ray structures for Molecular Dynamics (MD) simulations. This 
preparation included mutation of the substrates to the native forms, addition of missing 
hydrogen atoms considering protonation states as predicted by MOE, and solvation by 
adding a 2 Å layer of water. This generated solvated GlnRS…Gln-AMP/tRNAGln and ND-
GluRS…Glu-AMP/tRNAGln complexes, with total atom counts of 22158 and 20906 
respectively. Also, the Glu34Gln mutant of GlnRS, an isostructural mutation designed to 
investigate the structural role of Glu34 in the active site, was generated in silico. A recent 
experimental site-directed mutagenesis study on the Glu34Gln  mutant was observed to 
have comparable overall kinetics to the wild-type enzyme.26  
Finally, unconstrained molecular mechanics (MM) minimizations using the AMBER12 
force field until the root mean square gradient fell below 0.01 kcal/mol·Å were performed 
on all the studied systems. It should be noted that both GlnRS and ND-GluRS enzymes are 
considered ribonucleoprotein enzymes where the tRNA is essential for the catalytic 
mechanism to proceed properly.36 Thus all the MD simulations have been performed with 
the tRNA bound. The minimized structures were then submitted for 100 ps annealing 
equilibration from 150 to 300 K at constant pressure. The resultant structures were set up 
for a 10 ns simulation run with a time step of 2 fs as per the default settings of the MOE 
software. These settings include a cutoff at 10 Å for non-bonded interactions and tether 
ranges from 0–100 Å applied to the heavy atoms. All MD simulations were performed 
using the NAMD program.37 All sampled conformations in each MD simulation were 
analysed and clustered based on their root mean square deviations (RMSD) relative to the 
first structure. Notably, the equilibrium state was achieved after the first 5 ns where the 
system reached a stable conformation state. A representative structure of the most 
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prominent conformation was then truncated to include all atoms within 20 Å of the 
substrate to generate the chemical model for the following QM/MM calculation. 
 
      4.2.2 QM-Cluster and QM/MM calculation  
 
The Gaussian09 program package was used for all QM and ONIOM(QM/MM) 
calculations.38 In order to compare between the two different possible mechanisms, we 
started our investigation by performing QM-cluster-based calculations. This approach has 
been successfully used to examine many catalytic mechanisms.39 The chemical cluster 
models used herein for GlnRS and ND-GluRS, included the Gln-/Glu-AMP substrates and 
the 3′-terminal adenosine (Ado76) nucleotide of the tRNA moiety (Figure 4.1). In addition, 
they also included all residues that may participate in initiating the mechanism, stabilizing 
the transition state (TS), and/or neutralizing the phosphate-leaving group. The rest of the 
protein has been omitted after capping the carbon atoms. 
 
Figure 4.1. Schematic drawing of the QM models used for the QM-cluster and the QM-
region within the QM/MM models for (a) GlnRS (PDB ID: 1EUQ) and (b) ND-GluRS 
(PDB ID: 3AKZ). The substrate's aminoacyl moiety in each is highlighted in red. 
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More specifically, for the GlnRS model (total of 146 atoms) Asp66 has been included 
due to its role in positioning the Gln-AMP substrate through salt bridge formation with the 
α-NH2 group in the optimum orientation for the reactions. His43 and Lys270 are also 
included since they stabilize the phosphate groups and the carbonyl oxygen (Ocarb) of the 
substrate. Glu34 was also included in order to study the impact of its mutation on the 
mechanism. Finally, Lys72 was included due to its direct hydrogen bond interaction with 
Glu34. In the mutated Glu34Gln GlnRS model, the same residues have been represented 
except the Glu34Gln mutation. 
For the ND-GluRS QM-cluster model (total of 138 atoms), Arg28 and Arg216 were 
included due to their direct hydrogen bond interactions with the carboxylate groups of the 
Glu34 residue and the substrate (i.e. GluCOO−). In addition, Lys257 and Pro31 were 
included as they stabilize the developing negative charge on the phosphate group. Asp64 
was also incorporated because of the salt bridge formation with the substrate's α-NH3+ 
group. His220 was included to stabilize the developing negative charge on the substrate’s 
Ocarb centre. 
The M06-2X density functional method was used throughout this study as the QM 
method of choice as it is stated to provide a good description for non-covalent long-range 
interactions and has previously outperformed B3LYP in representing the kinetic energy 
barriers of different systems.40 
For all QM-cluster studies, and in order to approximately represent the protein's polar 
environment, optimizations were obtained at the M06-2X/6-31G(d,p) level of theory. 
Vibrational frequencies were also obtained at this level of theory so as to identify the nature 
of the stationary points and to estimate the thermal energy corrected to 298.15 K (ΔE298). 
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Afterwards, single point energy calculations were performed on the above structures 
using the IEFPCM solvation model with a dielectric constant (ε) of 4.0 at M06-2X/6-
311+G(2df,p) level of theory with inclusion of the appropriate ΔE298.41  
Subsequently, the ONIOM(QM/MM) method was employed to more extensively explore 
the catalytic mechanism.42-43 In this approach each enzyme-complex system was divided 
into two subsystems. The QM layer (reactive region) of each included the key active site 
residues (Figure 4.1) most relevant to the mechanism and was effectively identical to the 
corresponding QM-cluster model (except for the capped hydrogen atoms). Meanwhile, the 
surrounding protein (low-layer) was modelled using the AMBER96 forcefield.44 Optimized 
geometries, frequencies, and approximate thermal energy corrected to 298.15 K (ΔE298) 
were obtained at the ONIOM(M06-2X/6-31G(d,p):AMBER96) level of theory. Relative 
energies were determined by single point calculations on the above optimized structures at 
the ONIOM(M06-2X/6-311+G(2df,p):AMBER96) level of theory with inclusion of the 
corresponding ΔE298. 
4.3 Results and Discussion  
 
     4.3.1. MD simulation of wildtype/mutant GlnRS and ND-GluRS 
 
     As noted in the Introduction, in the substrate-assisted aminoacylation reaction it is 
necessary for the Ado762′-OH proton to be abstracted by one of the oxygen atoms of the 
substrate’s phosphate. For both the solvated wildtype GlnRS…Gln-AMP/tRNAGln and 
mutant Glu34GlnGlnRS…Gln-AMP/tRNAGln complexes, a plot of Ado762′O…O1p distances 
obtained during the course of the MD simulations is shown in Figure 4.2a. Importantly, 
their average distances were found to be 6.75 Å and 6.04 Å, respectively. These distances 
are too great for there to be a direct interaction between the Ado762′O and O1p centres. This 
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suggests that if the phosphate is to act as the base there needs to be a bridging water 
molecule to facilitate the proton transfer process. Indeed, in the MD simulations of both 
complexes, it was observed that the non-bridging phosphate oxygens (O1p and O2p) of the 
substrate were typically engaged in hydrogen bonding interactions with one or more water 
molecules. For GlnRS…Gln-AMP/tRNAGln and ND-GluRS…Glu-AMP/tRNAGlu the 3D-
RISM solvent analysis tool, as implemented in MOE, was used to further characterize the 
water distribution (i.e. average positions) around the phosphate (Figure 4.3). Notably, there 
is a significant localization of the water molecules around the substrates O1p and O2p 
centres in both complexes. This highly hydrated environment suggests water may play a 
role as a mediator in catalysis. 
	
 
Figure 4.2.	 Plots of the variation in some key distances in Ångström along 10 ns 
simulations: a) Ado762′-O…O1p distance for wildtype (blue lines) and mutant (red lines) 
GlnRS; b) Ado762′-O…Ccarb distance for wildtype (blue lines) and mutant (red lines) GlnRS; 
c) Ado762′-O…O1p distance for ND-GlnRS; d) Ado762′-O…Ccarb distance for ND-GluRS.  
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For both the wildtype GlnRS…Glu/tRNAGln and mutated 
Glu34GlnGlnRS…Glu/tRNAGln complexes the mechanistically relevant Ado762′O···Ccarb 
distance was monitored over the course of the 10 ns MD simulation and are shown in 
Figure 4.2b. Importantly, the average distances are calculated to be reasonably similar at 
3.98 Å and 3.81 Å, respectively. This suggests that they are positioned reasonably close to 
each other for the subsequent reaction. 
For the ND-GlnRS…Glu/tRNAGln complex, analogous plots of the Ado762′O…O1p 
(Figure 4.2c) and Ado762′O…Ccarb (Figure 4.2d) distances obtained over the course of the 
MD simulations give average values of 4.54 and 3.25 Å, respectively. Similar to the 
corresponding discriminating GluRS complexes (see above), while the average 
Ado762′O…O1p distance may seem too large for a proton transfer to occur, water may be 
able to facilitate this process by acting as a bridge between the Ado762′OH and O1p centre 
(see Figure 4.3). Thus, both GluRS and ND-GlnRS may share a common substrate-assisted 
mechanism (c.f. Figure 4.2a and c). 
 
	
Figure 4.3.	 The first solvation shell directly hydrogen bonded to the phosphate groups in 
the substrates; the water oxygen density is in blue and the water hydrogen density is in grey. 
Chapter 4 
	 82 
4.3.2 QM-Only and QM/MM calculation 
 
            4.3.2.1 Wildtype GlnRS Catalysed Aminoacylation with Glutamine 	
4.3.2.1.1 QM-Cluster: the substrate's phosphate acting as the base		
If the substrate's phosphate group acts as the base there is the potential for one of its 
non-bridging oxygens (O1p) or bridging (Ob) oxygen to act as the proton acceptor. Hence, 
using a QM-cluster approach we examined the feasibility of either to act as the required 
base in the aminoacylation process. It should be noted that given that the MD results 
suggest that the phosphate may play such a role via a water bridge, an appropriate model 
was used for these studies. The results obtained are given in Table 4.1. 
As can be seen, the QM-cluster calculations (see Computational Methods) indicated a 
clear kinetic and, in general, thermodynamic preference for O1p to act as the base through 
the assistance of a bridging water molecule, rather than the Ob atom. An energy barrier of 
23.5 kcal/mol is obtained when the reaction is initiated by the O1p atom compared to a 
significantly higher barrier of 60.8 kcal/mol in the case of the Ob atom. The phosphate 
leaving groups in the obtained intermediate complexes (IC) are in their mono-protonated 
forms, since there is no participation from the nearby lysine residues. Accordingly, in the 
subsequent hybrid ONIOM(QM/MM) investigations on the aminoacylation mechanism in 
which the phosphate is the base, only the O1p atom was considered. 
 
Table 4.1. Free energy values (in kcal/mol) obtained for the two different mechanisms 
considered in case of the two enzymes using QM-only approach. 
Enzyme RC TS-O1p IC-O1p TS-Ob IC-Ob 
GlnRS 0.0 25.6 26.2 59.7 14.0 
ND-GluRS 0.0 25.0 42.0 51.1 −17.3 
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4.3.2.1.2 QM/MM: the substrate's phosphate acting as the base  
The QM/MM optimized (see Computational Methods) structures of the stationary 
points (reaction, intermediate, product complexes, and transition structures) obtained for 
the GlnRS catalysed aminoacylation of tRNAGln by Gln in which one of the substrates non-
bridging phosphate oxygens acts as the base are schematically shown in Figure 4.4. The 
corresponding potential energy surface obtained is shown in Figure 4.5. 
In the reactive complex (GlnRC) moderately strong hydrogen bond interactions are 
observed between Ado762′OH of the tRNA and a water (W1) molecule, r(Ado762′OH…OW1) = 
1.82 Å, and between the same W1 and the substrate's non-bridging phosphate oxygen O1p, 
r(W1H…O1p) = 1.80 Å. The other non-bridging oxygen of the phosphate, O2P, is stabilized 
through hydrogen bonds with the side chains of two different residues, the cationic Lys270 
residue and the nearby His43 residue at distances of 1.92 and 1.86 Å, respectively (Figure 
4.4). Notably, this hydrogen bond network around O2p indicates that the O1p atom will be 
the more basic one and supports the hypothesis that it is the mechanistic base. Notably, 
there is no direct interaction between the Glu34 residue and the Ado762′-OH group. Instead, 
the former is strongly hydrogen bonded to the nearby Lys72 residue at a distance of 1.67 Å. 
This strong salt bridge interaction suggests that Glu34 is also unlikely to act as the 
mechanistic base. 
In addition, the tRNA adenosine terminal is concomitantly appropriately situated for 
nucleophilic attack upon the Ccarb centre of the Gln-AMP substrate with r(Ado762′O…Ccarb) 
= 3.10 Å. This geometry of the substrates in the GlnRC thus appears to support the 
feasibility of a water-mediated substrate-assisted mechanism. 
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Figure 4.4.	 Schematic representation of the obtained complexes along the studied 
aminoacylation mechanism together with selected key distances in Ångstrom; black color 
distances for the native enzymes, blue are for the Glu34Gln mutant.  
 Aminoacyl transfer proceeds through a concerted transition state, GlnTS (Figure 4.4). 
More specifically, O1p has deprotonated the Ado762′OH group through the assistance of the 
bridging W1 molecule. Concomitantly, the Ado762′-oxygen has approached the Ccarb centre 
of the Glu-AMP substrate such that the Ado762′-O…Ccarb distance is now just 1.63 Å with 
concurrent elongation of the Ccarb—Ob bond from 1.34 to 1.52 Å. This is found to be a late 
transition state, since the proton of the W1 molecule is completely transferred to the non-
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bridged oxygen O1p of the phosphate group, r(H―O1p) = 1.01 Å (Figure 4.4). 
Concomitantly, a typical single bond has been generated between the former Ado762′-H 
proton and the oxygen of W1 (OW1) with a bond length of 1.00 Å. The accumulated 
negative charge on the Ocarb atom is stabilized through hydrogen bond formation to the 
nearby backbone –NH– of the Glu34 residue, r(N(H)…Ocarb) = 1.81 Å), which is 0.11 Å 
shorter than the corresponding distance in the reactive complex GlnRC. It is noted that the 
hydrogen bonding interactions between the Lys270 and His43 residues and O2p are 
maintained with distances of 1.72 and 2.00 Å, respectively. The energy barrier for GlnTS is 
25.0 kcal/mol relative to the corresponding GlnRC, indicating an enzymatically permissible 
step (Figure 4.5).  
Collapse of GlnTS results in formation of the intermediate complex GlnIC1 featuring a 
tetrahedral Ccarb (Figure 4.4). In this intermediate the Ado762′O―Ccarb single bond has been 
formed with a length of 1.53 Å, while the Ccarb…OPO4 distance has further elongated to 
1.57 Å. Similar to GlnRC, the developed negative charge on the Ocarb atom in GlnIC1 is 
stabilized through hydrogen bond interaction with the backbone amide –N(H)– group of the 
nearby Glu34 residue with a Glu34N(H)…Ocarb distance of 1.81 Å. Thermodynamically 
GlnIC1 was calculated to be 4.0 kcal/mol higher in energy than the initial reactant complex 
GlnRC ( Figure 4.5). 
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Figure 4.5.	 The free energy surface for the aminoacylation mechanism of glutamine in the 
case of the wildtype GlnRS (black color surface) and the Glu34Gln mutant GlnRS (blue 
color (dashed) surface). GlnTS2 and GlnTS2′ were obtained through scan calculations. 
 
It should be noted that in GlnIC1 the distance between the side chain amine of the 
Lys270 residue and the substrates O2P oxygen is shortened to 1.66 Å, which is 0.05 Å 
shorter than the corresponding distance in the preceding transition state (GlnTS; Figure 4.4). 
This decrease in the distance better stabilizes the AMP group and facilitates the subsequent 
proton transfer step from the Lys270 residue to the adjacent O2P atom via GlnTS2 (Figure 
4.4). As shown in the calculated potential energy surface this second proton transfer occurs 
without a barrier (−12.0 kcal/mol relative to the GlnRC, Figure 4.4). That is to say, once 
formed GlnIC1 can react without a further barrier to give the final product complex, GlnPC. 
In GlnTS2 the AMP moiety, cleaved from the initial Gln-AMP substrate, has moved 2.87 Å 
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away from the glutamine moiety, which has itself now been transferred onto its cognate 
tRNAGln as indicated by the typical single-bond character of the Ado762′O―Ccarb bond which 
has length of 1.38 Å. 
As noted, the product complex GlnPC, is obtained once the second proton transfer is 
complete. Notably, the O2P―H bond has now formed with a length of 0.98 Å while the 
glutamine and AMP moieties now lay 3.15 Å apart, Figure 4.4. Importantly, the obtained 
product complex GlnPC lies −29.9 kcal/mol lower in energy relative to GlnRC and hence is 
thermodynamically favourable, Figure 4.5. Taken together, the obtained potential energy 
surface of this water mediated substrate-assisted mechanism implies a kinetically and 
thermodynamically feasible pathway. 
 
     4.3.2.1.3 QM/MM: the substrate's α-NH2 acting as the base 
 It has been suggested that the substrate-assisted aminoacylation mechanism in some 
aaRS enzymes exploit the aminoacyl substrate’s α-NH2 group as the base. This was initially 
proposed by our group during a study on the aminoacylation of ThrRS,31 and has also 
recently been proposed for the case of leucyl-tRNA synthetases (LeuRS).45 In ThrRS the α-
NH2  group is activated (made neutral and thus able to act as a base) by the presence of a 
Zn(II) ion, while in LeuRS the protonated form of the substrate's α-NH3+ group is 
deprotonated by a conserved aspartate residue.45 Due to the presence of an aspartate residue 
(Asp66) proximal to the substrate α-NH2 in GlnRS, we expanded our study to explore the 
possibility of the latter group being the mechanistic base. The optimized structures obtained, 
with select bond distances and corresponding free energies, are summarised in Figure 4.6. 
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As can be seen, the relative energies of each of the stationary points (intermediate and 
product complexes, and transition states) along the pathway are significantly higher in 
energy compared to the values obtained for the previous case where O1p acted as the base. 
For example, the corresponding first intermediate, GlnIC1″, is 26.8 kcal/mol higher in 
energy than the initial reactive complex GlnRC, which is the common complex to both 
possible pathways. Notably, the α-NH2 group no longer interacts with the Asp66 residue but 
instead forms a moderately strong hydrogen bond to the Ado762′OH group with a distance of 
r(NNH2…HO-2′Ado76) = 1.74 Å. The subsequent step is transfer of a proton from the 
Ado762′OH group to the α-NH2    moiety with concomitant formation of the Ado762′O―Ccarb 
bond. Now, however, this occurs via the transition state GlnTS″ at a cost of 57.8 kcal/mol 
relative to GlnRC (Figure 4.6). This is 32.8 kcal/mol more than for aminoacyl transfer via 
GlnTS1 (c.f. Figure 4.5). Additionally, the product complex GlnPC″ is thermodynamically 
unfavourable lying 44.4 kcal/mol higher in energy relative to GlnRC. Accordingly, these 
findings discount the possibility of the substrate’s α-NH2 group acting as the catalytic base 
in the GlnRS enzyme from both kinetic and thermodynamic perspectives. 
Figure 4.6.	 Optimized structures for the aminoacylation mechanism in the wildtype GlnRS 
where the substrate’s α-NH2 acts as the mechanistic base, together with energy values (in 
kcal/mol, relative to the reactive complex) in parentheses. For clarity, the atoms that are 
involved in the reaction are highlighted.
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4.3.2.2 Aminoacylation by the Glu34Gln mutant of GlnRS.  
The results reported in the above sections indicate that the Glu34 residue is not directly 
involved in the aminoacylation mechanism. Instead, it participates in a salt bridge with the 
protonated side chain of a nearby lysyl residue, r(Glu34COO−···+H3NLys72) = 1.67 Å. 
However, as noted in the Introduction, experimental studies on the mutation of Glu34 to 
glutamine observed a rate decrease in the enzyme but not inhibition. Thus, to better 
understand the role of the Glu34 residue in the mechanism in silico mutagenesis was 
performed in which it was substituted by the isoelectronic and isostructural residue 
glutamine. Except for the Glu34Gln mutation all other active site residues are the same as 
in the wildtype. The potential energy surface obtained is shown in Figure 4.5. 
Significant changes are observed in the reactive complex obtained for the Glu34Gln 
mutant, GlnRC′, compared to that obtained for the wildtype (GlnRC). In particular, the 
mutation causes the substrate to shift position relative to the surrounding residues. For 
instance, unlike in the case of the wildtype enzyme, there no longer is a hydrogen bond 
between the Ado762′OH group and the W1 molecule. The latter W1 does retain its hydrogen 
bond with a non-bridging oxygen of the phosphate group though it is slightly longer at 
r(W1OH···O1p) = 1.85 Å (Figure 4.4). Moreover, the Ocarb···N(H)Gln34 hydrogen bond 
distance has increased by 0.35 Å to 2.28 Å and accordingly weakened relative to the 
wildtype enzyme. Similarly, the O2p···HNHis43 hydrogen bond has now been extended by 
0.14 Å to 2.00 Å. These two interactions are intended to stabilize the negative charges on 
the Ocarb and O2p, respectively, and the longer distances indicate less charge stabilization in 
the Glu34Gln mutant. However, it is noted that the weakening of the O2p···HNHis43 
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hydrogen bond is at least partially compensated for by the large decrease of 0.33 Å in the 
Lys270NH3+···O2p hydrogen bond to 1.59 Å (Figure 4.4). 
The aminoacylation pathway obtained for the Glu34Gln mutant was in general the 
same as the wildtype. For instance, the first step of the mechanism proceeds through the 
tetrahedral oxyanion transition state GlnTS1′. Notably, for the latter no significant changes 
from the analogous wildtype GlnTS1 (c.f. Figure 4.4) are observed in the interactions 
between the substrate and the surrounding residues. Thermodynamically, however, GlnTS1′ 
is 39.8 kcal/mol higher in energy with respect to its corresponding reactive complex, 
Figure 4.4. That is, for the Glu34Gln mutant the barrier for the first step is 14.8 kcal/mol 
higher in the energy. Since there is a negligible difference in the geometries of GlnTS1 and 
GlnTS1′, this energetic difference may be due to the structural influences of the Glu34Gln 
mutation on the reactive complex GlnRC′. More specifically, in the latter the mutation 
causes the Ado762′OH to be positioned in a less productive orientation for the subsequent 
substrate-assisted mechanism and thus, larger structural changes are required for the 
reaction to proceed. 
Collapse of the transition state GlnTS1′ leads to the generation of intermediate complex 
GlnIC′, which is 37.2 kcal/mol higher in energy than GlnRC′, Figure 4.5. It is noted that this 
is 33.2 kcal/mol higher in relative energy to the corresponding initial reactant complex than 
GlnIC. As shown in Figure 4.5 the wildtype and Glu34Gln intermediate complexes GlnIC 
and GlnIC′ respectively, are geometrically analogous; the two complexes possessing the 
same interactions, with similar distances, between the ligand and active site residues, 
Figure 4.4. Indeed, the largest difference is just 0.04 Å in the His43NH···O2p hydrogen bond. 
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Similar to the wildtype catalysed aminoacylation, the subsequent proton transfer from 
the side-chain protonated amine of Lys270 to the O2p atom occurred without a barrier via 
GlnTS2′. As shown in Figure 4.4 there are no significant differences in the distances 
between GlnTS2 and GlnTS2′; although the latter is 21.7 kcal/mol higher in energy. In the 
resulting product complex formed, GlnPC′, the AMP and glutamine are 3.09 Å apart from 
each other. The product GlnPC′ is thermodynamically favourable by 9.3 kcal/mol compared 
to GlnRC′. Notably, however, it less stable than the corresponding wildtype product GlnPC 
by 20.6 kcal/mol.  
 
  4.3.2.3 ND-GluRS Catalyzed Misacylation of tRNAGln by Glutamate 
 
As noted in the Introduction, in most prokaryotes the aminoacylation of tRNAGln is 
catalysed by the non-discriminating aaRS ND-GluRS. In particular, it binds and charges the 
non-cognate tRNAGln with glutamate, yielding Glu-tRNAGln, which is then converted to 
Gln-tRNAGln by a tRNA-dependent amidotransferase.18 To investigate the generality of this 
water-mediated substrate-assisted aminoacylation mechanism within this class of enzymes, 
we also investigated its feasibility in the ND-GluRS enzyme. 
As for discriminating GlnRS initially, QM-only calculations were performed on the 
two possible substrate-dependent mechanisms in which either the phosphates Ob or O1p 
oxygen centres act as the base, Table 4.1. Similar to the previous findings in the case of 
GlnRS, of these two when the O1p is acting as the required base leads to the most 
kinetically feasible mechanism with an activation energy of 24.2 kcal/mol, compared to 
50.3 kcal/mol in the case of Ob atom. It is worth noting that for the Ob mechanism, the 
intermediate complex IC-Ob is lower in energy than IC-O1p due to a proton transfer from 
the Lys270 residue to the O2p atom, resulting in a neutral phosphate leaving group. 
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However, due to the high barrier in the case of the Ob mechanism, all subsequent hybrid 
QM/MM calculations used O1p as the base. 
	
Figure 4.7.	 Schematic drawing of the complexes obtained during the O1p substrate-assisted 
aminoacylation mechanism of ND-GluRS, together with selected key distances in 
Ångstrom. 
 
The QM/MM optimized structure of the GluRC, derived from the previous MD 
simulations, is schematically shown in Figure 4.7. As for GluRS the Glu-AMP and the 
tRNA adenosine terminal (Ado762′OH) appear to be suitably positioned with respect to each 
other and the active site residues for the substrate-assisted mechanism to take place. For 
instance, again an active site water, W1, is positioned as a bridge between the 2′OHAdo76 of 
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the tRNA and the O1p of the Glu-AMP substrate with O(H)W1···O1p and W1O···Ado762′-
(H)O distances of 1.71 Å and 1.65 Å, respectively (Figure 4.4). 
Notably, the O2p atom is more stabilized, and thus less basic than O1p, due to the 
hydrogen bonding network it forms with the backbone –N(H)– group of the nearby Ser32 
residue (r(O2p…HNSer32) = 2.16 Å) and two distinct water molecules with O2p…Owater 
distances of 1.70 and 1.90 Å. The His220 residue, which will help stabilize the negative 
charge that develops on the substrate’s Ocarb centre, directly hydrogen bonds to the latter 
with r(HHis220…Ocarb) = 2.18 Å. Meanwhile, the α-NH3+ group of the Glu-AMP substrate is 
stabilized through salt-bridge formation with the nearby Asp64 residue at distance of 1.77 
Å. In addition, the substrate’s carboxylate group is stabilized by hydrogen bonding to the 
guanidinium side chains of two arginine residues, Arg216 and Arg28. Specifically, Arg28 
forms two moderately strong Arg28N(H)…OGlu hydrogen bonds at distances of 1.77 and 1.62 
Å while other Arg216’s side chain forms a single hydrogen bond at 1.82 Å. 
The orientation of the substrate in GluRC appears to favour a W1-mediated 
deprotonation of the Ado762′OH group by O1p. This facilitates the first step of the 
aminoacylation mechanism; attack of the Ado762′O− on the substrate’s Ccarb centre which 
occurs via GluTS1, Figure 4.7. It was noted that in GluTS1 the O1p centre has effectively 
fully accepted a proton from the bridging water W1. It does, however, retain a hydrogen 
bond with the OW1 centre at a distance of 1.51 Å. Concomitantly, the Ado762′O…Ccarb 
distance has significantly shortened to 1.54 Å while the Ob…Ccarb bond has elongated 
slightly to 1.62 Å. Furthermore, the HHis220…Ocarb hydrogen bond distance has shortened by 
0.39 Å to 1.89 Å, which is 0.2 Å shorter than the analogous interaction in GlnRS, Figure 
4.4. Importantly, the energy required for this step, i.e., the energy of GluTS1 relative to 
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GluRC, is calculated to be 25.4 kcal/mol, indicating an enzymatically feasible barrier 
(Figure 4.8). 
The required energy for this step is 3.7 kcal/mol less than the obtained activation 
barrier for the same step in GlnRS, Figure 4.8. This may be due to the presence of an extra 
hydrogen bond in GluTS between the transiently charged Ado762′O and the nearby side chain 
hydroxyl of Ser32, r(Ado762′-O…HSer32) = 1.91 Å, which would provide more charge 
stabilization to the accumulated negative charge on the Ado762′-oxygen. 
	
Figure 4.8.	 Free energy surface for the aminoacylation mechanism of glutamate by ND-
GluRS. 
 
This transition state leads to the formation of the intermediate GluIC, in which the 
substrates glutamyl moiety is now bound to the tRNA adenosine terminal by a covalent 
bond with the Ado762′-oxygen. Concomitantly, the covalent bond between the substrates 
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glutamyl and AMP components has been cleaved as indicated by a Ccarb…Ob distance of 
2.93 Å, Figure 4.7. Notably, GluIC is almost thermoneutral with GluRC, lying 0.9 kcal/mol 
lower in energy, Figure 4.8.  
It should be noted that there are significant structural differences between GluIC and 
GlnIC. Most significantly, the latter is a tetrahedral intermediate, the Gln…AMP (Ccarb…Ob) 
bond not yet being cleaved. Consequently, it lies higher in energy than the corresponding 
reactant complex, GlnRC. In contrast, GluIC more closely resembles the product complex 
wherein the Glu…AMP (Ccarb…Ob) bond has been cleaved and the Ado762′O-Glu covalent 
bond has formed. The thermodynamic stability of GluIC is also due in part to the extra 
charge stabilization provided to the O2p and Ob centres through the formation of strong 
hydrogen bonds to the nearby water and side chain hydroxyl of Ser32 at distances of 1.52 
and 1.54 Å, respectively. 
 Unlike the intermediate complex obtained for GlnRS (GlnIC) where a lysyl is directly 
hydrogen bonded to the ligand, in GlnIC the lysyl residue (Lys257) is hydrogen bonded to a 
second active site water molecule W2, r(Lys257H…OW2) = 1.52 Å. Consequently, the 
subsequent proton transfer from Lys257 to a non-bridging oxygen of the AMP's phosphate 
to stabilise the charge on the leaving group takes place through W2 via GluTS2, Figure 4.7. 
In this transition state, the transferring proton is approximately mid-way between the side 
chain amine nitrogen of lysyl257 (NLys257) and the W2 oxygen with distances of 1.28 Å and 
1.23 Å, respectively. Meanwhile, the proton being concomitantly donated by W2 to the 
phosphate is 1.07 and 1.41 Å from the OW2 and O2P centres, respectively, Figure 4.7. As 
was the case for GlnRS, at the present level of theory this second step of the mechanism is 
calculated to occur via GluTS2 without a barrier, Figure 4.8.  
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Moreover, the Ob atom is now involved in hydrogen bonding interactions with the 
−N(H)− and side chain hydroxyl of Ser32 with distances of 1.86 and 1.62 Å, respectively. 
In the final product complex GluPC, Lys257 is now neutral having donated a proton via W2 
onto the O2p atom, r(W2O…H) = 1.51 Å. Again, the overall aminoacylation process is 
predicted to be thermodynamically favorable as GluPC lies 3.7 kcal/mol lower in energy 
than the initial reactant complex GluRC. 
These results are in accord with our observations on GlnRS. The water-mediated, 
substrate-assisted mechanism is kinetically and thermodynamically feasible in case of the 
ND-GluRS. The first step, deprotonation of the Ado762′-OH group by O1p and concomitant 
nucleophilic attack upon the substrate's Ccarb, is rate-limiting.  
4.4 Conclusion 
 
The aminoacylation mechanism of glutamine and glutamate amino acids to tRNAGln by 
Glutaminyl- and ND-Glutamyl-tRNA synthetases was investigated computationally. Initial 
MD simulations indicated that the tRNA Ado762′OH terminus and the Gln-/Glu-AMP 
substrates are correctly orientated for a substrate-assisted mechanism with consistent 
Ado762′O…Ccarb and Ado762′O…O1p distances over the course of the simulations. Moreover, 
our preliminary QM–only calculations supported the preference for the O1p atom to act as 
the base, over the Ob atom. Further investigations also supported the preference of this O1p 
base over the substrate’s α-NH2. 
The ONIOM calculations established that this mechanism proceeds through two steps. 
The first step is a water mediated substrate assisted deprotonation of the Ado762'-OH group 
with concomitant formation of a Ccarb–O-2'Ado76 bond. This step is also the rate-limiting 
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with energy barriers of 25.0 and 25.4 kcal/mol in the cases of GlnRS and ND-GluRS, 
respectively.  
For both GlnRS and ND-GluRS, a lysine residue was found to be positioned near the 
substrate such that it is able to neutralize the phosphate leaving group through barrierless 
proton transfers upon formation of a tetrahedral intermediate. The latter helps stabilize the 
anionic charge on the AMP leaving group and thus contributes to the overall 
thermodynamic favourability of the mechanism. 
The Glu34Gln mutation of GlnRS leads to an increase in the activation energy of the 
mechanism to 39.8 kcal/mol. This is likely due at least in part to the substrates not being as 
favourably positioned for reaction, demonstrating at least an important structural role for 
the Glu34 residue, although no direct catalytic role was discovered. 
Importantly, these findings suggest the substrate-assisted mechanism elucidated for GlnRS 
and ND-GluRS may occur within other class I aminoacyl-tRNA synthetases. 
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5.1 Introduction 
The remarkable accuracy in the translation of the genetic code of all organisms into 
proteins is closely tied to the outstanding specificity of the ubiquitous aminoacyl-tRNA 
synthetase (aaRS) family of enzymes.1-2 These enzymes are responsible for catalyzing the 
activation of their cognate amino acid via its reaction with ATP to form aminoacyl-AMP. 
Subsequently, and within the same synthetic (aminoacylation) active site they catalyze the 
transfer of the activated aminoacyl group onto its corresponding tRNAaa, yielding the desired 
aminoacyl-tRNAaa.3 Importantly, they are stated to be able to perform this overall process 
with an exemplary fidelity of 10−4, i.e., 1 aminoacylation error per 10000 reactions.2 
Consequently, this crucial class of enzymes has been the subject of many experimental and 
theoretical studies seeking to gain deeper insight into their catalytic accuracy.2, 4 
On the basis of size or chemical discrimination the active size pocket of an aaRS 
typically accommodates the corresponding cognate substrate amino acid while excluding 
non-cognate amino acids.5 However, due to electronic and/or structural similarities between 
some amino acids (e.g., threonine, serine, and valine), it is challenging for almost half of the 
aaRSs to correctly distinguish between cognate and non-cognate amino acids.6-7 Except for 
specific cases where moderate levels of mistranslation errors can be tolerated, or may even 
be necessary,8-9 any defects in the accuracy of translation can lead to protein misfolding, 
which is responsible for many fatal diseases.10 
In order to ensure accurate translation most aaRSs possess proofreading mechanisms. 
Specifically, in the synthetic site they may use pre-transfer editing mechanisms for which the 
most common is hydrolysis.11 For instance, a water molecule nucleophilically cleaves, the 
labile phosphoester bond of a misactivated amino acid. This type of editing is observed in 
many enzymes; e.g. LeuRS hydrolyzes misactivated Val-AMP12 and ThrRS hydrolyzes 
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misactivated Ser-AMP.13 However, many aaRS may also exploit a distinct second editing 
active site – the editing site – which catalyzes post-transfer editing of misacylated tRNA.11 
For example, AlaRS,14 ThrRS,15 and LeuRS16 enzymes utilize this type of correcting pathway 
to reject mischarged Gly-tRNAAla, Ser-tRNAThr, and Ile-tRNALeu, respectively. It has also 
been noted that some enzymes have a second, free-standing editing domain; for example, 
AlaRS has the AlaXp active site to correct any mislinked serine.17  
Our group has a long-standing interest in the mechanisms operating in aaRS enzymes, 
both regarding their synthetic activity and the pre-transfer editing functions of the synthetic 
site.18-19 The principal aim of this study is to expand the understanding of the post-transfer 
editing functions of threonyl-tRNA synthetase (ThrRS) enzymes. While it is thought that 
yeast mitochondrial ThrRS relies only upon pre-transfer editing,20 the ThrRSs found in all 
other species are suggested to also an editing site.15 This latter site is remote from the 
synthetic site and is responsible for the hydrolysis of misacylated Ser-tRNAThr. Structurally, 
the editing domain has been observed to be species-specific, with the two main types being 
bacterial and archaeal, and accordingly there are two different editing mechanisms.21 
In archaeal ThrRS, for example from Pyrococcus abyssi, the editing region is located in 
the N-terminal domain and the editing mechanism proceeds by a universal tRNA-mediated 
hydrolysis mechanism.5, 22-23 In contrast, in bacterial ThrRS, for instance from Escherichia 
coli, the editing region has a quite distinct structure and different hydrolytic editing 
mechanisms have been proposed. Unfortunately, despite experimental studies on various 
possible editing pathways, the exact mechanism remains an open question. 
Based on mutational and kinetic analyses it has been suggested that the binding domain’s 
His73, Lys156, His186 and Cys182 residues are the most mechanistically important.15, 24 
Notably, His73Ala mutation was observed to cause the most dramatic decrease in the rate of 
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hydrolytic editing, followed by Cys182Ala mutation.24,25 In addition, based on  experimental 
X-ray crystal structures it was concluded that the His73 residue is within hydrogen bonding 
distance of a water molecule (W1) thought to be positioned near the substrate.23 
Subsequently, the Schimmel and co-workers also concluded that the His73 and Lys156 
residues are well-positioned to partake in catalysis.25 Consequently, it was proposed that, as 
shown in Scheme 5.1a the His73 residue is neutral and acts as the required mechanistic base. 
Specifically, it promotes activation of W1 through proton abstraction thus enabling the 
oxygen of W1 to nucleophilically attack the misacylated substrate's (Ser-tRNAThr) Ccarb 
centre. This ultimately results in cleavage of the labile CCarb—O3′ ester bond. The 
regenerated free Ado763′O-tRNA oxyanion is neutralized via a second proton transfer from the 
nearby Lys156 residue through a bridging water molecule, W2. The enzymatic use of a 
neutral histidyl as a mechanistically important base, such as in serine proteases and 
flavocytochrome b2, is widely documented.26-27 
 
Scheme 5.1. Schematic illustration of the two proposed pathways for post-transfer editing as 
catalysed by bacterial E. coli ThrRS in which the mechanistic water nucleophile is activated 
by either (A) His73 or (B) Cys182 acting as the required base. 
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Recently, however, based on experimental oxidative stress studies on the editing domain 
of ThrRS, it has alternatively been suggested that the active site Cys182 residue may instead 
be the base, as shown in Scheme 5.1b.28-29 In particular, it was observed that treatment of E. 
coli ThrRS by H2O2 resulted in formation of a Cys182-derived sulfenic acid (Cys182SOH). For 
such a species to be formed the Cys182 must be in its thiolate form. Notably, this oxidative 
modification significantly increased misincorporation mistakes, and it was concluded that 
this was due to inhibition of the post-transfer editing of Ser-tRNAThr by ThrRS. Furthermore, 
and in contrast to the previously proposed mechanism above, it was suggested that of the 
three active site histidyl residues (His73, His77, and His186), His73 and His186 are both 
protonated and help activate the thiol of Cys182 and stabilize its thiolate form.28 Hence, an 
alternate post-transfer editing mechanism was proposed and is shown in Scheme 5.1b. These 
studies29 also noted that the editing site of ThrRS is similar to the active site of cysteine 
proteases, which are known to form sulfenic acids, and that oxidation of cysteine residues to 
sulfenic acids often occurs in ROS signaling proteins.30 Moreover, it has been noted that the 
editing sites of AlaRS and ThrRS share considerable sequence similarity and that their active 
sites contain the same conserved residues; namely, two histidyl residues, and a cysteinyl.37 
Indeed, in the editing site of AlaRS the cysteinyl (Cys666) is in a nearly identical orientation 
to that of Cys182 in the editing site of ThrRS. Furthermore, mutation of Cys666 to alanine 
severely inhibited the ability of the editing site of AlaRS to deacylate Ser-tRNAAla. Hence, it 
has been suggested that these two aaRSs may share a common post-transfer editing 
pathway.31-33 
In the current study we have conducted a detailed, systematic multi-scale computational 
investigation using MD simulations and ONIOM(QM/MM) methodology to gain insight into 
the post-transfer editing mechanism in E. coli ThrRS. In particular, we have examined both 
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the previously proposed hydrolytic editing mechanisms of ThrRS in which either His73 or 
Cys182 acts as the mechanistic base, as well as possible alternate mechanisms and for a range 
of different potential active site protonation states. 
 
5.2 Computational Methods 					   5.2.1 Molecular Dynamics Simulations  
The high-resolution experimental X-ray crystal structure of the editing domain of 
threonyl-tRNA synthetase isolated from E. coli with the substrate analogue seryl-3'-
aminoadenosine (SerAA) bound within the active site (PDB ID: 1TKY)24 was selected as the 
template structure for all chemical models used in this study. The bound analogue was 
mutated back to the desired substrate (Ser-AMP) by replacing the relevant bridging –NH– 
group in SerAA with an oxygen atom. Hydrogen atoms were added as appropriate and 
according to their protonation states as determined from the pKa values calculated by both 
PROPKA 3.134 and the default protonation tool in the Molecular Operating Environment 
(MOE) software.35 Unconstrained Molecular Mechanics (MM) energy minimization using 
the AMBER12 forcefield was then performed on the generated model. The model was then 
solvated by adding a 2 Å layer of water around the entire complex (total 725 water molecules) 
followed by a second MM energy minimization which terminated once the root mean square 
gradient fell below 0.01 kJ/mol·Å2. The resulting complex was initially submitted for 100 ps 
equilibration from 0 to 300 K at constant pressure using the default settings of MOE which 
includes cut-offs for long range interactions of 10 Å. 
The mechanisms examined in this present study can be grouped into two broad 
categories; either His73- or Cys182-promoted editing. Hence, two template enzyme-
substrate complexes were generated. For the former scenarios, i.e. those in which His73 acts 
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as the base, the complex contained neutral His73, His186, and Cys182. These protonation 
states are consistent with their predicted pKa values (see above). For the alternate scenarios 
in which Cys182 acts as the base, consistent with the experimentally28 suggested ionization 
states the enzyme-substrate complex instead contained protonated His73 and His186 residues 
while Cys182 was deprotonated. Under constant pressure and temperature, the generated 
structures were then subjected to a second simulation for 500 ps, under the same conditions 
and 2 fs time steps, using the NAMD engine.36 The final conformation obtained in each 500 
ps simulation was then checked to ensure it was a suitable representative structure, and then 
MM minimized as above. Suitable QM/MM chemical models were then generated by 
truncating the resulting complex to include all residues and waters within 10 Å of the 
substrate. 
 
 5.2.2 QM/MM Investigations  
A two-layer ONIOM(QM/MM)37-38 approach was used and consequently the above 
derived chemical models were each divided into QM- (high-level) and MM-subsystems 
(low-level) as shown in Figure 5.1. In particular, the substrate, mechanistically most relevant 
residues, as well as select active site water molecules were included in the QM-region. The 
surrounding protein environment, and remaining waters, were placed in the low-layer and 
described using an appropriate MM method. This methodology has previously been 
successfully applied to explore different catalytic mechanisms.39 All ONIOM(QM/MM) 
calculations were performed using the Gaussian09 software package.40 
For those chemical models used to examine mechanisms in which His73 acts as the base 
the QM region contained: the substrate (Ser-Ado); the charge stabilizing residues Tyr104 and 
Gly95; the proposed catalytic residues His73 and Lys156; and Asp180 due to its role in 
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orienting the substrate appropriately by formation of a salt bridge with the substrate’s α-NH2. 
In addition, in the appropriate MD simulations an active site water (W1) molecule was 
observed to be hydrogen bonded to the His73 residue and concomitantly in close proximity 
to the Ccarb of the substrate. Meanwhile, a second water (W2) molecule was hydrogen bonded 
to the side-chain amine of Lys156. Hence, both of these bridging water molecules (W1 and 
W2) were also included. The QM-region consisted of a total of 111 atoms and is shown in 
Figure 5.1a.  
 
Figure 5.1. The template QM-region models used to study possible catalytic mechanisms of 
the ThrRS editing domain in which either (a) His73 or (b) Cys182 acts as the required base. 
 
For the chemical models used to examine mechanisms in which Cys182 acts as the base 
the QM-region was expanded to include the Cys182 and His186 residues. These QM-regions 
contained a total of 121 atoms and are shown in Figure 5.1b. Moreover, for all chemical 
models the α-carbon atoms of the amino acids in the low layer (at least one residue away 
from the QM layer) were held fixed at their initial positions in order to ensure the structural 
integrity of the model. 
To obtain optimized structures, each QM layer was treated using the hybrid DFT B3LYP 
method,41-43 widely applied in the study of catalytic and enzymatic mechanisms,44 in 
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conjunction with the 6-31G(d,p) basis set. In order to enhance the modelling of non-covalent 
and dispersion interactions, the empirical D3 dispersion correction by Grimme was applied.45 
This has previously been shown to significantly improve the accuracy of kinetic barriers.46 
Meanwhile, the AMBER96 force field was used for the MM region.47 Frequency calculations 
were also performed at this level of theory, ONIOM(B3LYP-D3/6-31G(d,p):AMBER96), to 
determine the nature of the stationary points and to calculate Gibbs free energy correction 
values (ΔGcorr). Relative energies were obtained via single point energy calculations on the 
above structures at the ONIOM(B3LYP-D3/6-311+G(2df,p):AMBER96) level of theory 
with inclusion of the corresponding ΔGcorr. It is noted that all ONIOM calculations were 
performed within a mechanical embedding formalism. 
 
5.3 Results and discussion 
As noted above it has been suggested that either His73 or Cys182 acts as the base to 
facilitate and promote editing through activation of an active site water. However, this is 
complicated by the existence of several acid/base residues within the editing site. In addition, 
once a base has gained a proton it could, in some scenarios, potentially then act as an acid. 
Consequently, in this present study the mechanisms studied can be categorized as falling into 
either His73- or Cys182-promoted editing mechanisms. However, for each of these we have 
examined several possible variations that differ by, for example, the protonation states of 
other editing site residues. In total, 11 different possible mechanisms have been elucidated 
and compared in terms of their chemistry and thermochemical feasibility. 
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   5.3.1 His73-promoted Editing Mechanisms 
         5.3.1.1 His73-promoted hydrolytic editing  
The editing mechanism of archaeal ThrRS proceeds through a substrate-assisted 
mechanism in which the Ado762′OH group of the tRNAThr moiety facilitates hydrolysis of the 
Ccarb–O3′Ado76 bond.23 In contrast, in the presently obtained optimized structure of the reactive 
complex (IRC) of the editing site of bacterial ThrRS, shown in Figure 5.2, the substrate is 
positioned such that no hydrogen bonding interaction is observed between the substrate’s 
Ado762′OH group and the nucleophilic active site water (W1). Instead, W1 is in close 
proximity to the catalytic His73 residue with which it forms a moderately strong hydrogen 
bond, r(His73N…HW1) = 1.88 Å. In addition, W1 is positioned in good proximity to the 
substrate's Ccarb center with a distance of r(W1O…Ccarb) = 3.17 Å, Figure 5.2. That is, W1 
seems well positioned for the subsequently required proton transfer onto His73 and 
nucleophilic attack at Ccarb. The Lys156 residue, specifically its side chain ammonium, forms 
a strong hydrogen bond with a second water (W2), r(Lys156H…OW2) = 1.81 Å, which also 
positions it near to the substrate. Meanwhile, the Asp180 residue helps hold the substrate in 
more catalytically productive conformation through formation of an Asp180COO−…H3N+SerAA 
salt bridge, r = 1.64 Å. The substrate’s Ocarb atom also forms a hydrogen bond with the 
backbone –N(H)– of the Gly95 residue at a distance of 1.89 Å. Optimized structures of 
stationary points (energy minima and transition states) along the mechanism, together with 
selected key distances, are shown schematically in Figure 5.2. The corresponding free energy 
surface (FES) for this mechanism is shown in Figure 5.3. 
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Figure 5.2. Schematic illustration of the optimized structures obtained (see Computational 
Methods), with select distances shown in Angstroms, for the His73 promoted mechanisms 
obtained with Lys156 protonating either the (1) Ado763′O or (2) Ocarb centers of the Ser-
tRNAThr substrate. 
 
The reaction is initiated by the imidazole of His73 abstracting a proton from W1 while 
concomitantly, the water's OW1 center nucleophilically attacks the Ccarb center of the 
substrate. This step proceeds via IaTS1 at a cost of 27.6 kcal/mol relative to IRC, suggesting 
an enzymatically high-energy barrier. In IaTS1 the proton liberated from W1 has significantly 
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shifted toward the His73 residue as indicated by the distances r(W1O…HW1) = 1.41 Å and 
r(W1H…N H73) = 1.16 Å. Furthermore, the oxygen of the developing W1OH– moiety is now 
only 1.75 Å away from the substrate’s Ccarb center having formed a weak partial bond. 
 
 
Figure 5.3. Free energy surfaces (kcal/mol) calculated (see Computational Methods) for the 
ThrRS editing domain mechanisms in which His73 acts as a base with Lys156 acting as an 
acid and protonating either the Ocarb center (blue line) or Ado763′-O (red line). 
 
Collapse of IaTS1 results in generation of the energetically stable tetrahedral 
intermediate complex IaIC1, which lies 21.6 kcal/mol higher in energy than IRC, Figure 5.3. 
In this complex, the His73 residue is now protonated, r(H73N–H) = 1.06 Å while the partial 
Ccarb–OW1 single bond has shortened markedly to 1.54 Å. Concomitantly, the Ccarb__Ocarb and 
Ccarb–O3′Ado76 bonds have lengthened by 0.06 and 0.14 Å, respectively, Figure 5.2.  These 
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latter increments are due to the change in the hybridization of the Ccarb toward pseudo sp3-
hybridization and stabilization of the increased negative charge on Ocarb by the single 
moderately strong hydrogen bond of length 1.76 Å it forms with the –N(H)– of the Gly95. 
The subsequent and final stage of the overall mechanism is cleavage of the Ccarb–O3′Ado76 
bond and formation of the neutral Ado76O3′H group. An examination of IaIC1 suggests that 
there are potentially three process by which this could occur. Namely, it may either occur by 
proton transfer from the side chain ammonium of Lys156 through the active site water W2 
directly onto Ado76O3′ or indirectly via Ocarb. Alternatively, the now protonated imidazole of 
His73 may act as an acid and directly protonate Ado763′-oxygen. Thus, each of these 
mechanisms were examined with the two most feasible being shown in Figures 5.2 and 5.3. 
 
5.3.1.1.1 Direct water mediated protonation of Ado763′O by Lys156  
The side chain ammonium of Lys156 is able to essentially directly protonate the 3′OAdo76 
center of IaIC1 via a mediating water W2. This step proceeds via IaTS21 with a free energy 
barrier of 33.4 kcal/mol, Figure 5.3. In this possible overall mechanism, the proton transfer 
represents the rate-limiting step. In addition, the high barrier suggests that the mechanism is 
unlikely to be enzymatically feasible. It is noted that IaTS21 appears to be a dissociative 
transition state since the proton has essentially been transferred onto the Ado763′-oxygen while 
the Ado763′O…Ccarb bond has concomitantly significantly elongated to 2.16 Å, Figure 5.2. The 
resultant product complex IPC lies 4.3 kcal/mol higher in energy than IRC; that is, this 
mechanism is also thermodynamically unfavorable. In IPC the Lys156 side chain amine is 
now neutral while the neutral Ado763′OH group has been fully formed. In addition, the 
Ado763′O–H distance is that expected of a typical O–H single bond with length 0.96 Å, while 
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the carbC−3′OAdo76 ester bond has been fully cleaved as indicted by its distance of 2.8 Å, 
Figure 5.3 
 
5.3.1.1.2  Indirect water-mediated protonation of Ado763′O by Lys156  
Alternatively, Lys156 may first transfer its ammonium proton via W2 onto the 
oxyanionic Ocarb center in IaIC1. Subsequently, an intramolecular proton transfer can occur 
from -OcarbH onto the 3′OAdo76 center of the leaving tRNA moiety, Figure 5.2. The first step 
in this process proceeds via IaTS22 at a cost of 32.6 kcal/mol relative to IRC, Figure 5.3. It 
is noted that while IaTS22 lies 0.8 kcal/mol lower in energy than IaTS21, it is still too high to 
likely be enzymatically feasible. Furthermore, structurally, W2 has substantially transferred 
its proton onto the substrates Ocarb center as indicated by the relevant distances of 
r(W2H···OW2) = 1.37 Å and r(W2H···Ocarb) = 1.11 Å, Figure 5.2. The resultant subsequent 
tetrahedral 1,1-diol intermediate complex (IaIC2) lies 1.1 kcal/mol higher in energy than IaIC, 
being 22.7 kcal/mol higher in energy relative to IRC, Figure 5.3. 
The subsequent proton transfer from the newly formed -OcarbH group onto the Ado763′-
oxygen is found to take place via the 4-membered-ring transition state ITS3, Figure 5.2. As 
noted earlier, the Ado762′OH group in the optimized chemical model herein is oriented in such 
a way that it is unable to readily participate in this step to help form a 6-membered-ring 
transition state. The energy required for this second step is extremely high with a barrier of 
69.6 kcal/mol relative to IRC, Figure 5.3, clearly indicating that editing via this possible 
mechanism is enzymatically unfeasible. It is noted that even if an alternative pathway for this 
second proton transfer reaction was possible, the barrier for proton transfer via IaTS22 in 
itself is higher than likely to be enzymatically feasible. The final product complex formed, 
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IPC, is the same as that obtained for the above described direct water meditated protonation 
mechanism. Hence, this possible alternate mechanism is also thermodynamically 
unfavorable. 
 
5.3.1.1.3 Protonation of Ado763′O by His73-H+.  
The His73 residue has also been proposed to act as an acid-base catalyst and thereby the 
proton transferred to the Ado763′-oxygen, cleaving the Ccarb—O3′Ado76 bond, may possibly 
originate from the protonated His73 residue formed in the first step of the mechanism, Figure 
5.2.25 However, the relative energy of the required transition state is 45.8 kcal/mol. Moreover, 
the product complex generated from this step is 24.1 kcal/mol higher in energy than IRC and 
is thus significantly more thermodynamically unfavored than IPC. 
 
5.3.1.2 His73-promoted editing through self-cyclization/lactone formation:  
In the reactive complex IRC it was observed that the substrate's serinyl side-chain, and in 
particular its b-OH group, could potentially undergo a conformational change. In particular, 
it could rotate such that it no longer interacts with the side-chain carboxylate of Asp180 as is 
common,5, 22 but instead could potentially interact with His73. Such a geometry and 
interaction may facilitate an alternate editing pathway in which cleavage of the aminoacyl-
tRNA's ester bond proceeds through formation of a 4-membered lactone ring, Figure 5.4. 
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Figure 5.4 Schematic representation of the optimized complexes, with select distances 
shown in Angstroms, obtained for a His73-promoted self-cyclization editing mechanism. The 
relative free energies (kcal/mol) are also given in brackets. 
 
 Similar cyclizations have been suggested to play a role in editing of other misacylated 
substrate's including the pre-transfer editing mechanism of MetRS previously reported by 
our group.18  
A scan of the potential energy surface for rotation around the substrate's serinyl side chain 
C__C bond leads to formation of the intermediate complex IbIC1 lying just 5.3 kcal/mol 
higher in energy than IRC. It is noted that the scan was performed as the energy surface was 
very flat; that is, the rotational barrier was quite small. Indeed, after empirical free energy 
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corrections were included the barrier estimated to be slightly lower than 0.0 kcal/mol, 
reinforcing that in vivo this rotation can occur essentially without a barrier. In IbIC1 the 
substrate’s serinyl b-OH is strongly hydrogen bonded to the neutral imidazole of His73 whilst 
also simultaneously in close proximity to the substrate's Ccarb center with distances of 
r(H73N···HOH) = 1.76 Å and r(OHO…Ccarb) = 2.79 Å. 
The oxygen of the b-OH is then able to nucleophilically attack the Ccarb center with 
concomitant transfer of the hydroxyl's proton onto His73. This step proceeds through IbTS2 
at a quite high cost of 31.4 kcal/mol relative to the initial reactant complex IRC. This high 
barrier may again be due in part to the increasing anionic charge on the Ocarb center during 
this step being stabilized by only its single hydrogen bond with the backbone -NH- of Gly95. 
The resulting tetrahedral intermediate IbIC2 lies slightly lower in free energy than IRC by 
−3.4 kcal/mol. Importantly, it must be noted that intermediate ligand has shifted position 
slightly so that the Ocarb oxyanion center is now hydrogen bonded to the protonated imidazole 
of His73 (i.e., His73-H+). This suggests that the latter residue may be able to transfer its 
proton onto the Ocarb oxyanion center in order to generate a neutral lactol. And indeed, such 
a proton transfer can occur essentially without a barrier via IbTS3, as indicated by the fact 
that its calculated free energy after empirical corrections is lower than that of IbIC2. 
Importantly, this results in formation of the low energy lactol IbIC3 which lies markedly 
lower in energy than IRC by 42.5 kcal/mol and is in fact the lowest energy complex along 
this pathway. 
Several possible reactions (not shown) were considered for the subsequent required 
cleavage of the Ccarb−3′OAdo76 bond. The lowest energy pathway was found to involve an 
intramolecular proton transfer from the newly formed –OcarbH group onto the Ado763′-oxygen. 
Chapter 5 
 119 
This step occurs via the four-membered ring transition state IbTS4 with a barrier of 33.3 
kcal/mol relative to IbIC3. This is the rate-limiting step of the reaction and its height suggests 
that at least in the editing domain of ThrRS this pathway is enzymatically unfeasible. The 
final product complex formed, IbPC, while thermodynamically favoured compared to the 
initial reactive complex IRC by 13.3 kcal/mol, is much higher in energy than IbIC3 by 29.2 
kcal/mol, Figure 5.3.  
 
5.3.2. Cys182-promoted editing Mechanisms: 
As noted above, it has also been suggested that the active site cysteinyl Cys182 may 
instead be able to act as a base to promote/catalyse the editing mechanism. Thus we 
systematically examined possible mechanisms through which this may occur, with a key 
difference between them being the protonation states of the conserved active site His73, 
Cys182 and His186 residues. However, as for the above mechanisms, in some cases several 
scenarios were considered based on for instance the source of the proton in the second stage 
and/or the site of substrate to which it is initially transferred. It is noted that as for the above 
His73-promoted editing mechanisms, the side chain of Lys156 was considered to be in its 
protonated form. 
 
5.3.2.1. Deprotonated Cys182 with protonated His73 and His186. 
 In the QM/MM optimized structure (see Computational Methods) of the reactant 
complex IIaRC, the anionic thiolate is stabilized by hydrogen bonds with the protonated 
imidazoles of His73 and His186 with distances of r(HisNH···SCys) =  2.26 Å and 1.90 Å, 
respectively, Figure 5.5. In addition, it forms a moderately strong hydrogen bond with the 
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nucleophilic water W1 with r(W1H…SCys182) = 1.89 Å. Similar to that observed in IaRC the 
Asp180 anchors the substrate via salt bridge formation with the substrate’s α-NH3+ group at 
a distance of 1.51 Å. Meanwhile, the W2 molecule is positioned close to the other side of the 
substrate through hydrogen bonding to the backbone carbonyl oxygen of the nearby Ile94 
residue with r(W2H…OIle94) = 1.65 Å, Figure 5.5. 
Deprotonation of W1 by the Cys182 thiolate facilitates nucleophilic attack of the oxygen 
of W1 on the substrate’s Ccarb center. This reaction proceeds through the transition state 
IIaTS1 at a cost of 17.4 kcal/mol relative to IIaRC, which is 10.2 kcal/mol less than the 
corresponding step in the above described His73-promoted mechanisms, Figures 5.3 and 
5.6. It is noted that it represents a late transition state as the W1 proton is substantially shifted 
toward the sulfur atom and the W1 oxygen has moved quite close to the Ccarb as indicated by 
their distances of r(W1H···SCys182) = 1.49 Å and r(W1O···Ccarb) = 1.73 Å, Figure 5.5. Similar 
to ITS1 in the His73-promoted mechanisms, the substrate’s Ocarb center is stabilized by 
formation of a strong hydrogen bond with the backbone of Gly95, r(Gly95N(H)…Ocarb ) = 1.78 
Å which, due to the increased negative charge on Ocarb, is 0.26 Å shorter than the same 
interaction in IIaRC, Figure 5.5. In addition, however, it also forms a strong hydrogen bond 
with a nearby active site water, r(Ocarb…HW) = 1.81 Å, which is simultaneously hydrogen 
bonded to the protonated imidazole of His73. The latter is made possible due to the Cys182 
now being neutral and remains hydrogen bonded to His186-H+. This additional stabilizing 
hydrogen bond of Ocarb may help explain the markedly lower reaction barrier obtained for 
this step.  
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Figure 5.5. Schematic illustration of the optimized structures obtained, with select bond 
distances shown in Angstroms, for the mechanism in which Cys182 acts as a base to activate 
an active water, and with Lys156 acting as acid and directly protonating the Ado763′-oxygen.  
 
Collapse of IIaTS1 in leads to the formation of intermediate complex IIaIC1, which 
possesses typical carbC−OH and RS−H bonds (r = 1.49 Å and 1.36 Å, respectively). Notably, 
IIaIC1 lies 13.7 kcal/mol higher in energy than IIaRC, which is markedly lower than the 
relative energy (21.6 kcal/mol) than the corresponding intermediate IIC1 in the His73-
promoted mechanisms, Figure 5.3. 
As for the above mechanisms in which His73 acted as the base, there are three possible 
proton donors (Lys156, His73, and Cys182) present for the continuation of the reaction; 
cleavage of the Ado763′O—Ccarb bond. Thus, each of the possibilities was then investigated, 
the most feasible mechanism obtained for each is discussed herein. 
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5.3.2.1.1. Direct protonation of Ado763′O by Lys156  
In IIaIC1 the Ado763′O center is strongly hydrogen bonded to a proton of W2 at a distance 
of 1.79 Å. Notably, W2 is simultaneously also positioned near the side chain ammonium of 
Lys156. For the above His73 catalyzed process, proton transfer from Lys156 onto the Ado763′-
oxygen gave the lowest barriers. For this present scenario it is found that such proton transfer 
from Lys156 onto the Ado763′O center can occur with the involvement of the bridging water 
molecule, but with an high free energy barrier, via IIaTS21 of 32.5 kcal/mol relative to IIaRC 
(Figure 5.6). This step also appears to share structural similarities to that described above in 
the analogous His73-promoted mechanism that proceeds via IaTS21. Namely, IIaTS21 also 
appears to be a dissociative transition state as the H···N+Lys156 distance has elongated 
significantly to 1.85 Å (i.e., has been transferred onto W2) while the carbC−O3′Ado76 bond has 
also been essentially wholly cleaved as indicated by its distance of 1.71 Å, Figure 5.5. 
Collapse of IIaTS21 leads directly to formation of the product complex IIaPC1 in which 
the tRNA's Ado76 ribose sugar and the noncognate serine amino acid are separated by a 
distance of 2.84 Å. The Ado763′O−H single bond has been formed with a length of 0.99 Å, 
Figure 5.4. Notably, this overall pathway was found to be thermodynamically favorable as 
IIaPC1 is 33.6 kcal/mol lower in energy than IIaRC, Figure 5.6. 
 
5.3.2.1.2. Protonation of Ado763′O involving His73-H+.  
In IIaIC it was observed that with neutralization of the Cys182 thiolate group, the 
protonated imidazole of His73 (His73-H+) has switched position and now is hydrogen 
bonded to a third editing site water molecule (W3). Thus, His73-H+ may in fact be able to 
act as an acid and transfer its proton on the intermediate. It was found that in fact His73-H+ 
Chapter 5 
 123 
is able to effectively transfer its proton via W3 onto the oxyanionic Ocarb center of IIaIC. 
Furthermore, this effectively occurs without a barrier via IIaTS22 as suggested by its slightly 
lower free energy relative to IIaIC (Figure 6). This low barrier also reflects the fact that 
IIaTS22 occurs early along this step; the His73N—H distance has lengthened only slightly to 
1.15 Å and the distance to the OW3 center is still quite long at 1.36 Å. Meanwhile, the W3O…H 
distance for the proton W3 concurrently donates to the substrate’s Ocarb center has increased 
significantly to 1.21 Å and the corresponding HW….Ocarb distance is relatively short at 1.25 
Å, Figure 5.7. 
 
Figure 5.6. FES obtained (kcal/mol) for the three possible editing mechanisms elucidated in 
which Cys182 acts as a base and His73 and His186 are protonated and the required acid for 
cleavage of the Ado763′O—Ccarb bond is: Lys156 (black line and labels); His73 (red line and 
labels); or Cys182 (blue line and labels). 
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Indeed, the subsequently formed 1,1 diol intermediate complex IIIC22, which contains a 
now tetrahedral sp3 hybridized Ccarb center, lies 11.0 kcal/mol lower in energy than the initial 
reactive complex IIaRC, Figure 5.6. The next and final step is transfer of the proton from the 
newly formed Ccarb–OH groups onto the 3′OAdo76 center. The lowest energy pathway for such 
a transfer was found to occur involve the –OH group formed from W1 and proceeds via the 
6-membered ring transition state IIaTS33. However, energetically this step has a high-energy 
barrier of 33.3 kcal/mol with respect to IIaIC2 and is in fact the overall rate-limiting step for 
this possible pathway, Figure 5.5 and Figure 5.6.This is likely at least partly a reflection of 
the high pKa (i.e. low acidity) of the Ado762′OH group which is integrally involved in this step 
(Figure 5.7). However, the resulting product complex (IIaPC2) formed, in which the 
Ado763′O—Ccarb bond is fully broken, is thermodynamically very favorable having an energy 
relative to IIaRC of −50.0 kcal/mol (Figure 6). 
 
 
 
Figure 5.7. Schematic illustration of the optimized structures, with selected bond lengths 
shown in Angstroms, obtained for the IIa editing mechanism (i.e., initial active site contains 
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Cys182S–/His73-H+/His186-H+) in which cleavage of the Ado763′O—Ccarb bond involves 
proton transfer from His73 (2: red labels) or Cys182 (3: blue labels). 
 
5.3.2.1.3. Protonation of Ado763′O involving Cys182SH.  
Alternatively, the neutral thiol of Cys182formed during the first step could potentially 
act as an acid to facilitate cleavage of the Ado763′O—Ccarb bond, Figure 5.7. More specifically, 
Cys182SH is able to transfer its proton onto the nearby Ado762′OH moiety while the latter 
concomitantly transfers its proton onto the Ado763′-oxygen, resulting in cleavage of the 
Ado763′O—Ccarb bond. However, this step proceeds through IIaTS23 with an energy barrier of 
27.9 kcal/mol relative to IIaRC (14.2 kcal/mol relative to IIaIC1). Again this is the overall 
rate-limiting step for this possible pathway. But, though it remains high, it is the lowest 
barrier amongst the three possibilities elucidated for when the editing site initially contains a 
deprotonated Cys182, and protonated His73 and His186, Figure 5.6. The resulting product 
complex IIaPC3 is the thermodynamically most favored of these three related pathways with 
an energy 51.0 kcal/mol lower than that of IIaRC. 
 
5.3.2.2. Deprotonated Cys182 with neutral His73 and His186 (Cys182S–/His73/His186).  
It is noted that all related AlaXps enzymes there are three residues (His9, His13 and 
Cys116) that are positioned similarly to those of His73, His186 and Cys182 in the editing 
site of ThrRS.7, 48 In addition, the Zn(II) binding-site in the aminoacylation site of ThrRS 
contains a similarly arranged deprotonated cysteinyl and two neutral histidyl residues.15 
Furthermore, the pKas predicted using PROPKA for these three residues in the editing site 
of ThrRS suggested that Cys182 may be deprotonated with His73 and His186 being neutral. 
Hence, we considered mechanisms in which these where their initial protonation states in the 
Chapter 5 
 126 
editing site with the optimized structures and thermochemistry of the two possible pathways 
elucidated given in Figures 5.8 and 5.9. 
 
 
Figure 5.8. Schematic illustration of the optimized structures (with select bond lengths 
shown in Angstroms) obtained for the editing pathways in which Cys182 acts as the base in 
the presence of neutral His73 and His186, and where either Lys156 (1: black labels) or 
Cys182 (2: red labels) acts as the required acid for the second proton transfer. 
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In the QM/MM optimized structure of the corresponding reactive complex IIbRC, the 
thiolate of Cys182 forms a hydrogen bond with an active site water molecule (W1) with 
r(Cys182S…HW1) = 2.18 Å (Figure 5.8). Notably, this orients W1 such that its oxygen (OW1) is 
positioned just 2.64 Å from the substrate's Ccarb center, a distance which is significantly 
shorter by 1.40 Å than observed in IIaRC. This suggests that W1 is well placed for the 
subsequent required nucleophilic addition, Figure 5.8. This seemingly better positioning 
may also be due to the fact that unlike in IIaRC, the thiolate of Cys182 does not form a 
hdyrogen bonding network with His73 and His186 due to their being neutral. Instead, and in 
addition to its hydrogen bond with W1, Cys182S– also forms a moderately strong hydrogen 
bond of length 2.16 Å directly with the Ado762′OH group (Figure 5.8). This appears to help 
bind and orient the substrate in a more conducive conformation for subsequent reaction.24 
The analogous pathway for activation and nucleophilic attack of W1 on the substrate, as 
previously obtained for IIaRC was elucidated. Again, the thiolate of Cys182 is able to abstract 
a proton from W1 while the oxygen (OW1) of the latter simultaneously nucleophilically 
attacks the substrate's Ccarb center, Figure 5.8. In contrast, however, this reaction proceeds 
via IIbTS1 at an cost of just 9.9 kcal/mol, 8 kcal/mol lower than for the analogous reaction 
via IIaTS1. (Figure 5.9). Indeed, of all the systems considered herein, this is the lowest barrier 
for activation and subsequent nucleophilic attack by the active site water. 
 It is noted that in IIbTS1, the Cys182S…HO2′Ado76 hydrogen bond has been maintained 
though it has lengthened slightly to 2.28 Å. Meanwhile, and the developing negative charge 
on the Ocarb center is again stabilized through its quite strong hydrogen bond with the 
Gly95N−H group; r(Gly95N(H)…Ocarb) = 1.67 Å. This latter distance is 0.12 Å shorter, and thus 
stronger, than observed in the IIaTS1. As before, this step results in formation of an 
oxyanionic tetrahedral intermediate complex (IIbIC), in which the r(Gly95N(H)…Ocarb) 
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interaction has shortened markedly to 1.58 Å (Figure 5.8). Significantly, as shown in Figure 
5.9, IIbIC is just 4.4 kcal/mol higher in energy than the initial reactive complex IIbRC. Hence, 
in terms of relative free energy, it is the lowest in energy of all such intermediates IIC, IIaIC, 
and IIbIC obtained herein. 
As for the other systems examined, the subsequent cleavage of the Ado763′O—Ccarb bond 
requires an acid to ultimately transfer its proton, directly or indirectly, onto the leaving 
tRNAThr's Ado763′-oxygen. In this present scenario, the most probable proton sources are the 
ammonium of Lys156 or the now neutral of Cys182. Hence, both possible pathways were 
considered. 
 
5.3.2.2.1. Protonation of Ado763′O involving Lys156.  
In both IIbRC and, in particular, IIbIC, a second active water (W2) is positioned near 
both the ammonium of Lys156 and the Ado763′-oxygen. Indeed, in IIbIC the water W2 
simultaneously forms strong hydrogens bonds with both of these groups; r(Ado763′O…HOW2 
= 1.78 Å) and r(Lys156NH…OW2 = 1.70 Å), Figure 5.8. Water-mediated transfer of a proton 
from the ammonium of Lys156 onto the Ado763′-oxygen is able to proceed through IIbTS21 at 
an enzymatically feasible cost of 20.8 kcal/mol relative to the initial reactive complex IIbRC, 
Figure 5.9. As for all other mechanisms elucidated this barrier is the rate-limiting step of the 
overall mechanism. Importantly, however, it is the lowest barrier obtained for this step of all 
systems considered in this investigation.  
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Figure 5.9. FES obtained (kcal/mol) for the two possible editing mechanisms elucidated in 
which Cys182 acts as a base and His73 and His186 are neutral and the required acid for 
cleavage of the Ado763′O—Ccarb bond is: Lys156 (blue line and labels); or Cys182 (red line 
and labels). 
 
In the product complex, IIbPC1, the noncognate serine and tRNAThr formed are now 
significantly separated as illustrated by r(Ccarb…O3′Ado76 = 3.19 Å). Notably this product 
complex was also thermodynamically the most favorable of all obtained being 53.6 kcal/mol 
lower in energy relative to IIbRC, Figure 5.9. Collectively, the free energy values obtained 
for this pathway, both kinetically and thermodynamically, support the likelihood of the 
editing mechanism at least involving Cys182 as a water activating base. 
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5.3.2.2.2. Protonation of Ado763′O involving Cys182.  
The close proximity of the now neutral thiol of Cys182 to the Ado762′OH group suggests 
the possibility that Cys182 may be able to acts as the acid, with the assistance of the Ado762′OH 
group to protonated its adjacent Ado763′O center, Figure 5.8. However, such a process occurs 
via IIbTS22 and requires an energy of 26.7 kcal/mol relative to IIbRC, which is higher than 
obtained above for when Lys156 acted as the required acid. Furthermore, the resulting 
product complex IIbPC2 is less favoured than IIbPC1 being only 16.7 kcal/mol lower in energy 
than IIbRC. Thus, the Lys156 residue is kinetically and thermodynamically preferred as the 
required acid. 
 
5.3.2.3. Activation of Cys182 by His73, in the presence of a protonated or neutral His186. 
 It has been suggested that at least part of the role His73 may be to activate, deprotonate, 
the thiol of Cys182.28 In this scenario both Cys182 and His73 would necessarily initially be 
neutral, while His186 maybe either protonated or neutral. For completeness, both possible 
scenarios were examined; that is, we examined possible mechanisms which being with 
activation of Cys182. For the case in which initially both His73 and Cys182 are neutral but 
His186 is protonated the optimized structure of the pre-reactive complex lies 10.3 kcal/mol 
lower in energy than IIaRC; the reactive complex formed after activation. Furthermore, 
proton transfer from the thiol of Cys182 onto His73 occurred with a barrier of 21.6 kcal/mol. 
While this barrier is feasible, the previously described subsequent editing mechanisms that 
proceed via IiaRC (Figure 5.6) all have markedly high barriers that are likely enzymatically 
unfeasible. This proposal was thus discounted. 
Alternatively, His73 may activate Cys182 in the presence of a neutral His186, i.e., all 
three conserved residues (His73, His186 and Cys182) are initially neutral. The resulting free 
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energy surface for the mechanism elucidated, along with schematic illustration of the 
corresponding QM/MM optimized structures obtained, is shown in Figure 5.10. As before, 
the first step is deprotonation of the catalytic Cys182 thiol by His73;28 that is, the conversion 
of the pre-reactive complex IIcPRC into the required reactive complex IIcRC. This proton 
transfer occurs via , IIcTS1 with a required energy of 21.7 kcal/mol. Notably, this barrier is 
only 0.1 kcal/mol higher than obtained for the analogous step in the presence of a protonated 
His186 suggesting that it does not exert significant influence on the activation step. In the 
reactive complex IIcRC the Cys182 is now deprotonated while His73 protonated and His186 
remains neutral. Importantly, it lies just 0.4 kcal/mol higher in energy than the pre-reactive 
complex IIcPRC, Figure 5.10 
 
 
Figure 5.10. FES obtained (kcal/mol), together with optimized structures with select bond 
distances shown (Angstroms), for the ThrRS editing domain's mechanism IIc in which 
Cys182 acts as a base, but Cys182, His73 and His186 are all initially neutral. 
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In IIcRC the Cys182 thiolate is hydrogen bonded to an active site water (W1), 
r(Cys182S…HW1) = 2.04 Å. The latter moiety W1, as observed in the other mechanisms 
examined herein, is also positioned in reasonable proximity to the substrate's Ccarb center with 
a W1O…Ccarb distance of 3.22 Å. As in the previous scenarios, the thiolate of Cys182 facilitates 
nucleophilic attack of W1 at the substrate's Ccarb center by simultaneously abstracting a 
proton from W1. In this present chemical system, this step proceeds through IIcTS2 at a cost 
of 27.9 kcal/mol (Figure 5.10). This is in fact the highest barrier obtained of all mechanisms 
considered herein for the formation of a tetrahedral intermediate complex. Notably, it is 18.0 
kcal/mol higher than that obtained for the corresponding step in the most preferred model 
IIb (i.e., IIbTS1; Figure 5.9).  
The oxyanionic tetrahedral intermediate formed, IIcIC, is 16.7 kcal/mol higher in energy 
than the initial pre-reactive complex IIcPRC. The second and final step is cleavage of the 
Ado763′O—Ccarb bond. This is again found to preferentially occur simultaneously by a water-
mediated proton transfer from Lys156 onto the Ado763′-oxygen. This reaction proceeds via 
IIcTS3 and requires just 8.4 kcal/mol with respect to IIcIC; 25.1 kcal/mol relative to IIcPRC. 
In the product complex IIcPC the now hydrolysed non-cognate serine and tRNAThr are 2.84 
Å apart. In addition, it's formation is thermodynamically favoured having a relative energy 
of -43.2 kcal/mol. However, while this is therefore clearly an exergonic mechanism, and 
more favourable than some of the alternative pathways considered, its barrier for the rate-
limiting step in this case is thermodynamically less favorable than that of the preferred 
mechanism, IIb1 (see Figure 5.9). 
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5.4 Conclusion 
In this study we have performed an extensive systematic MD and QM/MM investigation 
on the post-transfer editing mechanism catalyzed by the editing domain of ThrRS from 
Escherichia coli for deaminoacylation of mischarged Ser-tRNAThr. In particular, a range of 
possible scenarios have been examined in which either of the potential mechanistic bases 
His73 or Cys182 deprotonate an active site water to facilitate the latter’s nucleophilic attack 
on the substrate’s carbonyl center in a hydrolytic editing process. In addition, we examined 
the potential of a His73-promoted pathway involving a non-hydrolytic self-
cyclization/lactone formation. In total, the chemistry and feasibility of 11 different possible 
mechanisms, within different possible active site protonation states, were examined and 
compared. 
When His73 acts as the initial base five different mechanisms were considered in which 
it deprotonates either a nucleophilic water molecule (W1, resulting in hydrolytic editing) or 
the Ser-AMP substrate’s serinyl β-OH, resulting in lactone formation. For those pathways in 
which His73 activates W1 the mechanism essentially occurred in two stages: (i) nucleophilic 
attack of W1 at the Ser-AMP's Ccarb center to form a tetrahedral intermediate; and (ii) 
cleavage of the Ado763'O—Ccarb bond with protonation of the Ado763'-oxygen. The first stage 
is a common one-step reaction with a free energy barrier of 27.6 kcal/mol. For the second 
stage, several possible proton sources were considered. The most favorable pathway 
proceeded via a one-step reaction in which Lys156 protonates the Ado763'-oxygen through a 
second active site water molecule (W2) with a rate-limiting barrier of 33.4 kcal/mol. For the 
His73-promoted lactone formation pathway, deprotonation of the β-OH group with 
formation of the cyclic tetrahedral intermediate occurred with a barrier of 31.4 kcal/mol. The 
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rate-limiting step of this pathway, however, was cleavage of the Ado763'O—Ccarb bond at a 
cost of 32.8 kcal/mol. 
For the Cys182-base scenarios, three chemical models with varying combinations of 
protonation states for the conserved His73, His186 and Cys182 residues were used to 
investigate the feasibility of six possible mechanisms. As with the alternate His73-promoted 
hydrolytic editing mechanism, these occurred in two stages as above. Of all mechanisms 
considered herein, the most kinetically and thermodynamically feasible pathway was 
obtained when both His73 and His186 are in their neutral states, and Cys182 is in its thiolate 
form. The first stage of the mechanism, Cys182 activation of W1 and formation of the 
tetrahedral intermediate, occurs in one-step with a barrier of 9.9 kcal/mol. For the second 
stage, cleavage of the Ado763'O—Ccarb bond, the most favorable pathway also occurs in one 
step with Lys156 protonating the Ado763'-oxygen via W2 with a free energy barrier of 20.8 
kcal/mol. The resulting product complex, with a relative free energy of −53.6 kcal/mol with 
respect to its corresponding initial reactive complex, was also the most favored of all of the 
mechanisms. Hence, the present results support the conserved Cys182 residue as being in its 
thiolate form and acting as the required mechanistic base that initiates editing within the 
editing domain of E. coli ThRS. 
Importantly, given the noted similarities to the editing site of AlaRS and related enzymes 
that share the same catalytic motif, this mechanism may be more generally applicable. 
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6.1 Introduction 
 
The central role of the aminoacyl-tRNA synthetase (aaRS) family of enzymes is to 
catalyze the linkage of amino acids to their corresponding tRNA.1 For each existing amino 
acid there is an aaRS that catalyzes its coupling onto the cognate tRNA via two half-stepscoo 
all within their synthetic site: activation and acylation. First, the amino acid is activated via 
reaction with adenosine triphosphate (ATP) to form an aminoacyl-adenylate intermediate 
(aaAMP), followed by transfer of the aminoacyl (aa) moiety onto its cognate tRNAaa. 
Impressively, this loading process occurs with a misacylation error of ~1 in every 10,000 
reactions.3 Thus, aaRSs play a key role in the accurate translation of an organism's genetic 
code into proteins.2 Defects in the aminoacylation process can result in misfolded and thus 
incorrectly functioning proteins, which can eventually lead to disease states such as 
neurodegeneration.4 
Due to structural and chemical similarities between some amino acids it can be 
challenging for the synthetic site of aaRSs to achieve proper discrimination. Consequently, 
many exploit proof-reading (editing) mechanisms that selectively act against incorrectly 
activated amino acids or aminoacylated tRNAaa to degrade them, often back to their 
constituent components (Scheme 6.1).7 For example, several aaRS use a tRNA-independent 
pre-transfer editing mechanism (Scheme 6.1; reaction 3) whereby the aminoacyl-adenylate 
is hydrolyzed within the synthetic site.8 
However, pre-transfer editing is not always solely sufficient to ensure the necessary 
fidelity of aminoacylation, such as between isoelectric amino acids. Hence, an additional 
post-transfer correction (editing) mechanism is often employed using a distal active site.9 
Indeed, almost half of the aaRSs utilize post-transfer editing and thus behave as double sieve 
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models.10 In this proofreading mechanism, misacylated tRNAaa is shuttled to the editing site 
where the ester bond between the incorrect aminoacyl moiety and tRNAaa is cleaved 
(Scheme 6.1). Interestingly, a triple-sieve editing mechanism is used by alanyl-tRNA and 
prolyl-tRNA synthetases to ensure accurate aminoacylation.11 
 
 
Scheme 6.1. Schematic representations for the aminoacylation and editing mechanisms 
employed by ThrRS. 
 
For instance, threonyl-tRNA synthetase (ThrRS) is a class II synthetase that must 
necessarily discriminate between its cognate substrate threonine from the non-cognate 
substrate serine. It is known to utilize a variety of editing mechanisms including pre-transfer 
editing against serinyl-adenylate.7,12-13,14 Unfortunately, such editing is not sufficient to 
achieve the necessary required high fidelity. With the exception of mitochondrial ThrRS, 
bacterial, eukaryotic and archaeal ThrRS all possess a remote active site for post-transfer 
editing.13 It is generally accepted that the editing domain sequence of ThrRS is not 
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possess a universal editing domain found in both Thr- and AlaRS, archaeal ThrRS employs 
a unique N-terminal post-transfer editing region.14 Accordingly, two different catalytic 
scenarios have been suggested for the respective editing mechanisms in bacterial/eukaryote 
and archaeal ThrRS. In the post-transfer editing mechanism of E. coli (bacterial) ThrRS,14 
an active site cysteinyl15 or histidyl10 residue is thought to act as the base that deprotonates 
the nucleophilic water and initiates the reaction. 
In contrast, the editing mechanism of archaeal ThrRS is thought to be a paradigm for 
most of the editing domains in the other aaRSs.16 Moreover, previous sequence analysis 
demonstrated a substantial sequence similarity between the archaeon Pyrococcus abyssi 
ThrRS (Pab-NTD) and D-amino acid deacylases (DTD).17,18 The latter domain is used by 
aaRSs responsible for hydrolyzing misacylated D-aa-tRNA, thus preserving the 
homochirality of proteins.19 The activity of this enzyme is extended to all the tRNAs 
misacylated by a D-amino acid 46 Given their similarities, Pab-NTD ThrRS has been shown 
to be capable of accommodating several D-amino acids, and thus is proposed to complement 
the role of DTD in ensuring protein homochirality.3,20 
For Pab-NTD, due to the apparent lack of direct involvement of the enzyme residues in a 
way that could facilitate catalysis, post-transfer editing has been suggested to take place 
through a substrate-assisted mechanism.3,7 In particular, based on experimentally obtained 
structures, the free hydroxyl group of the adenosine ribose sugar of the tRNA (Ado762′- or 3′-
OH for class I and II respectively),  appears to be the only potential base in close proximity 
to the substrate's scissile ester bond. Furthermore, a significant inhibition in editing has been 
observed upon its removal.10,21 Thus, it has been suggested that the Ado762′-OH or Ado763′-OH 
group of the substrate (aa-tRNA) triggers the reaction by orienting a nucleophilic H2O 
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molecule in close proximity to the aa-tRNA ester bond, i.e., the Ado762′-/3′-OH group plays a 
structural or anchoring role.10 However, the precise role played by this hydroxyl group is still 
debated. 
The post transfer editing mechanism for different aaRSs has been the subject of several 
computational studies. For example, Tateno and coworkers22 performed a Molecular 
Dynamics (MD) study in order to identify essential residues in the editing mechanism of 
leucinyl-tRNA synthetases for removing the noncognate valine.22 A nucleophilic H2O 
molecule was observed to be consistently hydrogen bonded with the Ado763′OH group and in 
close proximity to the carbonyl carbon (Ccarb) of the substrate (Val-tRNAleu). Consequently, 
quantum mechanics/molecular mechanics (QM/MM) free energy simulations were 
performed to explore the reaction. It was concluded that it involves a self-cleaving hydrolytic 
mechanism assisted by the substrate's own Ado763′OH group.7,16 The hydrolytic editing 
mechanism of the mislinked alanine in the freestanding editing domain (INS) of prolyl-tRNA 
synthetases has also been explored using QM/MM calculations.23 Similarly, it was concluded 
that the Ado762′OH group is crucial for positioning the nucleophilic H2O for subsequent 
nucleophilic attack on the substrate's Ccarb center. 
In this current study, we have complementarily used both MD simulations and QM/MM 
methods to gain insights into the role played by the substrate's Ado762′OH group in the post-
transfer editing mechanism of Pab-NTD ThrRS. Similarities between the fully-substrate 
bound editing site and biocatalysts involving ribozymal catalysis were noted.24,25 In 
particular, the function of the free RNA hydroxyl group is either to appropriately position 
and anchor the nucleophilic H2O26 or to directly participate in the catalytic mechanism in the 
ribosome.27 Hence, the investigations were broadened to examine the applicability and 
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feasibility of analogous tRNA substrate-mediated pathways in the editing site of ThrRS 
including concerted and step-wise anchoring, and single or double proton shuttle 
mechanisms (Schemes 6.2 and 6.3). 
 
6.2 Computational Methods  
6.2.1 Molecular Dynamics Simulations 
The Molecular Operating Environment (MOE) program28 was used to prepare all 
chemical models for the MD simulations with the X-ray crystal structure of the editing 
domain of ThrRS from Pyrococcus abyssi with bound seryl-3'-aminoadenosine (PDB ID: 
2HL1)3 used as the initial template. The link nitrogen atom in the ester bond was replaced 
with an oxygen atom and the protonation states of all the residues were assigned according 
to the PropKa protonation tool implemented in MOE. All crystallographic water molecules 
were removed except for two positioned near the substrate. The model was then minimized 
using the molecular mechanics (MM) forcefield AMBER12. The complex was then solvated 
by adding a layer of water to 6 Å around the enzyme-ligand system, resulting in a system 
with total number of 11000 atoms. The generated chemical model was then submitted for a 
second MM minimization using AMBER12. 
The final complex was then submitted for an unconstrained 10 ns MD simulation using 
the NAMD program,29 with a time step of 2 fs under constant pressure and temperature until 
the system reached an equilibrium state. The generated conformations from this MD 
simulation were analyzed based on their root mean square deviations (RMSD) of the heavy 
atoms of their active site residues. The obtained RMSD values were then clustered and the 
most representative structure (with the most prominent conformation) was chosen for the 
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subsequent QM/MM calculations. This structure was then minimized using the AMBER12 
forcefield. Finally, a suitable chemical model for the QM/MM calculations was then derived 
by truncating the system to only include all residues and waters within 20 Å of the active 
site’s substrate (2000 atoms in total). 
 
6.2.2 QM/MM calculations 
To elucidate the proofreading mechanism, we utilized the hybrid ONIOM QM/MM 
approach30-31 as implemented in the Gaussian 09 suite of programs.32 This approach has been 
shown to be a powerful tool for examining many related catalytic mechanisms.33-34 The entire 
chemical model was divided into two subsystems based on their level of contribution to the 
reaction, Figure 6.2. The active region, high layer, was described using a quantum 
mechanical (QM) method while the remaining protein environment is treated using a MM 
method. 
 
 
Figure 6.1. Illustration of the high layer (QM region) of the QM/MM model used in this 
study. 
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The QM region, consisting of 88 atoms, included the substrate 3'-seryl-adenosine 
(SerAA), a model of serine bound to the A76 residue of tRNAThr, two H2O molecules and 
the backbone chain of Pro116 and Ala82 as they are thought to stabilize the accumulated 
negative charge on the oxygen atom (Ocarb) in the transition state. In addition, the R-group 
of Lys121 was included as it is thought to be important in orienting and positioning the 
nucleophilic H2O molecule in close proximity to the substrate’s ester group.7 In addition, 
Lys121 is also conserved in the editing sites of other aaRSs wher it is thought to play a similar 
role.35 Glu134 was also included in the QM region due to its role in positioning the substrate 
through a salt bridge formation with the substrate’s α-NH2.3 Indeed, mutation of either 
Glu134 or Lys121 dramatically diminishes post-transfer editing activity.3 To describe the 
QM region the density functional theory methods B3LYP.36 M062X and M06HF37 in 
conjunction with the 6-31G(d,p) basis set were used, while the AMBER96 forcefield38 was 
used to describe the surrounding protein environment, i.e, the low (MM) layer. 
Hence, optimized geometries and frequencies were obtained at the ONIOM(B3LYP/6-
31G(d,p):AMBER96) level of theory, as were the corresponding Gibbs free energy 
corrections (ΔGcorr). Relative energies were determined by performing single point energy 
calculations on the above optimized structures at the ONIOM(B3LYP/6-
311+G(2df,p):AMBER96) level of theory. Only the Ca centers in the low layer were held 
fixed, all other atoms being free to move during optimizations. 
It is important to note that all mechanisms were studied using three different DFT 
functionals; B3LYP, M062X and M06HF. In particular, we have evaluated the ability of 
these functionals to reliably and accurately describe the studied mechanisms and their 
thermochemistry, with the results summarized in Table 6.1. It was observed that the 
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mechanism was sensitive to the % of HF exchange-correlation (XC) included. The M06HF 
functional, that has the highest XC% contribution, provided a better kinetic description of 
the mechanism. It is also clear from this table that, M062X gave more reasonable energy 
values relative to B3LYP, in agreement with previous theoretical studies on ribozymal 
catalytic mechanisms.39-40 Thus, in the following discussion we will focus only on the data 
obtained using the M06HF functional to describe the QM region. 
 
6.3 Results and Discussion 
6.3.1. Concerted mechanism 
   Initially, the substrate Ser-AA in the optimized reactive complex (RC) was found to be 
positioned in the optimal orientation required for the subsequent nucleophilic attack through 
salt-bridge formation between the Glu134COO– group and the serine’s side chains (α-NH2 and 
the β-OH) at r(Glu134COO–…HOβSer) = 1.89 Å and r(Glu134COO–…H2NαSer) = 1.57 Å. More 
importantly, the nucleophilic H2O molecule (W) is also placed nearby the substrate in 
optimal position to interact with the ester bond, r(OW…Ccarb) = 2.93 Å, and the angle of 
nucleophilic attack (ÐOw…Ccarb––Ocarb) is 87.6°. The latter water molecule is held in this 
position through forming a strong hydrogen bond network with the main chain Ocarb of 
Pro116 residue, r(HW… OPro116) = 1.43 Å, the side chain of Lys121 residue, r(HW…NLys121) 
= 1.41 Å, as well as the Ado762′OH group,  r(HW…OAdo76) = 1.91 Å. Moreover, the Ocarb atom 
forms a moderately strong hydrogen bond interaction with the main chain −NH− of the Ala82 
residue at a distance of  2.15 Å. The hydrolytic mechanism is initiated by a nucleophilic 
attack of the oxygen atom of the water molecule (Ow) on the Ccarb of the substrate, leading to 
Chapter 6 
 148 
the formation of a new Ccarb−Ow bond. This is followed by cleavage of the ester bond, where 
the bridged oxygen (Ob) abstracts proton from the dissociated H2O molecule. 
 
6.3.1.1 Anchoring Mechanism: 
   In this mechanism, the nucleophilic H2O molecule attacks the Ccarb atom and its proton is 
instantly shifted toward Ob atom of the ester bond through a 4-membered ring transition state 
(ITS4), Scheme 6.1. The obtained free energy barrier for this step is found to be 32.7 
kcal/mol, which is quite a high barrier enzymatically, as a result of the geometrically 
constrained 4-membered ring. In this transition state, the substrate is positioned in a less 
productive hydrogen bond orientation relative to the main chain −NH− of Ala82 residue, 
which is required to stabilize the generated negative charge on the oxyanion. In this position, 
the Ocarb…HNAla82 interaction is now weaken at distances of 2.30 Å with 0.15 Å further 
relative to RC, Table 6.2 
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Scheme 6.2. Schematic illustration of the concerted mechanisms studied for: (a) the 
anchoring mechanism (4-membered ring); (b) proton Shuttle (6-membered ring); and (c) 
double-proton shuttle (8-membered ring). 
 
    ITS4 is followed by the formation of the product complex (PC1) where the Ccarb…Ob 
distance is drastically elongated to 3.07 Å. Obviously, the Ado762′O of the adenosine-leaving 
group is stabilized by forming a new (Ob––H) single bond with a length of 0.97 Å, whereas 
the departure of serine amino acid is facilitated by forming a new Ccarb––OHw1 bond with 
length of 1.32 Å.  Relative to the initial reactive complex RC, the product complex PC1 lies 
5.6 kcal/mol lower in energy suggesting a thermodynamically favorable product complex. 
The free energy surface for this concerted scenario is shown in Figure 6.1. 
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Figure 6.2. The optimized molecular structures for the obtained transition states (TSs) with 
selected bond lengths in Angstroms (Å). 
 
    Moreover, to better clarify the precise role for Ado762′OH group following the current 
anchoring pathway, we investigated the mechanism in the presence of the deoxy substrate 
Ado762′H group instead of Ado762′OH. Notably, the missing hydrogen bond between W 
molecule and the substrate’s Ado762′OH led to a negligible change in the position of the W 
molecule to the Ccarb by an increase of just 0.07 Å relative to the distance obtained in the 
wildtype RC. Identical to the RC, the W1 molecule is tightly held in this place by forming  
a strong hydrogen bond with the main chain Ocarb of P116 with a distance of 1.40 Å in 
addition to the presence of the conserved Lys121 residue (Ow1…HLys121) at a distance of 1.41 
Å. Also, the angle of the nucleophilic attack (ÐOw…Ccarb___Ocarb) is now 90.14°. Thereby, 
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the previously proposed role of the Ado762′OH group to align the nucleophilic W in 
appropriate orientation might be possible inaccurate. More interestingly, the obtained energy 
barrier for the 4-membered concerted mechanism was found to be even more favorable than 
the one obtained in the presence of the Ado762′OH group with energy value of 25.4 kcal/mole 
(data not shown). 
 
 
Figure 6.3. The calculated free energy surface in kcal/mol for the concerted mechanisms to 
cleave the ester bond of the mischarged Ser-tRNAThr using M06HF functional. 
 
      In order to fill this gap of understanding, an alternative mechanism that might provide a 
complete picture regarding the actual role of the Ado762′OH group in the mechanism has been 
explored. 
6.3.1.2 Proton-Shuttle Mechanism 
 
     In this pathway, the proton transfer to the leaving Ob atom is shuttled through the 
assistance of the bridging Ado762′OH group, see Scheme 6.1, and subsequently we rather 
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obtained a 6-membered cycle transition state, Scheme 6.1B. In fact, the 6-membered cycle 
formation/breaking mechanism in the ribosome studies is found to proceed with a lower 
energy barrier relative to 4-membered one.37 This preference is due in part to the presence of 
more hydrogen bonds and more productive angles for the protons transfer process. 
Importantly, the driving force for this kind of mechanisms is the development of low barrier 
hydrogen bond (LBHB), which is known to significantly contribute in facilitating many 
enzymatic catalysis.38 This type of LBHB interaction takes place when two atoms or more 
with similar pKa values form strong hydrogen bonds and thus can share a proton matching 
the geometry of our system. The optimized transition states with the important bond lengths 
for this mechanism (ITS6) are shown in Figure 6.2. The energy barrier for this step was 
found to be 26.1 kcal/mol, approximately 6.7 kcal lower than the value obtained in the 4-
membered one (ITS4) and hence enzymatically more feasible (Figure 6.3). In this ITS6, the 
developed negative charge on the oxyanion atom is stabilized through hydrogen bond 
formation with the amide linkage −NH− of the Ala82 residue at a distance of 2.05 Å which 
is 0.10 Å shorter and thus stronger interaction than the corresponding one in ITS4. 
 
Table 6.1. Calculated energy barriers in kcal/mol for the various mechanisms (represented 
by their transition state label) obtained at the ONIOM(DFT method/(6-
31G(d,p):AMBER96). 
 
DFT 
Method 
Transition State 
ITS4 ITS6 ITS8 II41 IITS14 IITS24 IITS16 IITS26 IITS26` 
B3LYP 31.1 34.8 48.5 49.3 41.9 45.6 40.3 43.1 36.2 
M062X 34.9 33.1 38.1 39.7 36.0 39.8 30.6 29.0 40.7 
M06HF 32.7 26.1 31.5 36.9 32.3 36.0 25.9 30.45 25.9 
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   In an effort to identify a lower energy barrier via better stabilization of  the oxyanion in 
ITS6, we attempted to provide extra hydrogen bond interaction as suggested before.39 
Specifically, we expanded our chemical model in the QM layer to comprise more residues 
(main side chain of His83 residue and an extra bridged H2O molecule), offering more 
hydrogen bond to the Ocarb atom, r(Ocarb…HH2O) = 1.80 Å. Reoptimization of the new 
complexes along the same concerted proton shuttling pathway did not lead to a considerable 
change in the energy barrier relative to the smaller QM model (data not shown). Thus, charge 
stabilization on the Ocarb atom does not contribute significantly in the obtained energy barrier 
in the system studied herein. 
 
   6.3.1.3 Double–Proton shuttle Mechanism 
      Notably, there are two water molecules trapped near the critical Ado762′OH group in our 
chemical model. Thereby, an 8-membered ring concerted mechanism is also explored in our 
investigation. Specifically, the proton transfer process from the nucleophilic W molecule to 
the Ado762′OH group takes place through a second bridged water molecule (double-proton 
shuttle mechanism), ITS8 in Scheme 6.2c. 
In contrast to ITS6, ITS8 costs a higher energy barrier with a value of 31.47 kcal/mol, Figure 
6.3 and Table 6.1 However, regardless of the increased number of hydrogen bonds involved 
in the proton transfer process in ITS8, it is less energetically favorable due in part to its 
geometric distortion, suffers from steric hindrance, Figure 6.2 Moreover, ITS6 has a quite 
strong hydrogen bond with more planar ÐOcarb__Ocarb…NHAla82 bond angle of 156.2° for the 
oxyanion stabilization; while the same angle in the case of ITS8 is found to be less productive 
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with value of 116.2°, (although r(Ocarb…NHAla82) = 1.87 Å), indicating a deviation of the 
substrate from the most productive orientation in the active site.  
    The optimized molecular structures with selected bond lengths for places where bond 
formation and bond breaking take place are shown in Figure 6.2. Comparing between the 
key bond distances in these three transition states, (ITS4, ITS6 and ITS8) it was noticed that, 
the most significant change in the geometry of the models corresponds to locations where 
bond forming and breaking takes place. Specifically, the Ccarb__Ob bond distance (r1) is 
mostly cleaved in case of ITS4 and ITS6 complexes with values of 1.79 and 1.65 Å 
demonstrating a late transition state while in the ITS8 the same bond is slightly cleaved at a 
distance of 1.48 Å. In agreement with this observation, we noticed the newly forming bond 
OW__Ccarb (r2) is more advanced in the case of ITS4 and ITS6 with distances of 1.53 and 1.48 
Å than its value of 1.61 Å in ITS8, Figure 6.2.  
 
6.3.2. Two-step Mechanisms 
       6.3.2.1. Anchoring Mechanism 
The accumulated negative charge on the oxyanion group in the transition states was thought 
to be the main reason for the overestimated barriers. As a result, an alternative step-wise 
mechanism was proposed through two subsequent steps with two 4-membered ring transition 
states along the pathway, Scheme 6.3, pathway a.35, 40-41  
   In the first step of this mechanism, a 4-membered ring (IITS14) is formed through a 
concurrent step of a nucleophilic attack on Ccarb and the proton of the W molecule is instead 
transferred to Ocarb atom. The latter proton transfer might provide more charge neutralization 
to the developed negative charge on the Ocarb atom, Scheme 6.3. This transition state leads 
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to a formation of diol intermediate complex (IC) where Ccarb atom forms two single bonds 
with two different OH groups (OHW or OHcarb). This intermediate complex is followed by a 
second proton transfer from one of the new hydroxyl groups to the Ob, stabilizing the leaving 
group in the product complex (PC1 or PC2) through another 4-membered transition states 
(IITS24 or IITS24′), Scheme 6.3. 
 
 
 
Scheme 6.3. Schematic representation for the two-step mechanisms studied involving a: (a) 
4-membered ring proton shuttle; and (b) 6-membered ring proton shuttles. 
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After exploring all these possibilities, the obtained barriers are found to be quite high, 
Table 6.1. Accordingly, the two-step anchoring mechanism is also kinetically inappropriate. 
Overall, the generated oxyanion is not the only factor that influences the obtained energy 
barriers; the constrained 4-membered ring transition state has a significant impact on the 
energy costs as noticed previously in similar chemical systems.36, 42 Subsequently, another 
two-step proton shuttle mechanism through a 6-membered cycle transition state has been 
considered, Scheme 6.3. 
 
     6.3.2.2 Proton-Shuttle Mechanism 
This proton shuttle mechanism is initiated by a proton shift from the Ado762′OH group to 
the Ocarb atom. Though IITS16, an advanced Ow…Ccarb distance (r2) at 1.31 Å is observed to 
represent a new bond formation. Importantly, the negatively charged Ocarb atom is further 
counterbalanced via the shuttled proton from the Ado762′OH group at Ocarb__H bond length of 
1.42 Å (r2), Figure 6.2. However, the energy barrier for this step is found to be 25.9 
kcal/mol, which is just 0.17 kcal lower in energy than the concerted one (ITS6). Indeed, the 
latter transition state is considered the most feasible step among the other transition states. 
The next step is the formation of the diol IC, which is identical to the previous one mentioned 
in the 4-membered step-wise mechanism. Afterwards, a second proton transfer process 
occurs from one of the newly generated hydroxyls of the IC to the Ob atom and then 
formation of product complex where the labile ester bond is cleaved and the serine is 
released, Scheme 6.3, pathway b. As we discussed earlier in the step-wise anchoring 
mechanism, there are two different possibilities for the reactions to move from the 
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intermediate IC into one of the product complexes PC1 or PC2. In the first possibility, the 
second proton shuttle step will take place from OHw hydroxyl group to the Ob atom though 
a cyclic 6-membered transition state (IITS26). A higher energy barrier than the first one with 
value of 30.5 kcal/mol is needed for this IITS26 to proceed. Alternatively, the second step 
proton transfer (IITS26′) occurred through a proton shuttle from the OHcarb atom to the Ob 
atom at a lower energy barrier with value of 25.9 kcal/mol, Figure 6.4. The obtained key 
distances for these two transition states are shown in Figure 6.2. Notably, the facile Ocarb__Ob 
bond (r5) is slightly cleaved to a distance of 1.58 Å in case of IITS6. Meanwhile the same 
bond is observed to be 1.87 Å in case of IITS26, indicating a late transition state. This 
significant difference in the bond lengths induces a geometric change in the surrounding 
residues; the negatively charged Ob center in IITS26′ is counterbalanced by forming a quite 
stronger hydrogen bond with the nearby Lys121 residue with the assistance of a bridged 
water molecule, r(Ob…HW1) = 1.46 Å. This hydrogen bond is not observed in the IITS26, 
which might be the reason for its higher energy barrier with respect to IITS26`. In addition, 
the accumulated negative charge on Ocarb atom, that is neutral in IITS26, is neutralized by the 
amide chain –NH– of Ala82 at distance of 2.42 Å in IITS26′. 
      The following step will be the generation of different product complexes according to 
the source of the offered proton to the leaving group as well as the position of the OH group 
in the releasing serine, Scheme 6.3. Both product complexes are thermodynamically 
favorable and lie at -5.8 and -2.3 kcal/mol in energy for PC1 and PC2 respectively. The 
obtained free energy surface for the optimized complexes along these pathways is shown in 
Figure 6.4. 
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Figure 6.4. The obtained free energy surface in kcal/mol for the most favorable step-wise 
mechanism occurring through a 6-membered ring transition state. 
 
Collectively, the post transfer editing pathway is believed to be more favored through a step-
wise proton shuttle mechanism from a kinetic perspective. Additionally, the two-step 
mechanism gave a slightly more stable transition state (IITS26) than the concerted one (ITS6), 
Table 6.1.  
6.3.3 D-amino acid deacylase function 
 
AaRSs play a central role in preserving the overall homochirality of the protein by 
discriminating between the enantiomeric species of the cognate L-amino acid against the 
noncognate D-amino acid.43 This homochirality is maintained by using another freestanding 
checkpoint called D-amino acid deacylases (DTD) responsible for hydrolyzing the 
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misacylated D-aa-tRNA.44,45 The activity of this enzyme is not restricted for specific tRNA, 
but is extended to all the tRNAs misacylated by a D-amino acid. Interestingly, previous 
sequence analysis demonstrated a substantial sequence similarity between the N-terminus 
motif in Pab-NTD ThrRS and DTD.44,45 As a result, Pab-NTD ThrRS was found to be 
capable of accommodating several D-amino acids, and thus is proposed to complement the 
role of DTD in perpetuating the homochirality.3, 46 To study the ability of the current editing 
model to hydrolyze the D-Thr–tRNAThr and function as a deacylase, we investigated the 
proton shuttle editing mechanism with D-Thr-AA as the substrate. 
 
 
 
Figure 6.5. The obtained free energy surface for the deaminoacylation of D-threonine by 
the editing site of ThrRS. 
 
Notably, the optimized IIIRC for this new complex shows that the nucleophilic W 
molecule is held in the optimal position required for nucleophilic attack, r(Ow…Ccarb) = 2.92 
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Å. Similar to the obtained geometry in RC in which serine is the substrate, W is oriented 
productively as a result of forming strong hydrogen bonds with Ado762′OH, the side chain of 
Lys121 and the main chain Ocarb of Pro116 with distances of 1.93, 1.41 and 1.43 Å, 
respectively. Following the concerted proton-shuttle mechanism where the rate limiting step 
is a 6-membered cycle transition state (IIITS6), we observed a kinetically favorable barrier 
with 29.2 kcal/mol with respect to IIIRC. The obtained bond distances for this transition state 
indicates a late transition state where the carbO__Ow bond is more advanced toward a typical 
single bond (1.48 Å) and the Ccarb…Ob bond is mostly cleaved at a distance of 1.65 Å. The 
substrate’s oxyanion group is stabilized through forming a moderately strong hydrogen bond 
with the main chain of Ala82 residue, r(Ala82NH…Ocarb) = 2.02 Å. Later, IIITS6 is followed 
by the formation of IIIPC where the ester bond of D-threonine-AA substrate is entirely 
cleaved, r(Ccarb…Ocarb) = 2.45 Å, and a new single OH bond is formed in the leaving group. 
The free energy surface for the correcting mechanism of D-threonine is shown in Figure 6.5 
Accordingly, the elucidated editing mechanism takes place through a kinetically feasible 
barrier if D-threonine is the substrate. This barrier is a strong precursor suggesting the 
possibility of the Pab-NTD editing model to employ the extra DTD function. Importantly, 
this editing pathway for eliminating the attached D-amino acid might be universal for the 
other DTD enzymes, which has substantial similarity to the one studied here. 
6.4 Conclusion  
 
To explore the post-transfer proofreading mechanism of the archaeal ThrRS editing site, 
we applied molecular dynamics (MD) and quantum mechanics/molecular mechanics 
(QM/MM) methodologies. Assessing three different DFT functionals; B3LYP, M062X and 
M06HF indicated the sensitivity of the computational models to the amount of XC% 
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included and the M06HF functional with a full-HF exchange functional resulted in the lowest 
energy barriers. 
After exploring different editing mechanisms, the obtained energy barriers of either the 
concerted or the stepwise mechanisms via the geometrically constrained 4-membered ring 
transition state are kinetically less favorable compared to the 6-membered ones. 
Interestingly, the role played by the Ado762′OH group to align the nucleophilic H2O molecule 
in close vicinity to the ester group is suggested experimentally, removing it during the 4-
membered ring mechanisms showed negligible differences in the calculated energy barriers. 
Significantly, the contribution of the Ado762′OH group in the proton shuttle from the 
nucleophilic water molecule to either the Ob (concerted) or Ocarb (two-step) dramatically 
decreases the energy barrier to 26.1 and 25.9 kcal/mol, respectively. Importantly, in a good 
match with the experimental results, the Ado762′OH group is found to necessarily trigger the 
correction mechanism. Additionally, using this elucidated mechanism, an extra deacylase 
activity of the editing site of archaeal ThrRS has been confirmed.  
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7.1 Introduction 
 
The accuracy of the genetic translation of RNA is of central importance for the proper 
functioning of the coded proteins and cell survival. This process is carried out by the 
fundamental aminoacyl-tRNA synthetases (aaRSs), enzymes that are noted for their 
remarkable precision.1 Importantly, any limitation in the fidelity of translation can result in 
fatal diseases including cancer.2-3 The entire family of enzymes is split into two main 
subclasses, class I and class II, according to structural differences in their catalytic sites.5 
Each of the twenty aaRSs is only responsible for the transfer of its native amino acid to the 
cognate tRNA. Therefore, a deeper understanding of the accuracy of the catalytic function 
of the aaRSs is a matter of growing interest.4   
The active site of the aaRS catalyzes a two-step process, namely amino acid activation 
and tRNA acylation. Initially, it juxtaposes both the amino acids and the ATP in a 
productive orientation for the activation step to occur. In this step, the carboxylate group’s 
oxygen atom of the amino acid nucleophilically attacks the phosphorous atom of the ATP 
molecule leading to the formation of aminoacyl-AMP and releases the inorganic 
diphosphate group (Scheme 7.1).6 The acylation step then takes place, whereby the amino 
acid is covalently attached to the terminal adenosine of the cognate tRNA, resulting in 
aminoacyl-tRNA.  
In fact, aaRSs perform their functions with a translation error rate of 1:10000, which is 
remarkable enough for aaRS to be known as the paradigm of molecular specificity.7 In 
order for the aaRS to achieve this outstanding specificity, their active sites recognize the 
corresponding amino acids and reject any larger or similar ones. However, it is a complex 
task for some of these enzymes to correctly distinguish their native amino acids and reject 
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the isosteric and isoelectronic noncognate ones.8 To ensure the high fidelity of the 
translation process, aaRS utilize numerous proofreading mechanisms including pre-transfer 
(removing the misactivated adenylate) or post-transfer (excluding the misacylated-tRNA) 
editing mechanisms.9-10  
The location for post-transfer editing to take place is a separate active site known as 
the editing domain.7 Meanwhile, the hydrolysis of the undesired aa-AMP intermediate can 
occur in several different places places.12 Firstly, the synthetic site might eject the 
misactivated aa-AMP substrate into the cytoplasm which then undergoes uncatalyzed 
hydrolysis.13 Alternatively, this hydrolysis might take place in the synthetic site by a 
tRNA-independent pre-transfer editing process. However, within the synthetic site is the 
most common location for pre-transfer editing pathway in aaRSs.  
Unusually, IleRS, a class I aaRS, seldom utilizes a tRNA-dependant pre-transfer editing 
mechanism.14-15 This atypical reaction contributes almost one-third to the entire editing 
mechanism employed by Escherichia coli IleRS. In fact, IleRS’s exclusion of the 
structurally similar valine takes place by employing both pre- and post-transfer hydrolysis 
processes.16-17  
In the pre-transfer tRNA-dependant mechanism, the misactivated Val-AMP is 
transferred from the synthetic site to the remote editing region and then the pre-transfer 
proofreading takes place. This suggestion was supported by a recent X-ray crystal structure 
of the misactivated Val-AMP substrate in the editing region of E.coli IleRS.18 Accordingly, 
it is suggested that the editing domain is the dedicated location that hosts all the different 
types of editing mechanism employed by IleRS in contrast to most of the aaRS.19 
Furthermore, it has been argued that IleRS is able to accommodate the homocysteine and 
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edit it before its incorporation to the tRNA to help prevent, for instance, cardiovascular 
diseases.20 In response, we explored the pre-transfer editing mechanism against 
homocysteine in the editing region of IleRS using a suitable X-ray structure (PDB ID: 
1WK8).18 
The class II aaRS seryl-tRNA synthetase (SerRS), which is responsible for the ligation 
of serine to the corresponding tRNASer, relies only on pre-transfer editing to discriminate 
against the misactivation of the noncognate and structurally similar cysteine and threonine 
aminoacids.21 Despite the lack of a separate editing region, the pretransfer editing in SerRS 
is sufficiently efficient as to achieve an outstanding level of discrimination.22 In particular, 
methanogenic archaeal SerRS contains a Zn(II) metal ion in its active site that is essential 
for substrate recognition.23 Moreover, SerRS is also responsible for charging the tRNASec 
with serine for the indirect biosynthesis of selenocysteine (Sec).24 
It is generally accepted that the active site of most aaRSs do not have a catalytic 
residue that can promote the reactions, and as a result a substrate-assisted mechanism is the 
most common scenario,25-28 although there are suggested exceptions.29 Importantly, a self-
cyclization mechanism has been suggested in the active sites of many enzymes to edit 
against the toxic homocysteine (Hcy).11 In this mechanism, one of the nonbridging oxygens 
of the phosphate group (O1p) of the aa-AMP substrate acts as the base that deprotonates the 
substrate's thiol. The resulting thiolate sulfur then attacks the sp2 carbonyl carbon of the 
substrate (Ccarb) and the resultant thiolactone is released, Scheme 7.1.30 Similarly, LysRS 
excludes misactivated ornithine-AMP in the form of ornithine-δ-lactam, by which the 
terminal ammonium group of the substrate was deprotonated and the resultant R-NH2 is the 
nucleophile.31 Consequently, the pre-transfer editing mechanism by IleRS against the 
Chapter 7 
 170 
unnatural amino acid Hcy, and SerRS against the non-cognates cysteine and threonine 
might follow the same pathway through self-cyclization mechanism.  
 
Scheme 7.1. The generally proposed self-cyclization mechanism in the pre-transfer editing 
against Hcy.11  
AaRSs are widely recognized as novel drug targets for different infectious diseases.32 
IleRS in particular has been identified as the target for the antimicrobial compound 
mupirocin, which is currently being used for treatment of both bacterial skin infections and 
the fatal parasitic infection African Trypanosomiasis.33-34 Essential to the development of 
new and more potent therapeutic drugs is a more complete understanding of how such 
enzymes may act against them.35-36  
In this study, we have computationally investigated the pre-transfer editing 
mechanisms of IleRS and SerRS against possible noncognate amino acids. In particular, the 
applicability of the common substrate-assisted self-cyclization mechanism for such 
reactions was examined. 
7.2 Computational Methods 
 
      2.1 Molecular Dynamics Simulations 
 
      We started our simulation by considering X-ray structures of each enzyme with bound 
substrate analogues, PDB ID: 1WK818 and 2CJ923, respectively. Using the Molecular 
Operating Environment (MOE) software37 we performed the required chemical 
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modification for each enzyme to mutate the substrate to its native form. The Val-adenosine 
monosulfate (AMS) analogue substrate in 1WK8 was changed to Hcy-AMP; the sulfur 
atom in sulphate group was mutated to the native phosphorous atom Hcy-
AMP…IleRS/tRNAIle. Moreover, in case of 2CJ9, the sulfur atom in the sulfate group of 
the Cys-AMS was mutated to phosphorous atom and three different models containing 
three different substrates naming Ser-AMP….SerRS/tRNASer and the noncognate Cys-
AMP…CysRS/tRNACys and Thr-AMP….SerRS/tRNASer have been prepared. The 
ionization states of all the residues have been identified based on the predicted pKa using 
the available tool in MOE. In each generated model, we have performed solvation using 2 
Å layer followed by MM minimization using AMBER12 forcefield. Later, the minimized 
systems were initially submitted for 100 ps equilibration from 0 to 300 K temperatures at 
constant pressure where tether ranges from 0 to 100 Å have been applied on heavy atoms.  
 
Figure 7.1. The selected residues treated in the QM layer in SerRS (left model) and in 
IleRS (right model). 
R353
R336
E355
C306
C461
N345
Zn(II) Cys-AMP
D328
P324
G325
Hcys-AMP
SerRS (PDB ID: 2CJ9) IleRS (PDB ID: 1WK8)
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Then, under constant pressure and temperature, each generated model was submitted 
for 10 ns MD simulation with a time step of 10 ps using the NAMD engine.38 The 
conformations generated from the MD simulations were then analyzed based on their root 
mean square deviation (rmsd) values which then clustered and the average structure with 
the most prominent conformation has been selected to be the representative model. Starting 
from this structure we derived our QM/QM chemical models after truncating it to include 
the first shell of the residues around the substrates. (Total number of atoms is 744 atoms in 
IleRS and 656 atoms in SerRS). 
 
   7.2.2 QM cluster and QM/QM calculations 
 
     To investige the validity of self-cyclization mechanism in the pre-transfer editing 
pathway in the studied models, the alternative hybrid ONIOM (QM/SE) scheme was 
used.39-40 In this approach, each system has been divided into two main subsystems 
according to their importance into the catalytic mechanism. The active site residues are 
considered in the high layer that is represented by DFT using the hybrid functional 
B3LYP41-42 as implemented in Gaussian 0943, Figure 7.1. Meanwhile, the surrounding 
protein environment is treated by semiemperical (SE) PM3 method instead of the standard 
QM/MM to improve the description of the coupling interaction.44 Indeed, this methodology 
has been noticed to be successful in exploring different catalytic mechanisms and Zn-
metalloenzymes in aprticular.45-47 In the case of IleRS, the QM layer comprises the Hcy-
AMP substrate, Asp328 residue that form a salt-bridge interaction with the amino group of 
the substrate as well as the backbones of Pro324 and Gly325 residues. In addition to four 
water molecules were added to stabilize the accumulated negative charges on the Ocarb and 
O2p during the progress of the reaction, total number of atoms in this layer is 84 atoms.  
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Meanwhile, the QM layer in SerRS contained the substrate, Arg353, Arg336 and 
Asn345 residues and two water molecules to help neutralizing the phosphate oxygens as 
well as Ocarb atom. Moreover, the tetracoordinated Zn(II) with its binding residues (Glu355, 
Cys461 and Cys306) have been added to the high layer due to the direct coordination 
between the substrate-NH2 group and the Zn(II) metal ion, total number of atoms in this 
QM layer is 107 atoms, Figure 7.1. Later, frequency analyses were also computed at 
ONIOM (B3LYP/6-31G(d,p):SE), which is the optimized level of theory, in order to 
ensure the nature of the stationary points and also to calculate Gibbs free energy (ΔGcorr). 
Relative energies were calculated by performing single point energy calculations at the 
ONIOM (B3LYP /6-311+G (2df,p): PM3) level of theory.  
To gain further details regarding the impact of protein environment on the behavior of 
the catalytic mechanism and the overall geometry of the active site, we have explored the 
mechanism using Quantum Mechanics cluster calculations.48 The QM cluster approach is 
known to be a successful tool for studying enzymatic reactions.49 In this approach, only the 
active site’s significant residues (which is identical to high layer of QM/SE system used 
herein) are considered in the cluster calculation. As described in the methods section, only 
the active site residues are excised and the remaining protein is omitted. Each residue was 
capped by adding a hydrogen atom to the respective carbon (143 atoms). Afterwards, 
single point energy calculations were performed using B3LYP/6-311+G(2df,p). Meanwhile, 
the frequency calculations were also performed at the optimization level of theory 
(B3LYP/6-31G(d)) to estimate the Gibbs free energy corrections (ΔGcorr).    
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7.3 Results and discussion 
 
     7.3.1 MD results 
According to our MD simulation on both IleRS and SerRS, the substrates were 
noticed to adopt a unique bent conformation in the active site. The aminoacyl-adenylates 
functional groups, i.e., the R–SH terminal of Hcy and Cys or the R–OH of Thr and Ser 
amino acids are in an optimum orientation for a proton transfer reaction to take place with 
the assistance of O1p of the AMP group. Figure 7.2 indicates the change in these distances 
along the 10 ns MD simulation as well as the adopted conformation for both Cys and Hcy 
in SerRS and IleRS, respectively. During 10 ns simulation run the average SHcy…O1p 
distances are found to be 3.58 Å, 5.53 Å and 5.39 Å for Cys-AMP, Thr -AMP and Ser-
AMP, respectively in the active site of SerRS, Figure 7.2A. In addition, the intramolecular 
distance between the R-S(O) group and the Ccarb atom is noticed to be 3.27, 2.87 and 2.86 
Å for Cys-AMP, Thr-AMP and Ser-AMP, respectively. Similarly, in the active site of 
IleRS, the average HcyS…O1p distance during the simulation run was found to be 4.54 Å 
while the HcyS…Ccarb is found to be 4.57 Å, Figure 7.2B. Accordingly, the active site 
pockets of IleRS and SerRS recognize all the substrates in a specific conformation required 
for the self-cyclization mechanism.  
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Figure 7.2.  The conformation adopted by the substrate as well as a plot indicating the 
change in selected key distances resulted from the MD simulation; A) for the Cys-AMP in 
SerRS and B) for Hcy-AMP in IleRS. 
7.3.2 QM/SE Investigations  
 
        7.3.2.1 Pre-transfer editing against Hcy-AMP by IleRS 
The first optimized model using QM/SE calculations for Hcy-AMP in the active site of 
IleRS suggested a less favorable orientation of the substrate, IRCHcy. In this state, the a-
H3N+ is hydrogen bonded to the nearby Asp328 residue with Asp328COO
-…N+H3 distance 
of 1.85 Å, Figure 7.3. Interestingly, the R–SH terminal of the Hcy-AMP substrate is not 
positioned nearby the O1p atom which is required for initiation of the reaction. 
Consequently, we performed a dihedral scan calculation around Cb__Cg bond to obtain a 
better conformation of the substrate for the pre-transfer editing mechanism to proceed. This 
dihedral scan cost a free energy barrier of 24.3 kcal/mol (ITS1Hcy) and lead to the formation 
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of IICHcy where the R-SH group of the Hcy substrate is tilted down to form hydrogen bond 
with the O1p atom, Figure 7.3. This hydrogen bond interaction is formed with the 
assistance of a bridging water molecule (W1) at HcyS(H) …OW1 and O1p…HW1 distances of 
2.15 and 1.69 Å, respectively, Figure 7.3.  
In this intermediate complex, the substrate is positioned productively for the 
subsequent concerted mechanism through a cyclic transition state ITS2Hcy. The O1P atom 
deprotonates the R-SH of the Hcy-AMP with the assistance of the mediating W1 and the 
thiolate group attacks the Ccarb atom of the substrate to complete the substrate-assisted 
mechanism with an energy barrier of 23.2 kcal/mol. Relative to the energy barrier required 
for ITS1Hcy, ITS2Hcy is more kinetically favorable and therefore the first transition state (of 
the dihedral scan) is the rate-limiting step. In ITS2Hcy the HcyS…Ccarb distance has 
shortened to 2.22 Å and concomitantly the Ccarb___Ob bond has significantly lengthened to 
1.72 Å. Moreover, in this late transition state the O1p atom becomes protonated by forming 
typical O1p__H single bond with a length of 1.01 Å. Also, it should be noted that the 
transient thiolate ion in this step is stabilized via the formation of moderately strong 
hydrogen bonds to the bridged W1 and another water molecule with distances of 2.17 and 
2.59 Å, respectively. Moreover, the negative charge on the O2P atom is also stabilized 
through hydrogen bond formation with a nearby water molecule with distance of 1.71 Å.  
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Figure 7.3. Optimized molecular structures during the studied substrate-assisted self-
cyclization mechanism in IleRS with selected key distances as well as free energy 
differences. The values in blue color obtained using QM-cluster calculations.  
 
In the product complex the homocysteine has formed a thiolactone, IPCHcy, which can 
then be released from the active site, Figure 7.3. Notably, this step is found to be exergonic 
as the IPCHcy lies lower in energy than IRCHcy at −24.6 kcal/mol. In this step, the 
HcyS__Ccarb distance is 1.78 Å, indicating a typical C__S single bond. Meanwhile, the 
Ccarb…Ob bond is entirely cleaved at 3.11 Å. The Asp328COO…H3NHcy salt bridge 
interaction is maintained during the reaction, demonstrating the importance of the Asp328 
residue in positioning the substrate for the reaction to proceed. After studying the same 
mechanism using QM methodology, the overall scenario is found to be kinetically feasible 
following the same two-step mechanism obtained in the QM/SE calculations, with 
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insignificant changes to the bond distances. This reasonable change in the interactions may 
be a result of the flexible geometry of the models when studied in the gas phase. We also 
explored the possibility that the bridged oxygen (Ob) could be the base that initiates the 
reaction. According to our QM calculations, the rate-limiting step is now the second 
transition state with an energy barrier of 45.9 kcal/mol, indicating an enzymatically 
unacceptable barrier (data not shown). Thus, the O1p atom is the initiator of the reaction.  
   
 7.3.2.2 Pre-transfer editing against Cys-AMP by SerRS 
The model generated from the initial MD simulation of the Cys-AMP…SerRS 
structure was submitted for QM/SE simulation. In the first optimized reactive complex, 
IIRCCys, the Cys-AMP substrate adopts a more linear conformation, unlike its orientation in 
the previous MD simulation. In this orientation, the Ocarb atom is hydrogen bonded to the 
amide NH2 of Asn345, r(NH2…Ocarb) = 2.41 Å. The O1p atom is stabilized by the 
formation of hydrogen bonds to the guanidine groups of two nearby arginine residues, 
Arg336 and Arg353; Arg363 provides two moderately strong hydrogen bonds with 
distances of 2.44 Å and 1.85 Å while a single hydrogen bond with distance of 1.75 Å is 
provided by Arg353, Figure 7.4. Considering the charge stabilization around the O2P atom, 
the O1p is relatively less susceptible to hydrogen bonding interactions except for the 
formation of two hydrogen bonds with two different water molecules, r =1.85 and 1.75 Å. 
The O1p atom is thus more basic and hence more likely to act as the base. The Zn(II) ion 
adopts a tetracoordinate geometry where the N atom of the substrate’s a-NH2 occupies the 
fourth coordinated ligand with distance of 2.15 Å. Notably, this geometry is maintained 
during the progress of the reaction. Similar to the self-cyclization mechanism of Hcy-AMP 
in the editing site of IleRS, the overall mechanism occurs through two main steps. Initially, 
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a dihedral scan was performed around the Cb__Cg bond to obtain a more favorable 
orientation of the CysSH group for the substrate-assisted mechanism. Then, the 
deprotonation/nucleophilic attack of thiolate group onto the Ccarb to form the cysteine 
thiolactone, Figure 7.4.  
 
Figure 7.4. Optimized molecular structures along the studied substrate assisted mechanism with 
selected key distances when Cys-AMP is the substrate in IleRS.  
Owing to obtain more favorable position for the nucleophilic attack to take place, the 
IIRCCys complex is then submitted for dihedral scan calculation which noticed to be barrier-
lees with an energy of −8.1 kcal/mol, IITS1Cys in Figure 7.5. This remarkable low barrier 
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demonstrated the strong preference of the Cys-AMP to adopt the telted conformation for 
the pre-transfer editing mechanism to occur.  
Later, is the formation of the intermediate complex IIIC1Cys where the substrate is in 
more reactant-like orientation, Figure 7.4. This intermediate complex lies at −5.7 kcal/mol 
relative to IIRCCys supporting the feasibility of this intermediate, Figure 7.5. 
The binding orientation of the Cys-AMP enables the Cys-SH group to be in direct 
interaction with the O1P atom of the substrate, r(CysS-H…O1p) = 2.89 Å, while maintaining 
the other hydrogen bond interactions with the substrate, Figure 7.4. This IIICCys is 
followed by a concerted transition state, IITS2Cys, where an intramolecular deprotonation of 
the thiol group by the O1p atom is accompanied by nucleophilic attack on the Ccarb atom, 
Figure 7.4. This step was found to be rate limiting with an energy barrier of 14.6 and 20.4 
kcal/mol relative to IIRCCys and IIIC1Cys, respectively, Figure 7.5. Accordingly, the 
proposed pre-transfer editing in SerRS against the noncognate Cys takes place through a 
kinetically feasible self-cyclization mechanism. In this transition state, the Ccarb…Ob bond 
is partially cleaved at 1.60 Å, while the S…Ccarb is partially formed at 2.12 Å, Figure 7.4. 
 Moreover, the hydrogen atom of the substrate’s R-SH group is entirely shifted towards 
the O1p atom, r = 0.98 Å, indicating a late transition sate. Arg336 and Arg353 are found to 
play essential roles in stabilizing the developing negative charge on the Ocarb and O1p 
atoms. Arg336 forms two hydrogen bonds with distances of 2.05 and 1.84 Å, while Arg353 
provides further charge stabilization to the Ocarb atom with a hydrogen bond distance of 
1.96 Å, Figure 7.4. All these factors may contribute to the obtained enzymatically feasible 
barrier. From this transition state is formed the product complex IIPCCys where the Cys 
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thiolactone is completely established and Ccarb has moved 2.97 Å away from the Ob atom. 
Notably, the Arg336 and Arg353 residues maintain their hydrogen bond interaction with 
the Ccarb and O2p atoms. Arg336 forms two moderately strong hydrogen bonds with 
distances of 2.13 and 1.79 Å to the Ocarb and O1p atoms, respectively. Similarly, the 
guanidine group of Arg353 forms hydrogen bond interactions at 2.03 and 1.74 Å, Figure 
7.4.  
 
Figure 7.5. The free energy surface of the self-cyclization mechanism in SerRS; the black, 
red and blue colored surface is for Cys-AMP substrate, Thr-AMP and Ser-AMP substrates, 
respectively.  
This IIPCCys is found to be thermodynamically favorable with an energy 3.6 kcal/mol 
lower than IIRCCys, Figure 7.5. The formation of this 4-membered cysteine thiolactone is 
thermodynamically less favorable than the formation of the 5-membered homocysteine 
thiolactone, which is likely to be a result of the geometrically constrained 4-memered ring 
versus the more favorable 5-memberd one obtained in the IPCHcy. 
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  7.3.2.3 Pre-transfer editing against Thr-AMP by SerRS 
 
As mentioned in the Section 7.1, the aminoacylation site of SerRS accommodates the 
native serine amino acid and edits against the structurally similar cysteine (Section 7.3.2.2) 
and threonine. Accordingly, we expanded our study to examine the validity of a self-
cyclization mechanism in the pre-transfer editing against the non-cognate Thr-AMP. 
Overall, the mechanism is noticed to be identical to the case of Cys-AMP and takes place 
through two main steps, Figure 7.6. The Thr-AMP is in the linear conformation in the first 
optimized structure, IIRCThr, similar to our observation of IIRCCys. Notably, the type of 
interaction between Thr-AMP substrate and surrounding residues is almost identical to the 
analogous Cys-AMP, Figure 7.6. The only significant difference between the two 
substrates is the absence of a hydrogen bond between substrate’s Ocarb with the nearby 
Asn345. The Zn(II) ion adopts a tetracoordinate, tetrahedral geometry with the substrate 
being the fourth ligand through its amino group, r(a-NH2…Zn) = 2.10 Å.  
The first step in the mechanism is the dihedral scan which was found to be kinetically 
accessible with an energy barrier of just 0.7 kcal/mol relative to IIRCThr, Figure 7.5. This 
scan process lead to the generation of a thermodynamically favored (−0.6 kcal/mol lower in 
energy than IIRCThr intermediate complex IIIC1Thr, where the Thr-AMP substrate adopts a 
bent conformation, Figure 7.6. In this conformation, the OH group of the substrate is 
directly hydrogen bonded to the O1p atom with distance of 2.26 Å. The following 
cyclisation step is initiated by intramolecular proton abstraction from the alcohol group by 
the substrate’s O1p atom and concomitant nucleophilic attack onto Ccarb to form a cyclic 
tetrahedral intermediate. The energy barrier for this step is 26.6 kcal/mol relative to 
IIIC1Thr indicating an enzymatically acceptable rate-limiting step, Figure 7.5. 
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In the product complex, IIPCThr, the Ob___Ccarb bond is cleaved entirely at 3.08 Å and a 
cyclic lactone derivative is formed, Figure 7.6. However, the formation of IIPCThr is 
thermodynamically unfavorable at 2.6 kcal/mol higher than IIRCThr which is 6.1 kcal/mol 
more than the IIPCCys, Figure 7.5.  
 
 
Figure 7.6. Optimized molecular structures of the studied substrate-assisted editing 
mechanism of SerRS with selected key distances in Å when Thr-AMP is the substrate. 
 
     7.3.2.4 The validity of pre-transfer editing against the cognate Ser-AMP 
 
Our calculation was further extended to include the native Ser-AMP substrate to 
investigate the difference between the cognate and the noncognate substrates in the self-
cyclization mechanism. Initially, the information obtained from our MD simulation did not 
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highlight any significant difference between them. Using the QM/SE approach, the first 
optimized model, IIRCSer indicates an identical binding geometry of Ser-AMP to the other 
non-cognate Cys-AMP and Thr-AMP substrates. The Ser-AMP substrate is positioned 
linearly in the active site and its a-NH2 group coordinates to the tetrahedral Zn(II) metal 
ion with distance of 2.11 Å. Moreover, careful investigation of the type and distances of 
interaction between Ser-AMP substrate and the surrounding environment indicates a 
negligible change during the progress of the reaction relative to the Cys-AMP and Thr-
AMP cases. 
Following the two-step substrate assisted mechanism, we have successfully identified 
all the structures along the pathway, Figure 7.7. The dihedral scan results in an energy 
barrier of 4.3 kcal/mol which is 12.5 and 3.6 kcal/mol higher than the required energy for 
the corresponding step in Cys-AMP and Thr-AMP, respectively, Figure 7.5.  
This IITS1Ser is followed by the formation of the IIIC1Ser where the serine’s OH group 
forms a hydrogen bond with the O1p atom of the substrate with distance of 2.12 Å, Figure 
7.7. Unlike the corresponding complex in the case of the non-cognate substrates, the IIICSer 
is thermodynamically higher in energy than IIRCSer by 7.4 kcal/mol indicating that this is a 
less favorable orientation for the Ser-AMP substrate relative to the linear one, Figure 7.5. 
Next is the deprotonation of the OH group of the substrate by the adjacent O1p atom 
and simultaneous nucleophilic attack of the incipient alkoxide on the sp2 Ccarb of the 
substrate, Figure 7.7. This step was observed to have a high-energy barrier at 31.5 and 24.1 
kcal/mol relative to its corresponding IIRCSer and IIIC1Ser, Figure 7.5. 
In fact, this is the highest energy barrier obtained among all the studied substrates, 
indicating the infeasibility of SerRS to edit out the cognate serinyl substrate. We tried to 
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explore any geometrical change which might be the reason for this significant difference in 
the energy barrier between CysTS and SerTS. Our careful investigations on the transition 
states demonstrate the identical binding of the substrates in both cases. Particularly, the 
exact same types of interaction with negligible change in the distances have been noticed, 
Figure 7.4 and Figure 7.7. Considering the difference in the pKa value between the Cys 
and Ser amino acids with the former being more likely to give its proton, this may be a 
considerable factor indicating the lower cost in energy to obtain IITSCys, Figure 7.5.  
In the product complex IIPCSer the cyclic serine intermediate is formed 2.97 Å away 
from the monoprotonated AMP. Interestingly, unlike our finding for the other substrates, 
the formation of IIPCSer is found to be energetically unfavorable and lies 17.7 kcal/mol 
higher in energy than the corresponding IIRCSer, Figure 7.5.  
Notably, relative to IIPCCys there is a significant change in the geometry of IIPCSer. 
Specifically, Arg353, which is known to have a stabilizing interaction with the Ocarb atom 
in both IIPCCys and IIPCThr, shows no interaction in IIPCSer, Figure 7.7. Instead, it forms a 
single hydrogen bond interaction with O2p atom with a distance of 2.18 Å. Accordingly, 
the pre-transfer editing against Ser-AMP is not enzymatically feasible from both a kinetic 
and thermodynamic perspective.  
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Figure 7.7. Optimized molecular structures along the studied substrate-assisted mechanism 
with selected key distances when Ser-AMP is the substrate. 
 
7.3.3. Self-cyclization mechanism using QM-only approach 
 
    To study the impact of treating the protein environment implicitly, we have utilized 
QM-only approach to study the same mechanism. Except for Asn345, similar models to the 
QM layer in the QM/SE model have been prepared with total number of 65 atoms. We 
successfully characterized all the intermediates and transition state along the pathways for 
the different substrates Cys-AMP Thr-AMP and Ser-AMP. Notably, due to the gas phase 
optimization utilized in this case, considerable change in the types of interaction between 
each substrate and the surrounding amino acids (data not shown).  
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Figure 7.8. The relative free energy surface of the self-cyclization mechanism in SerRS 
utilizing QM-only approach; the black, red and blue colored surface is for Cys-AMP 
substrate, Thr-AMP and Ser-AMP substrates, respectively.  
 
Despite these structural changes the obtained free energy surfaces (Figure 7.8) is 
quite similar to the ones obtained utilizing the more accurate QM/SE approach. The rate 
limiting step is found to be IITS2′ prior to the formation of the final product complex IIPC′. 
As for the QM/SE findings, the rate-limiting step for the self-cyclization of Ser-AMP is 
noticed to have the highest energy cost. Furthermore, the obtained intermediate complex 
for the Ser-AMP substrate is less thermodynamically stable relative the cases for the other 
non-cognate substrates. In all the studies cases, the product complex was found to be 
energetically favorable yet it is the least stable in the case of the cognate Ser-AMP 
substrate. Overall, the QM-only methodology could provide satisfactory estimations of the 
free energy surface in less time.  
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7.4 Conclusion 
 
    The pre-transfer editing mechanism in IleRS and SerRS has been extensively explored 
utilizing Molecular Dynamics, Quantum Mechanics/Semiempirical (QM/SE) and QM 
approaches. Our findings indicated that both enzymes employ self-cyclization mechanism 
to prevent the incorporation of the misactivated Hcy, Cys and Thr substrates. Our MD 
simulation demonstrated the tendency of all the studied substrates to adopt bent 
conformations in their corresponding active sites. Furthermore, in case of the editing of 
IleRS against Hcy-AMP, the rate limiting step is found to be the first transition state that 
involves a dihedral scan and costs relative free energy of 24.3 kcal/mol. However, in the 
case of the pre-transfer editing in SerRS, the rate limiting step is the second transition state 
with a concerted step of intramolecular proton shift from the R-SH/-OH group of the 
substrate to the substrate’s O1p atom and a concomitant nucleophilic attack on the sp2 Ccarb 
atom. This step has energy barriers of 26.0 and 14.6 kcal/mol for the non-cognate Cys-
AMP and Thr-AMP substrates, respectively.  
Meanwhile the same step is found to enzymatically infeasible if Ser-AMP is the 
substrate and a kinetic barrier of 31.5 kcal/mol was obtained. Additionally, the following 
intermediate complex in the studied substrate-assisted mechanism for IleRS (with the Hcy-
AMP substrate) and SerRS showed a relatively stable complex where the substrates adopt 
tented conformations suitable for the editing mechanism to proceed through self-
cyclization. Lastly, the generation of the cyclic product complex where the non-cognate 
amino acids and AMP are moved apart are found to energetically favorable except the case 
for the native Ser-AMP. Interestingly, omitting the impact of the protein environment 
during the QM only approach lead to a successful treatment of the mechanism and the 
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obtained free energy surface shows significant homology with the corresponding ones from 
the more accurate QM/SE methodology.  
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 8.1 Introduction 
 
   Due to increasing resistance against current antibacterial drugs, an urgent need to develop 
new antimicrobial agents for novel targets has arisen.1 Among the various enzymes used as 
antibiotic targets, aminoacyl tRNA synthetases (aaRS) have been widely validated as novel 
antimicrobial agents.1-3 AaRS are a ubiquitous family of enzymes that play a crucial rule in 
protein biosynthesis. Based on some differences in structural characteristics, this family of 
enzymes is divided into two main classes: class I and class II.4 AaRS catalyze the attachment 
of the cognate amino acid onto its respective tRNA through two main half-steps. Initially, 
the amino acid is activated by reacting with adenosine triphosphate (ATP), forming an 
aminoacyl-adenylate (aa-AMP), Scheme 8.1. Then, the activated amino acid is covalently 
attached to either the 2′- or 3′-OH group (based on the class) of the 3′-terminal adenosine 
(Ado76) of the corresponding tRNAaa. 
Insertion of a noncognate amino acid into a protein sequence will lead to abnormally 
folded proteins6 that directly trigger serious diseases such as neurodegeneration, 
tumorgenesis, and eventually cell death.7-9 Hence, for each amino acid there is a specific 
aaRS which must be able to discriminate between the structurally similar amino acids in the 
cellular pool to guarantee faithful translation; employing different proofreading functions in 
either their catalytic sites (pre-transfer editing) and/or in a separate editing region (post-
transfer editing).5, 10 Consequently, they are able to perform their task of aminoacylating their 
corresponding tRNA with outstanding fidelity; the mistranslation error is on the order of 10-
4.5 Since there are known structural differences between bacterial and human aaRS, 
inhibition of aaRS function in bacteria can be exploited to cause selective prevention of their 
growth and thus elimination of the infection.11 In particular, bacterial threonyl-tRNA 
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synthetase (ThrRS) is a primary antibiotic target that has been considered recently through 
the uncompetitive inhibitor Borriledin which inhibits the catalytic function of ThrRS through 
binding to a hydrophobic region near the active site.12 More specifically, upon binding it 
induces a conformational change in the adjacent active site and, as a result, obstructs the 
optimal binding of the substrate to the cofactor. In addition, ThrRS has been proven to have 
a significant function related to angiogenesis as antiangiogenesis action is observed upon its 
inhibition by Borriledin.13 However, the binding site of Borriledin is conserved in both 
bacterial and human ThrRS, and thus it lacks selectivity for the bacterial enzyme.14 
 
Scheme 8.1. Schematic representation of the general two-step aminoacylation mechanism 
catalyzed by aaRS. 
In contrast, the aminoacylation (catalytic) site does exhibit structural differences between 
the bacterial and human species. Hence, the alternative use of competitive inhibitors that 
bind in the catalytic site may display better selectivity for the bacterial enzyme.15 In such 
cases, binding of the inhibitor would render the cognate threonine unable to bind and hence 
the rate of aminoacylation would be significantly diminished. Most of these types of 
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inhibitors are naturally occurring compounds; for instance, the most clinically widely used 
aaRS inhibitor is mupirocin, a bacterial isoleucyl-tRNA (IleRS) synthetase inhibitor.16 Other 
naturally occurring inhibitors include indolmycin17 that acts against tryptophanyl-tRNA 
synthetase, cispentacin2, 18 that functions against IleRS and prolyl-tRNA synthetase, 
ascamycin2 that inhibits phenylalanyl-tRNA synthetase, and albomycin19 which represses 
serinyl-tRNA synthetase function. Another competitive inhibitor is β-Hydroxynorvaline 
(βHNV), an unnatural amino acid that differs by a single –CH2- group from threonine, has 
been experimentally shown to readily bind to the catalytic site of ThrRS.20-21 
A number of experimental studies have been performed to understand the catalytic 
activity of ThrRS as well as the main features of its active site.20, 22-25 It is well-known that 
its catalytic site contains an essential Zn(II) that adopts a penta-coordinated structure:20, 23 
binding to three enzyme residues (His385, His351 and Cys334) in addition to the threonine 
substrate's a-NH2 and β-OH groups. The noncognate substrate serine, also having a β-OH 
group, can bind in a similar manner to the Zn(II) metal atom and thus can be activated by 
ThrRS while valine cannot.26 Importantly, ThrRS appears to only recognize and activate 
amino acids that can form a Zn(II)-O-β interaction. The non-natural amino acid βHNV 
contains just such a substituent OH group and does bind within the active site Zn(II) in a 
manner similar to that of the threonine. As a result, ThrRS is unable to discriminate against 
it with high fidelty, and instead catalyses its activation and subsequent aminoacylation at a 
high rate; only 30-fold less than the cognate threonine.20 Moreover, ThrRS appears to possess 
no ability to edit against βHNV in either its aminoacylation site nor editing sites. As a result 
it is incorporated into the protein sequence, acting as inhibitor for its growth.21 
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Herein, we have performed detailed computational studies to gain deeper insights into the 
aminoacylation of βHNV within the synthetic site of ThrRS in order to more fully understand 
the required chemical characteristics to achieve proper inhibition. We have followed the 
same substrate-assisted concerted scenario elucidated by our group previously and shown in 
Scheme 8.1,27 using MD simulations in combination with detailed ONIOM(QM/MM) 
calculations.28 Furthermore, we investigated the active site-bound βHNV which may be 
helpful for designing potentially more potent analogues. To determine the most effective 
chemical conformation, we have considered the acylation mechanism for a systematic 
isomeric series of substrates, based on the position of the substituted ethyl relative to the 
substrate’s α-NH2 group. Moreover, since protein biosynthesis is a homochiral process, we 
have also investigated enantioselective translation of βHNV.29 Additionally, we have also 
performed an assessment on the performance of a variety of GGA density functionals to 
obtained reliable results. Finally, we performed further calculations to verify the critical role 
played by the Zn(II) in the active site by mutation with the structurally similar but larger and 
toxic Cd(II) which also has a closed shell. We then recalculated the relative free energy of 
the aminoacylation pathway in the presence of Cd(II). 
8.2 Computational Methods 
 
To prepare the βHNV chemical model with the right conformation, we compared between 
the chemical stability of three different possibility according to the orientation of the –C2H5 
group as in Figure 8.1. Notably, isomer b was found to have the lowest energy accordingly, 
the most stable amongst the other isomers followed by conformer c., Figure 8.1. Therefore, 
we mainly considered these two conformers for subsequent MD and QM/MM calculations. 
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Figure 8.1. Optimized structures of the different βHNV isomers with different orientations 
of the terminal methyl using the B3LYP/6-31++G(d,p) level of theory. 
 
8.2.1 Molecular Dynamics simulation: 
 
    Based on recent X-ray crystal structures (PDB ID: 1QF6) for the cognate threonine in 
ThrRS active site22 and previous studies done by our group, we adjusted the βHNV ligand 
orientation mimicking the Thr-AMP….ThrRS/tRNAThr template to obtain the βHNV-
AMP….ThrRS/tRNAThr Michaelis complex for the two conformers, a and b, Figure 8.1, 
using the Molecular Operating Environment (MOE)30 software package. The protonation 
states of the residues were assigned according to the protonation tool implemented in MOE. 
The two obtained models were solvated by adding a 2 Å layer of water molecules followed 
by molecular mechanics (MM) minimization using the AMBER12 forcefield until the root 
mean square gradient fell below 0.01 kcal/mol·Å. Under constant pressure, the generated 
structures were then submitted for 100 ps annealing equilibration from 150 to 300 K. Finally, 
the generated complexes were then submitted for 10 ns MD simulation with a time step of 2 
fs using NAMD engine.31 All simulations were carried out under unconstrained pressure and 
temperature and at a cutoff of 10 Å for non-bonded interactions and tether ranges from 0–
100 Å applied to the heavy atoms. Latter, we analyzed the generated trajectories based on 
their root mean square deviation (RMSD) differences. Clustering analyses were then carried 
a) b) c)
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out and a representative structure with the most dominant conformation for each complex 
was chosen for the subsequent analysis. Notably, after performing alignment analysis 
between these two representative models, we did not observe any considerable changes in 
the average distances for the most important interactions between the ligand and the 
surrounding active site residues. After superimposing the two active sites, an RMSD value 
of 0.31 Å was noticed, Figure 8.2. Thereafter, we minimized the representative models using 
the AMBER12 forcefield and then truncated them to generate our chemical models for the 
subsequent QM/MM analyses (see below). 
                                            
Figure 8.2. Overlay of the representative active site structures for the two substrate isomers 
(H atoms are omitted for clarity). 
 
8.2.2 QM/MM Investigations 
 
The overall chemical structure is divided into two main subgroups within the active site 
based on their importance to the catalytic mechanism applying the ONIOM formalism32-34 
as implemented in Gaussian 09.35 The first subsystem is the chemically reactive region 
consisting of 129 atoms and described at a QM level. This region include the βHNV-AMP 
substrate, the Zn2+ atom and its three ligating residues, His385, His511, and Cys334, two 
glutamine residues (Gln484, Gln381), three positively charged residues, Arg363, Arg383, 
aaAMP%
Zn(II)%
H385%
H351%
C334% A76%
R363%
D383%
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Lys465, the adenosine76 of the cognate tRNAThr, and two water molecules. The second 
subsystem is the remaining environment and was modeled using MM (total number of atoms 
is 2283). The density functional theory B3LYP method,36-38 that has been previously 
demonstrated to give the best performance in the description of Zn mettalloenzymes,39 with 
the 6-31G(d,p) basis set was used to treat the QM region within the mechanical embedding 
(ME) formalism, while the AMBER96 force field40 was used to describe the MM layer. 
Furthermore, to estimate the sensitivity of the QM region to the amount of Hartree-Fock (HF) 
exchange-correlation included, we performed an assessment on the kinetic performance of a 
variety of GGA density functional (B3LYP* (15% HF contribution), B3LYP± (10% HF), 
BP86 (0% HF), and M06L (0% HF)). Moreover, in order to address the major limitation of 
the B3LYP functional in the description of vdW effects,41 we included Grimme’s DFT-D3 
empirical dispersion corrections.42-43 It has been found that including dispersion corrections 
enhances the reliability of the calculated energy barriers to better replicate experimental 
results.44 Thus, we reoptimized our complexes after including such dispersion corrections.. 
For all the ONIOM calculations studied herein, relative energies were calculated by 
performing single point energy calculations at the ONIOM (X/6-311+G (2df,p):Amber96) 
level of theory where X is the different functionals used for the optimization. To characterize 
the nature of the stationary point as well as to calculate Gibb’s free energy (ΔGcorr) and zero-
point vibrational energy (ZPVE) correction values, frequency analyses were computed at the 
optimization level of theory, i.e., ONIOM (X/6-31G(d,p):Amber96)-ME.  
8.3 Results and Discussion 
 
      8.3.1 Exploring the most enzymatically feasible isomer 
 
      In agreement with our previous calculations for the most dominant coordination state of 
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Zn(II),28 the first structure we obtained from our QM/MM optimization on the first substrate 
(case b in Figure 8.1) contains a tetrahedral coordinated Zn(II) metal ion where the βHNV-
AMP ligand is monoligated to it only through its α-NH2 group (bPRC). A high-energy barrier 
of 183.8 kJ mol-1 was obtained for the rate-limiting step; too high to be considered 
enzymatically feasible (data not shown). Alternatively, the Lewis acidity character of Zn(II) 
with the assistance of the unbounded Asp383 residue allows the substrate to be in its 
deprotonated form, a common behavior in many Zn-metalloenzymes.45-47 More specifically, 
we obtained alternative pre-reactive complex inside this active site which differs in the 
protonation state of  βHNV-AMP’s hydroxyl group, Scheme 8.1.28 This enables the βHNV-
AMP substrate to be bidentately ligated to the Zn with both α-NH2 and the β-O- groups. The 
latter observation is facilitated by the known flexibility of Zn(II) which can switch between 
coordination states.39, 48-49 Notably, the difference in energy between these two prereactive 
complexes (bPRC and PRC) is obtained to be just 0.74 kJ/mol and with a barrierless proton 
transfer process at -22.6 kJ/mol, Figure 8.3. In this starting from the structure of βHNV-
AMP with deprotonated hydroxyl group, we followed the same suggested scenario, where 
the subsequent step is the cleavage of the Zn(II)…NβHNV bond to form the reactive complex, 
RC. In this RC, the NβHNV atom forms a moderately strong hydrogen bond with the hydrogen 
atom of the Ado763'-OH group, r(βHNVN…H3'O)= 1.74 Å,  and the Zn(II) atom is then switched 
from pentacoordinated to tetracoordinate geometry whereas the βHNV substrate is 
monoligated to the Z(II) through only its deprotonated β-OH group, r(βHNVOZn)= 1.99 Å, 
Scheme 8.2. The optimized structures for the obtained transition states and product 
complexes with selected bond lengths are shown in Scheme 8.2. The free energy surface for 
the aminoacylation mechanism of βHNV-AMP is shown in Scheme 8.3. 
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Figure 8.3. The calculated free energy surface obtained at the ONIOM(B3LYP/6-
311G+(2df,p):AMBER96)+ΔGcorr level of theory for the overall acylation mechanism for the 
neutral form (red surface) and deprotonated form (black surface) of βHNV-AMP substrate. 	
Following this reactive complex, the reaction takes place through a concerted step where 
the Ado763'-OH is deprotonated, r(Ado763'O…H)= 1.52 Å, by the α-NH2 group of the substrate 
concomitant with nucleophilic attack of the Ado763'-oxygen on the Ccarb center, 
r(Ado763'O…Ccarb) = 1.88 Å, with an enzymatically feasible energy barrier of 90.2 kJ/mol. The 
next step is formation of the product complex, PC in which a single bond between the Ccarb 
and the now deprotonated Ado763'-O of the ribose sugar is formed, r(Ado763'-O…Ccarb)= 1.37 
Å. As part of the concerted step, this is synchronous with cleavage of bO…Ccarb bond as 
indicated by the 3.15 Å separation.  
Indeed, because of the complete proton transfer from the nearby Lys468 residue through 
a bridging H2O molecule to form a typical pro-RO-H single bond, the accumulated negative 
charge on the Opro-R atom has been partially neutralized, facilitating the release of the 
phosphate group as in the product complex PC, Scheme 8.2. This product complex lies 28.8 
kJ mol-1 lower in energy with respect to bPRC. 	
!22.6%
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90.2%
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159.6%
21.6%
TS1%
TS2%
PRC%
RC%
PC%
aPRC%
bPRC%
Chapter 8 
	 203 
Scheme 8.2. The optimized molecular structures with selected bond lengths for the obtained 
complexes in case of two different isomers. Blue colored values are for isomer (B) and the 
black text for isomer (A).         
 
 
Collectively, βHNV can be easily acylated in the catalytic site of ThrRS matching the 
experimental results.21 Moreover, we tested the possibility of acylation of the other 
conformations of βHNV-AMP (isomer a Figure 8.1). The optimized molecular structures 
with selected bond lengths for this conformation are shown in Figure 8.2. It is clear from 
this scheme that the types of interaction of these two isomers with the surrounding residues 
are almost identical in all the obtained complexes along the aminoacylation pathway. For 
clarity, an overlay of the active sites of the reactive complexes for the two conformations is 
shown in Figure 8.4.  However, following the same aminoacylation mechanism, the energy 
barrier for the proton transfer step where the neutral substrate (aPRC) is converted to its 
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deprotonated form (PRC) proceeded with a higher energy barrier than the first case with a 
value of 20.8 kJ/mol (TS1). In comparison with conformation b, this value is approximately 
45.5 kJ/mol higher in energy. More importantly, the rate limiting-step was obtained to occur 
through transition state with an enzymatically unfavorable energy barrier of 159.6 kJ/mol 
(TS2). The product complex (PC) lies 21.6 kJ/mol higher in energy with respect to aPRC; a 
relative energy difference of 50.4 kJ/mol, supporting the preference of only the first isomer 
to be acylated which might guide the experimentalists for developing more potent inhibitors.  
 
Figure 8.4. Overlay of the two QM layers of the reactive complexes for the two different 
conformations (a and b) of βHNV-AMP (H atoms are omitted for clarity). 
 
       8.3.2. An assessment on the performance of HF-XC: 
 
 Furthermore, we performed an assessment of a wide range of functionals to describe the free 
energy surface of aminoacylation given the b conformation of unnatural amino acid βHNV. 
Full reoptimizations were carried out using the functionals described in the methods section. 
Notably, the mechanisms underwent through a similar trend displaying negligible changes 
in the geometry; the bidentate substrate is more stabilized than the monodentate one. 
H385
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D383 D381
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Specifically, the prereactive complex (PRC) with the deprotonated βHNV-AMP substrate 
lies lower in energy than the corresponding neutral one by -5.47, -6.77, -6.62 kJ mol-1 for 
B3LYP*, B3LYP± and BP86, respectively. Continuing the calculation starting from PRC, 
we obtained the free energy surface for each functional, Figure 8.5. 
 
 
Figure 8.5. Free energy surface for the aminoacylation mechanism of βHNV using variety 
of DFT functionals. 
 
Notably, there is a good correlation between the amount of HF-XC included in each 
method and the respective energy barrier. The smaller the portion of %XC, the lower the 
energy barrier. Specifically, with respect to PRC (deprotonated substrate and thus 
pentacoordinate Zn(II) ion), the calculated free energy barriers are found to be 87.6, 77.8, 
61.8 kJ/mol, for B3LYP*, B3LYP± and BP86, respectively with BP86 to be most suitable 
functional to describe such systems kinetically. Although varying the functionals shows a 
dramatic impact on the energy barriers, the thermodynamic aspect is relatively unaffected 
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since the calculated energy differences of the product complex for each method are quite 
similar; -27.5, -26.8 and -25.1 kJ/mol for B3LYP*, B3LYP± and BP86, respectively.  
Overall, the coordination geometry of the Zn(II) ion in the all studied functionals changed 
typically from pentacoordinated in the case of a bidentate ligand (PRC) to tetracoordinated 
in RC and the obtained bond lengths in PRCs are almost identical, Table 8.1.  The latter 
geometry was found to be consistent until formation of the product complex, PC. The 
significant improvement in the obtained barrier was not a result of the representation of the 
Zn(II) binding environment.  
 
Table 8.1. The calculated bond lengths, in Å, for Zn(II) binding environment using different 
DFT functionals.  
 	
8.3.3. The impact of including dispersion correction on the PES: 
 
      Adding dispersion correction to the GGA functionals has been widely shown to reduce 
their limitations of describing long range interactions.50-51 The geometry of the obtained 
complexes were reoptimized using Grimme’s dispersion corrected B3LYP-D3 and BP86-
Functional Zn-C334 Zn-H351 Zn-H385 Zn-NH2 Zn-OH 
B3LYP 2.47 2.02 2.13 2.14 2.14 
B3LYP-D3 2.46 2.10 2.00 2.14 2.15 
B3LYP* 2.46 2.12 2.00 2.14 2.15 
B3LYP± 2.46 2.11 2.00 2.12 2.17 
BP86 2.45 2.09 1.99 2.19 2.19 
M06L 2.37 2.14 2.01 2.19 2.09 
B3LYP/LANL2DZ 2.49a 2.19a 2.09a 2.22a 2.09a 
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D3. Although there are slight differences in the interaction distances in the overall complexes, 
the calculated energy barrier for the acylation mechanism treated by B3LYP-D3 functional 
was found to be 93.3 kJ/mol relative to the PRC, Figure 8.6. Moreover, the energy of the 
formed PC was thermodynamically favored with value of -51.1 kJ/mol with respect to PRC. 
Therefore, the B3LYP-D3 method better represents our transition metal complexes and gives 
results that are more suitable kinetically as well as thermodynamically than B3LYP. Also, 
we performed the same calculation using BP86-D3. Typically, in comparison with BP86, 
including long range interaction correction greatly improves the description of the energy 
barrier to be 54.4 kJ/mol relative to the corresponding aPRC, Figure 8.6.  
Consequently, our system is found to be very sensitive to both the dispersion correction 
as well as the amount of XC% contribution in the utilized functional. Thus, we decided to 
investigate the behavior of the hybrid meta exchange-correlation functional M06-L. As one 
of Minnesota functionals, it was originally developed to approximately account for long 
range interactions through empirical parameterization.52-53 In addition, it has 0% HF 
contribution which was found to be reliable for describing systems containing transition 
metals.54 Using this functional to describe the mechanism under study, the resulting barrier 
was not as good as the one obtained using BP86, 128.1 kJ/mol relative to PRC.  
 
Figure 8.6. The obtained free energy surface for the acylation mechanism using dispersion 
corrected functionals. 
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However, the obtained product complex, PC, lies 25.2 kJ/mol lower in energy relative 
to PRC, Figure 8.5. The description of this functional for the Zn(II) complex interactions in 
PRC does not possess any marked difference in the distances relative to the other functionals, 
Table 8.1. To expand our study, we also assessed the performance of the effective core 
potential LANL2DZ basis set for the description of Zn(II), while the remaining atoms were 
represented by 6-31G(d,p). After reoptimizing the complexes, the obtained free energy 
surface for the acylation of βHNV-AMP is shown in Figure 8.5 and the energy barrier for 
the rate-limiting step increased slightly by to 101.7 kJ/mol with respect to bPRC which was 
described with a normal basis set. The generated PC is 24.9 kJ/mol lower in energy than 
bPRC. Although this basis set gave slightly less reliable kinetic energy in comparison with 
the common 6-31G(d,p) basis set, it provided us with a considerable barrier, supporting our 
mechanism at less expense computational time, certainly an advantage for TM complexes. 
In addition, by measuring the interaction distances between Zn(II) and the bound ligands, 
Table 8.1, the obtained values are very similar; more evidence supporting the use of 
LANL2DZ to describe this system.  
       8.3.4. Mutation of the active site’s Zn(II) to Cd(II):  	
To investigate whether the Zn(II) ion is essential, we determined the free energy surface 
for aminoacylation of βHNV replacing Zn(II) with the chemically similar Cd(II). 
Replacement with Cd(II) is expected to exhibit a great impact on proceeding with the 
proposed mechanism. Indeed, we used the GenECP methodology to treat the metal with the 
LANL2DZ ECP and the remaining atoms with the 6-31G(d,p) basis set, similar to the 
investigations above. Unlike the Zn(II) complexes, the ligand binds differently to the Cd(II), 
forming a unique prereactive complex, PRCCd, in an octahedral coordination geometry. In 
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this structure, the interaction distances with the other protein residues (His383, His351 and 
Cys334) are elongated and weakened, Table 8.1. Also, the β-OH group of the substrate 
remains neutral and forms a quite strong hydrogen bond with the nearby Asp383 residue, 
r(AspCOO–…HOβHNV) = 1.49 Å. However, this β-OH group is coordinated to the Cd(II), 
r(Cd…OHβHNV = 2.21 Å), Scheme 8.3. In addition to an active site H2O molecule that binds 
to Cd(II), r(Cd…OH2) = 2.34 Å, and becoming the sixth ligand in the octahedral geometry, 
PRCCd.  
Interestingly, in case of the reactive complex where r(βHNVN…HOAdo76) = 1.86 Å, the β-
OH group is deprotonated and it is now firmly binds to the Cd (II) atom, r(Cd…OHβHNV) = 
2.44 Å) and the Cd…OH2 bond is lengthened to 2.94 Å. For the rest of the obtained complexes 
along the reaction pathway, the Cd(II) is in a tetracoordinated geometry and the H2O 
molecule no longer binds to Cd(II). Following the same acylation mechanism, the energy 
barrier for the rate-limiting step of the mutant complex (TSCd) is observed to be 172.63 
kJ/mol, much higher than the one observed for the native Zn(II) complex, Scheme 8.3. 
To investigate the reasons for this high barrier, we superimposed the geometry of the two 
transition states (for the mutant and wild type enzymes) and there are no considerable 
differences; however, a distinct agreement in the obtained types of interactions was observed. 
The obtained high-energy barrier may be due in part to the change in the coordination 
geometry of Cd(II) from the 6-coordinate PRCCd to the 4-coordinate TSCd. 
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Scheme 8.3. Optimized molecular structures with selected bond lengths in Angstroms and 
relative energies (in parentheses; kJ/mol) for the obtained complexes in case of the Cd(II)-
mutant complexes.  
 
Similarly, the resulting PCCd is thermodynamically unfavorable, lying 59.7 kJ/mol higher 
in energy than PRCCd. Based on these results, we argue that the single mutation of Zn(II) to 
Cd(II) results in a drastic kinetic and thermodynamic changes in the free energy surface. 
Thereby, we have unveiled the pivotal role played by Zn(II) its presence is mandatory for 
the mechanism to proceed. Relative to Cd(II), the size of Zn(II) is small enough to bind only 
three residues, Cys334, His351 and His385, in addition to the substrate. Except for the 
substrate-binding mode, the tetracoordinated geometry obtained in the wildtype ThrRS 
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between the Zn and the protein residues was consistent during the overall mechanism, 
Scheme 8.3. 
8.4 Conclusion 
 
     Using MD simulations followed by ONIOM(QM/MM) calculations, we elucidated the 
aminoacylation mechanism of βHNV in the active site of ThrRS. In agreement with our 
previous studies, the substrate should be in its ionized form for the reaction to occur. 
Although two different conformations of βHNV-AMP bind in a similar manner to Zn(II) and 
interact similarly with the other residues in the active site of ThrRS, a specific conformation 
was found to be more kinetically favorable. This information is valuable in terms of 
understanding the chemical features of the unnatural βHNV that could compete with the 
cognate threonine for aminoacylation.  
Moreover, the accuracy of different GGA density functionals, namely; B3LYP (20% 
HF), B3LYP*(15%HF), B3LYP± (10%HF), BP86 (0%HF), and M06L have been assessed 
in terms of their reliability in providing reasonable energy barriers for our system. The BP86 
functional was found to be the most reliable kinetically and including dispersion correction 
(BP86-D3) improve its accuracy in description of the pathway kinetically. The less 
computationally expensive LANL2DZ was successful in representing the chemical reaction 
kinetically without any considerable changes in the Zn(II) coordination geometry. The 
importance of Zn(II) to promote the catalytic mechanism has been further verified by 
performing our calculations in a mutated complex (Zn(II) to Cd(II)). The calculated energies 
of the transition state as well as the product complex of the mutant are drastically increased, 
preventing progress of the reaction. 
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9.1 Introduction 
 
The fundamental aminoacyl-tRNA synthetase (aaRS) family of enzymes are well known 
by their vital role in protein biosynthesis1 in which they display exceptional catalytic 
fidelity.2 For each amino acid, there is a particular enzyme responsible for its 
aminoacylation to its corresponding tRNA.3-4 This family of enzymes is divided into two 
classes, class I and class II, which are based on the distinct architecture of the protein. Each 
class is comprised of ten amino acids.5 AaRSs catalyze aminoacylation processes in two 
steps, namely, activation and acylation. In the activation step, the amino acid reacts with 
adenosine triphosphate (ATP) forming an aminoacyl-adenylate intermediate (aa-AMP).6 
This step is followed by an acylation step in which the amino acid is covalently linked to 
its cognate tRNA through either the 2'- or 3'- OHAdo76 of the tRNA terminal adenosine, 
depending on the enzyme class, forming the aminoacyl-tRNA product.7  
In fact, it is well established that the accurate translation of amino acids is crucial for 
proteins to function properly. A high number of mistranslation errors can lead to misfolded 
proteins that promote many fatal diseases including neurodegeneration.8-9 Importantly, in 
order to perform this outstanding task, aaRS employ editing functions by pre- and/or post-
transfer proofreading pathways either in the synthetic site or in a remote editing domain.10-
11 Mitochondrial ThrRS harbors a pre-transfer editing mechanism to correct misactivated 
serine before it is linked to tRNAThr.12 However, archaeal and bacterial enzymes employ 
post-transfer correcting mechanisms in the editing domain to hydrolyze misacylated Ser-
tRNAThr.13-14  
On the other hand, due to growing antibiotic resistance towards present antibacterial 
drugs, it has become essential to expand pharmaceutical research toward discovering novel 
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antimicrobial targets.15 The inhibition of the bacterial aaRS activity results in restricting 
bacterial growth and thus eliminating microbial infection.16-17 Accordingly, aaRSs are 
accepted as targets in antimicrobial therapy.18 One of the most common pathways exploited 
to inhibit the function of bacterial aaRS is through competitive inhibitors that are able to 
bind firmly inside the corresponding active sites. These competitive inhibitors are 
analogues to the native substrates with similar or even stronger binding affinities and 
thereby diminish the natural activity of the enzyme.  
ThrRS is one of the primary antibiotic targets and a number of competitive inhibitors 
have been synthesized and experimentally identified.19 In this study, many of the 
synthesized inhibitors that exhibited potent binding affinity are able to chelate to the Zn(II) 
in a bidentate fashion, similar to the native threonine. This Zn(II) ion is a unique feature of 
the active site of ThrRS and adopts a pentacoordinate geometry with the remaining three 
sites being occupied by three protein ligands (His351, His385 and Cys334).20 Intriguingly, 
the Zn(II) ion has a central role in recognizing threonine and serine as well as rejecting the 
isosteric valine.21 Moreover, the unnatural β-hydroxynorvaline (βHNV), differing from the 
cognate threonine by an ethyl group instead of methyl, was experimentally shown to be a 
substrate for ThrRS.22 βHNV shares the same side chain groups as the cognate threonine 
which enables it to bind identically to the Zn(II) ion, preventing ThrRS from being able to 
discriminate against it.23  
Zn(II) is the second most abundant metal in enzymes and Zn(II) metalloenzymes are 
encoded by approximately 10% of the human genome.24 Among other characteristics, its 
ability to adopt a range of coordination geometries contributes to its remarkable ubiquity in 
biological systems. Most commonly, a tetracoordinate Zn(II) is observed.25. The role of 
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Zn(II) as a cofactor can vary from structural, where it stabilizes protein conformation, to a 
catalytic one where it is directly involved in the mechanism.26  
 
Our main objective in this study was to suggest competitive binders in the active site of 
bacterial ThrRS by conducting hybrid DFT calculations on numerous proposed ligands. 
Based on our knowledge of the required criteria for an excellent chelating group to Zn(II), 
we attempted to identify potential ligands. Initially, we focused on elucidating the specific 
role of Zn(II) in the discrimination mechanism performed by this active site. This 
understanding then enabled us to tune a variety of ligand sets looking for ideal chemical 
reactivity. This protocol is widely used in drug discovery for similar Zn-containing 
systems.27-29 In these studies, the main factor representing potency was the value of the 
binding energy (B.E) of the proposed ligand which is derived from the previous equation, 
Scheme 9.1.  
9.2 Computational Methodology 
 
We performed our calculations utilizing the M05-2X functioal30 and 6-31+G(d) basis 
set as implemented in Gaussian0931 for the optimizations of the complexes, except for 
Zn(II) where 6-311G(d) is used. Based on a recent benchmark study, M05-2X 
outperformed a list of other DFT functionals in describing Zn-ligand compounds.32 Also, 
CH3
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Scheme 9.1. The equation used to estimate the B.E, X and Y represent the chelating 
groups while K and M represent the Push-Pull substituents. 
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the overall optimization method was used successfully in similar calculations.28 Frequency 
analysis was conducted at the optimization level of theory to ensure the nature of the 
stationary points. The considered Zn(II) geometry included the first coordination sphere in 
which two imidazole rings and methanethiol were used to represent two histidine (His351, 
His385) and cysteine (Cys334) protein residues Scheme 9.1, respectively. Moreover, a 
library of ligands with terminal heteroatoms were constructed, Scheme 9.2. 
 
9.2.1 Docking Analysis  
 
      For  the initial model, the X-ray structure of Escherichia coli ThrRS (PDB code: 
1QF6)20 was docked with the ligand. Docking calculations were performed using the 
Molecular Operating Environment (MOE) software.33 Then the entire complex was 
prepared for the investigation through protonation and solvation (adding a 2 Å layer of 
water solvent molecules). The considered ligands were also minimized using molecular 
mechanics (MM) minimization utilizing the AMBER12 force field available in MOE.  
Using the induced fit protocol, the receptor is kept rigid in the native conformation with 
the studied ligands free to move. The most favorable binding modes were selected 
Thereafter, the generated series of poses were rescored using the London dG protocol 
where the most favorable scores, determined by estimating the corresponding binding free 
energy values, indicate the conformation that has the most favorable hydrophobic, 
hydrophilic, and hydrogen bond interactions.  
We modified the second rescoring step to retain 100 different poses, the maximum 
value available in MOE. This is followed by conducting forcefield refinements through 
energy minimization on the resulting poses from the previous placement stage.  During this 
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energy minimization stage, a cut-off distance of 6 Å in combination with fixation of the 
side chains of the receptor was applied to speed up the calculation. A dielectric constant of 
4 was used to represent the electrostatics of solvation and the final energy is then estimated 
using the generalized Born solvation model. Lastly, the second rescoring has been 
performed using the GBV1/WSA dG forcefield-based scoring function which evaluates the 
binding free energy of the ligand in each pose. Notably, during the two rescoring stages, 
any duplication in the produced binding (H-bonding or hydrophobic interactions) pattern 
has been eliminated. 
9.3 Results and Discussion  
 
     9.3.1 DFT calculations 
 
A small model to represent the ThrRS Zn-binding site was constructed for the 
subsequent calculations. It has been demonstrated that the presence of a Zn(II) metal ion 
with its Lewis acidic character in most Zn-metalloenzymes imposes a change in the pKa 
values of the binding ligands.34-35 Specifically, the pKa of the ligand decreases followed by 
a relative increase in the pKa of neighboring bases, facilitating the proton transfer from the 
ligand’s β-OH group to this base. Consistent with this hypothesis, the active site of ThrRS 
has an adjacent base residue (Asp383) not ligated to the Zn(II) and strongly hydrogen 
bonded to the β-OH group of the substrate. Thus, we initially performed our calculations 
considering two different analogues, 1-amino-2-propanol and 1-amino-2-propoxide to 
represent the native L-threonine in the neutral and deprotonated OH group forms, 
respectively.  
     Notably, the neutral ligand is observed to bind in a monodentate fashion to the Zn(II) 
through its amine group, and thereby the overall Zn(II) is tetracoordinate. Meanwhile, 
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deprotonation of the OH group in the ionized threonine analogue enhances its Lewis 
basicity and thus enables the substrate to bind in a bidentate fashion to the metal ion to give 
a pentacoordinated Zn(II). Indeed, the latter coordination is consistent with the native 
threonine’s binding mode in the ThrRS active site, according to a recent X-ray structure.21 
Notably, the estimated B.E. for the ionized ligand (1a) is markedly larger (-507.1 kJ/mol) 
than the corresponding value of the neutral one (1g), only -59.2 kJ/mol, Scheme 9.2.  
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 Scheme 9.2. The most promising ligands considered in this study with their 
corresponding estimated binding energies in kJ/mol (values between brackets). The 
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Similar to other Zn complexes, ThrRS is energetically favored to have an overall 
neutral charge for the complexation.25 One of the reasons for the preference of the 
pentacoordinate Zn over the tetracoordinated one is that the overall charge of the complex 
is neutral only in the pentacoordinate form. Subsequently, the proposed library of ligands 
in this study contains ionized heteroatoms allowing for the formation of a pentacoordinated 
metal ion,  Scheme 9.2. On the other hand, it is well established that aaRSs play a critical 
role in preserving the homochirality of the synthesized protein.36 It is possible that the 
active site has editing activity against D-amino acids and accommodates only the L-form. 
Moreover, ThrRS maintains this enantioselectivity by harboring a separate editing 
domain called amino acid deacylases (DTD). Its role is to hydrolyze any misacylated D-
threonyl-tRNAThr.37 Accordingly, we considered two different enantiomers of the threonine 
analogue in the studied model (1a and 1b) and the B.E. for each model has been calculated. 
Notably, the B.E. values vary according to the studied enantiomer and the most preferred 
configuration that gave the highest B.E. is (R)-1-amino-2-propoxide (1a) with value of 35.5 
kJ/mol higher than the other conformation (1b),  Scheme 9.2. In order to better describe 
this phenomenon, two additional ligands, with chirality α to the amine rather than the 
alcohol, have been examined (1c and 1d). Importantly, various B.E. values have been 
observed with preference of the S-enantiomer, 1c in Scheme 9.2.  
As previously discussed, the synthetic active site of ThrRS cannot adequately 
distinguish between threonine and the structurally similar serine even with the presence of 
Zn(II) as a cofactor. Consistent with this observation, we also investigated the binding of a 
serine analogue (2-aminoethanol), 1e, to the Zn(II) complex. The resulting B.E. is found to 
be slightly lower than the corresponding value of the threonine analogue with a small 
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difference of 2.4 kJ/mol. In fact, it is documented that the difference in B.E. between the 
two amino acids is only 4.2 kJ/mol.38 Arguably, the subtle added donating ability of the 
extra methyl group in the threonine analogue enriches the electron density on the chelating 
oxygen atom and subsequently strengthens its ability to bind to the Zn(II) atom.  
Importantly, a comparison between 1c and 1a complexes showed that the methyl group 
attached to an α-NH2 group has less impact on the obtained B.E. unlike when it is 
positioned next to the O– atom. In agreement with that, inserting an extra methyl group on 
to 1a close to the α-NH2 group, ligand 2a, does not enhance the binding capability, and thus 
has nearly no influence on the estimated B.E. (-515.6 and -514.3 kJ/mol for 1a and 2a). 
However, adding an NH2 group to the chiral atom in ligand 2d, with it inductive ability as a 
donor group, greatly improved the biding efficacy and resulted in a B.E. of -524.1 kJ/mol,  
Scheme 9.2. Generally, tuning the binding potency has been achieved by changing the 
electronic properties of the attached substituents and electron donating substituents are 
energetically favored. Furthermore, the binding of a β-HNV analogue has been studied, 2b, 
and the observed B.E is considerable with a value of -513.5 kJ/mol. This B.E. value is 2.1 
kJ/mol less than the cognate threonine analogue, reasonably indicating β-HNV can be 
recognized in the active site of ThrRS.22   
 Meanwhile, valine can be rejected easily from this active site due to its inability to 
bind to the Zn(II) in a similar fashion to the cognate threonine.39 Based on our analysis on 
the binding of valine, it coordinates only through its α-NH2 and this results in 
tetracoordinated Zn(II) ion. Importantly, it exhibits extremely low B.E. with value of just 
−44.0 kJ/mol indicating an exceptionally weak binding affinity to the Zn(II) atom, 
matching experimental observations.23, 39 According to a previous related study,28 another 
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set of asymmetric conjugated ligands have been analyzed, 2e, 2f and 2g. The B.E. 
increased by increasing the electron donating capability of the substituent group, the ligand 
2g giving the most favorable B.E. with value of -498.6 kJ/mol. However, all three ligands 
displayed a weaker binding ability relative to the B.E. of the threonine analogues.  
In light of these findings, different sets of ligands have been studied, 3a-3g in Scheme 
9.2.  Overall, unlike the previous study that demonstrated the remarkable binding ability of 
aromatic ligands, our work showed aliphatic cyclic rings have a better binding ability. By 
comparing between 3b and 3e, both 6-membered ring ligands, we obtained a difference of 
87.3 kJ/mol in the estimated B.E. with the aliphatic ligand much preferred. The reason for 
the weak interaction of aromatic ligands is partially due to the involvement of the lone 
pairs of the bonded heteroatoms in the conjugated system. Also, the binding strength of 3b 
improved by 16.9 kJ/mol to -431.8 kJ/mol after inserting a N atom close to the bonded 
oxygen atom, ligand 3a in Scheme 9.2. Importantly, we also considered the two aromatic 
ligands that gave the highest B.E. to histone deacylase,28 3c and 3d. According to our 
calculations, the proposed aliphatic rings (3e, 3f and 3g) exceeded these ligands in terms of 
their binding capability,  Scheme 9.2.  
Chapter 9 
 227 
 
Figure 9.1. Optimized complexes with key bond lengths in Å of the binding geometries of 
selected ligands to the Zn(II) coordination sphere. 
  
Furthermore, among the three different sizes of the aliphatic cyclic ligands studied, 6-
membered cyclic ligands have the most favorable B.E., probably due to their less strained 
geometry. Globally, aliphatic chains are still energetically preferred with respect to the 
values of the B.E.. The optimized complexes for selected ligands together with some key 
distances are shown in Figure 9.1. 
Two additional sets of compounds were also examined, 4a-4g and 5a-5f. Our goal was 
to determine which atom has the strongest binding affinity. In this series of ligands, 
Scheme 9.2, comparisons between the type of electron donors in the dative bond (amine, 
alkoxide, sulfoxide) and the electron donating/withdrawing ability of the substituents 
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(hydrogen, amine, cyano) were performed. These compounds were run as neutral and 
dianionic ligands. In case of the neutral ligands, 4a, 4b and 4c, ligand 4b with two oxygen 
atoms showed the highest binding affinity followed by 4c with terminal sulfur atoms. 
Interestingly, relative to the neutral forms, the B.E. of the corresponding ionized ligands, 
4d, 4e and 4g, increased drastically due to having two anionic terminal atoms. The 
dianionic species in general showed extraordinary binding ability (almost twice the B.E. 
value of the threonine analogue). Notably, the most favorable binding ability was found in 
the dianionic species with two oxygen donors, ligand 4g, Scheme 9.2. 
 In agreement with the former findings, push-pull substituents induce a change in the 
value of the estimated B.E.. Furthermore, when the strong electron withdrawing cyano 
group (–CN) was placed on the two main carbons in different combinations, a considerable 
reduction in the B.E. has been noticed. Placing two CN groups has a greater impact on 
decreasing the value of the B.E. than a single CN group, as it is explicit in 5d and 5a. Also, 
a comparison between 5a and 4b demonstrates the influence of single CN group on the 
chelating ability. In case of 4b, the B.E. is slightly diminished relative to 5a due to the 
presence of the NH2 group with the latter energetically favored. It is also interesting to note 
the higher B.E. values for the ligands with no EWGs, 4d, 4e and 4f, compared to the 
structures with one or more EWGs 5a-5e,  Scheme 9.2.  
      
 9.3.2 Docking Results 
 
We performed this investigation considering only the most favored warheads based on 
DFT calculations. The phosphate group in Thr-AMP is replaced by a sulfamoyl group to 
link the ligand to the adenosine moiety. The ligand is surrounded by a net of hydrogen 
bonds with Arg363 residue as well as the adenosine fragment is replaced by indazole. All 
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four ligands studied, 1a, 4c, 4e and 4d bound properly in the active site. More specifically, 
the adenosine analogue is sandwiched through different hydrogen bond interactions, the 
most conserved one with the carboxylic group of Glu365.  
 
Figure 9.2. Cocrystal structures of selected ligands docked in the active site of E. coli 
ThrRS. The estimated values of the B.E. in kJ/mol are shown in blue. 
1a!
4d!
-18.4!
-20.7!
4e!
5c!
-18.9!
-19.9!
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Importantly, all the ligands chelate to the Zn(II) ion in a similar fashion to the cognate 
threonine, Figure 9.2. The calculated binding free energy indicated that the proposed 
ligands are more potent than the native threonine. Furthermore, in agreement with our DFT 
calculations, 4d is the most potent ligand having the highest binding energy of -20.7 kJ.  
 
9.3.3 QM/MM calculation 
 
In previous work by our group40, we performed a detailed QM/MM investigation on 
the aminoacylation mechanism of threonine in ThrRS using the same DFT functional and 
basis set. Using the same chemical model, we expanded the current work to explore the 
binding efficiency of three suggested candidates using a QM/MM model. Specifically, we 
replaced the native substrate threonine with the three ligands that showed the best binding 
energies, 4c, 4f and 4g. After performing full optimization of the new QM/MM models, we 
noticed that the three ligands chelate to Zn(II) through the two heteroatoms, Figure 9.3. 
Similar to the native threonine, Zn(II) is pentacoordinate and the two systems showed 
remarkable stability. 
 
Figure 9.3. Optimized QM/MM models for the catalytic site of ThrRS with the bound 
substrates, threonine(1a-2), key residues considered in the QM layer have been hided for 
clarity. 
 
 
4f!4c!4g!
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9.4 Conclusion 
 
     Based on our DFT calculations, it was observed that the B.E. is a notable indicator of 
the discrimination mechanism that takes place in the synthetic site of ThrRS against the 
structurally related serine, valine, and βHNV amino acids. Moreover, the binding capability 
is strongly related to the chirality and the basicity of the ligated atoms. Relative to the 
neutral ligands, the deprotonated ligands display a remarkable binding ability as 
demonstrated by their corresponding B.E. values. Furthermore, the B.E. of the ligands with 
two deprotonated heteroatom terminals dramatically increased, with the symmetric one 
preferred. This understanding guided us to propose a series of potent ligands that could 
bind more efficiently to Zn(II) relative to the native threonine.  
Additionally, to verify the reliability of the proposed potent ligands, we performed 
molecular docking as well as QM/MM investigations on the selected ligands, further 
supporting our preliminary results. Overall, our findings inform about the essential 
characteristics required for competitive inhibition against bacterial ThrRS and will 
hopefully inspire development of novel inhibitors. 
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10.1 Conclusions 
    Using a variety of computational enzymology protocols, we have successfully clarified 
the mechanisms of the aminoacylation and editing reactions catalyzed by the fundamental 
aminoacyl-tRNA synthetases and valuable atomistic details regarding their chemistry have 
been identified.  
In chapter 3, we used MD and QM/MM methods to examine the role played by the 
Zn(II) ion and active site residues in ThrRS's ability to discriminate between its cognate 
substrate L-threonine, and the non-cognate L-serine, L-valine and D-threonine. The present 
results suggest that a role of the Zn(II) ion, with its Lewis acidity, is to facilitate 
deprotonation of the side chain hydroxyl groups of the aminoacyl moieties of cognate Thr-
AMP and non-cognate Ser-AMP substrates. In their deprotonated forms these substrates 
are able to adopt a conformation preferable for aminoacyl transfer from aa-AMP onto the 
Ado-3'OH of the tRNAThr cosubstrate. Relative to the neutral substrates, when the 
substrates are deprotonated with the assistance of the Zn(II) ion the barrier for the rate-
limiting step is decreased significantly by 42.0 and 39.2 kJ/mol for L-Thr-AMP and L-Ser-
AMP, respectively. An active site arginyl residue also plays a key role in stabilizing the 
build-up of negative charge on the substrate's bridging phosphate oxygen during the 
mechanism. For the enantiomeric substrate, D-Thr-AMP, product formation is highly 
disfavoured and as a result, the reverse reaction has a very low barrier of 16.0 kJ/mol. 
In chapter 4, the aminoacylation mechanisms of glutaminyl-tRNA synthetase (GlnRS) 
and the non-discriminating glutamyl-tRNA synthetase (ND-GluRS) have been investigated 
by employing MD simulation, QM-cluster and QM/MM calculations. Our investigations 
demonstrated the feasibility of a water-mediated, substrate-assisted catalysis pathway with 
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rate limiting steps occurring at energy barriers of 25.0 and 25.4 kcal/mol for GlnRS and 
ND-GluRS, respectively. A conserved lysine residue participates in a second proton 
transfer to facilitate the departure of the adenosine monophosphate (AMP) group. 
Thermodynamically stable (−29.9 and −9.3 kcal/mol for GlnRS and ND-GluRS) product 
complexes are obtained only when the AMP group is neutral. This substrate-assisted 
mechanism may be common to the structurally similar aspartyl-tRNA synthetase (AspRS) 
and asparginyl-tRNA synthetase (AsnRS). 
In chapter 5, we have explored multiple possible post-transfer editing mechanisms 
for ThrRS from Escherichia coli. The editing site is known to contain two conserved 
histidyl's (His73 and His186) and a cysteinyl (Cys182), all of which could act as the 
required mechanistic base. We have performed detailed molecular dynamics (MD) and 
quantum mechanics/molecular mechanics (QM/MM) studies in which the protonation 
states of each of these residues was varied. Furthermore, using the various substrate-bound 
active site models obtained, we have examined previously proposed and alternative 
possible mechanisms for deaminoacylation of Ser-tRNAThr by ThrRS in which His73 or 
Cys182 act as the base; 11 mechanisms in total. The present results suggest that the most 
feasible mechanism is obtained when both His73 and His186 are neutral, while the thiol of 
Cys182 is deprotonated and acts as a base. The resulting reaction was found to proceed in 
two steps. First, deprotonation of an active site water by the thiolate of Cys182 with its 
concomitant nucleophilic attack at the substrate's Ccarb center occurs with a calculated free 
energy barrier of 9.9 kcal/mol. The subsequent, and overall rate-limiting step, is a water-
meditated proton transfer from Lys156 to the Ado763′-oxygen resulting in simultaneous 
cleavage of the Ado763′O—Ccarb bond with a free energy barrier of 20.8 kcal/mol. 
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In contrast to bacterial ThRS’s editing site, discussed in chapter 5,  in archaeal 
ThrRS, it has been suggested that the substrate’s 2′OHAdo76 is the only available 
mechanistic base, which is the focus of the investigations reported in chapter 6. The 
suggested role of this 2′OH group was to promote the reaction by orienting a nucleophilic 
water molecule close to the scissile Ser-tRNAThr ester bond. In this study, we performed an 
extensive computational investigation, using both Molecular Dynamics (MD) and hybrid 
ONIOM Quantum Mechanics/Molecular Mechanics (QM/MM) methods, to consider all 
possible editing mechanisms. The results of our investigation show that the 2′OHAdo76 
group plays a crucial role; the editing mechanism was found to proceed step-wise via the 
formation of 6-membered ring transition structure. Moreover, the elucidated mechanism 
was found to be applicable for the D-amino acid deacylase activity that is exhibited by the 
same editing domain. Three different functionals were considered in this study and the 
M06-HF functional was found to give the most enzymatically feasible energy barriers.  
In chapter 7, we used MD, QM/SE and QM methodologies to provide atomistic details 
regarding the pre-transfer editing against the non-cognate homocysteine (Hcys) by 
isoleucyl-tRNA synthetase (IleRS) as well as cysteine (Cys) and threonine (Thr) by seryl-
tRNA synthetase (SerRS).  Notably, in the two enzymes considered herein, pre-transfer 
editing follows a substrate-assisted self-cyclization mechanism. This mechanism is found 
to take place via two main steps, a dihedral scan around the substrate’s Cb__Cg bond 
followed by a concerted R-S(O)H deprotonation and nucleophilic attack on the substrate’s 
carbonyl carbon. Notably, the rate limiting step to edit against Hcy-AMP by IleRS is the 
first step with an activation barrier of 24.3 kcal/mol. Meanwhile, the highest energy barrier 
obtained during the editing against Cys and Thr by SerRS resulted from the second step 
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with values of 20.4 and 26.6 kcal/mol, respectively. Interestingly, following the same 
pathway to investigate the possibility of pre-transfer editing against the native Ser-AMP by 
SerRS, an energy barrier of 31.4 kcal/mol was obtained indicating an enzymatically 
infeasible process.  Additionally, an agreement between the relative free energy obtained 
by QM/SE with the corresponding values obtained by QM-cluster one was observed.  
In chapter 8, using MD and QM/MM methodologies we elucidated the escape from 
the fidelity by the unnatural β-Hydroxynorvaline (βHNV), in the aminoacylation site of 
ThrRS. Due to the presence of Zn(II) with its Lewis acidity character, only the ionized 
form of βHNV results in an enzymatically feasible barrier. Furthermore, consisten with the 
homochiral behavior of this active site, we observed that there is a specific conformation of 
βHNV that could be aminoacylated. Benchmarking analysis was performed and our system 
was found to be responsive to the %HF as well as the dispersion correction included in the 
used density functional theory. Importantly, the BP86-D3 functional was found to be 
superior to all the studied functionals in representing the rate-limiting step kinetically. The 
importance of Zn(II) in the aminoacylation mechanism was further emphasized when its 
substitution with the chemically similar Cd(II) led to a dramatic increase in the energy 
values and thus, less feasible from both thermodynamic and kinetic perspectives.  
In chapter 9, detailed DFT quantum chemical study was conducted to examine the 
binding ability of various ligands to Zn(II) in ThrRS by comparing the value of the binding 
energy (B.E) for each ligand relative to the native substrate, threonine. Our screening 
investigation showed that the native threonine should ligate in a bidentate fashion to this 
Zn(II) which lead to the highest B.E. Thereby, the synthetic site of ThrRS rejects 
noncognate amino acids that cannot perform this type of interaction. Moreover, based on 
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their ligation to the Zn(II) and the obtained B.E values compared to the cognate threonine, 
many potent ligands have been suggested. Importantly, ligands with deprotonated warheads 
showed the highest binding ability. Further investigation on the selected ligands using 
molecular docking and QM/MM confirmed our initial findings of the suggested 
competitive ligands being able to bind efficiently in the active site of ThrRS. The suggested 
ligands from this study are potential candidates for competitive inhibitors against bacterial 
ThrRS. 
This research should enable mechanistic investigations on the rest of the crucial family 
of aminoacyl-tRNA synthetases. Several of the elucidated catalytic mechanisms can be 
generalized to other members of this family, and thereby future work will be to explore 
applicability of such mechanisms. Moreover, many other questions need further analysis, 
including the first step of activation mechanism as well how each enzyme recognizes its 
cognate tRNA. Eventually, these findings should provide significant insights into the 
outstanding chemical fidelity of these enzymes. Consequently, this understanding should 
open many novel routes to approach our long-term goal in establishing collaboration with 
many experimental leaders who are currently working on the biochemical analysis of 
aminoacyl-tRNA synthases. 
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